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Cerebral small vessel disease and motor performance
Cerebral small vessel disease (SVD) encompasses all the pathological processes that 
affect small vessels of the brain. Unlike large vessels, small vessels cannot yet be 
visualized in vivo; therefore, the term SVD is used to describe the spectrum of parenchyma 
lesions that are thought to be caused by these vessel changes, including white matter 
lesions (WMLs), lacunar infarcts and microbleeds (Box 1).  Cerebral SVD is very common 
in elderly people and has emerged as an increasing health problem in the ageing 
population. WMLs occur in 90% of individuals over 60 years of age.1 Lacunar infarcts, 
which are frequently associated with WMLs, are also an accepted part of the SVD 
spectrum and are found in 20% of these subjects.2 Recently, cerebral microbleeds have 
been  recognized as another manifestation of cerebral SVD.3,4 Their prevalence ranges 
from 5% among people without neurological diseases to 33.5% among patients with 
ischemic stroke.5 There is accumulating evidence that there are also pathological changes 
associated with SVD, which are “invisible” to conventional MRI, in white matter areas 
appearing normal on conventional MRI [the normal-appearing white matter (NAWM)]6 
and in cortical areas (e.g. cortical microinfarcts7,8 and atrophy9). 
In this thesis we use the term SVD to describe the cerebral lesions related to arterio(lo)
sclerosis and vascular risk-factors (including diabetes and hypertension10), which is by 
far the most prevalent form of SVD. Other forms are the hereditary cerebral amyloid 
angiopathies, and other hereditary SVD, such as cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy (CADASIL), and inflammatory and 
 immunologically mediated SVD, but they will not be discussed in the framework of this 
thesis.
Subjects with SVD may have acute symptoms, such as transient ischemic attacks or 
lacunar syndromes, but also subacute manifestations, of which cognitive decline and 
dementia are among the most studied ones.11 The clinical spectrum seems to extend to 
motor disturbances as well, such as isolated gait disturbances and parkinsonism, 
although this has not been investigated in great detail. As brain-imaging abnormalities 
often exist long before evident symptoms occur, and the onset of subacute symptoms is 
often insidious, it has been suggested that the term cerebral SVD (in clinical studies) 
should be based on the brain-imaging features, including WMLs and lacunar infarcts.12 
The neural control of motor performance in humans is based on the integrative function 
of a number of systems at different levels of the peripheral and central nervous system; 
peripheral receptors (sensory feedback), the spinal cord, such as the automated spinal 
locomotor pattern generators (automated programs for locomotion), supraspinal 
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structures (initiation and adaptation of the motor pattern to environmental and motivational 
conditions), motor nerves and the muscle system (execution of the strategies). In contrast 
to other animals, gait/motor performance in humans is significantly influenced by the 
supraspinal structures. Multiple brain regions, connected by white matter tracts, are 
involved in this supraspinal control of gait13 and other movements. 
Chapter 1.1
Box 1 Conventional MRI expressions of cerebral small vessel disease
White matter lesions
In cerebral SVD, a number of abnormalities can be observed 
with conventional MRI sequences, encompassing ischemic 
and hemorrhagic manifestations. 
WMLs are defined as white matter hyperintensities on 
T2-weighted sequences, such as fluid-attenuated inversion 
recovery (FLAIR) scans, which are not, or only faintly, 
hypo-intense on T1-weighted images. They range from 
small focal lesions to more or less confluent areas that 
are bilaterally and symmetrically sited in the hemispheric 
white matter. 
Lacunar infarcts
Lacunar infarcts are defined as foci with low signal intensity 
on T1- and T2-weighted images, ruling out enlarged 
perivascular spaces and infraputaminal pseudo-lacunes.32-34 
There is no full consensus on the size of lacunar infarcts; 
the maximum accepted diameter is 15 mm, because this is 
the size derived from the original pathological studies.32 
A consensus on the minimum diameter is more difficult to 
establish; we used a cut-off size of 2 mm.
Microbleeds 
Cerebral microbleeds are round or ovoid lesions, seen on 
gradient-echo T2*-weighted imaging as black lesions with 
a blooming effect, representing hemosiderin deposits.35 
They are mostly located in the basal ganglia or cortical-
subcortical areas. They must be distinguished from other 
potential mimics such as iron or calcium deposits, bone 
or flow voids. Various size cut-off points have been used 
to classify microbleeds, with a maximum diameter of 
5-10 mm.36
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It is thought that motor disturbances in subjects with SVD occur due to white matter 
tract disruption and hence disconnection of cortical-cortical and cortical-subcortical 
connections, although until now there is no proof for this assumption. An interesting 
finding is that individuals with SVD, even with an identical WML load, appear to have a 
variable expression with regard to their motor performance.14 Despite the high prevalence 
of cerebral SVD,1 only a part of these individuals have gait disturbances or (other) 
parkinsonian signs, such as bradykinesia, rigidity and tremor.15 
A more detailed understanding of the contribution of SVD to motor performance would be 
interesting for several reasons; first of all from a pathophysiological point of view. Secondly, it 
may be of clinical use in estimating the clinical impact of SVD found on MRI in an older adult 
referred for gait/motor problems (i.e. in deciding whether or not the patient’s motor disturbance 
is attributable to the vascular changes found on MRI, or whether other disorders should still 
be in the differential diagnosis). Thirdly, isolated mild gait disturbances or (other) parkinsonian 
signs might be considered as the beginning of a clinical continuum with severe gait 
disturbances and full-blown parkinsonism as the end-stage (in combination with dementia 
and urinary incontinence also called Binswanger’s disease), which are associated with 
functional impairment, institutionalization and death.16-19 If SVD prove to be highly associated 
with parkinsonian signs, this might open possibilities for intervention early on in this cascade, 
thereby delaying and ultimately preventing mild motor disturbances to progress to severe gait 
disturbances or parkinsonism. It would therefore be interesting to investigate this association 
among subjects with only mild to moderate symptoms, but without parkinsonism. Fourthly, in 
trials among subjects with SVD, there is increasing interest in the use of imaging parameters 
as surrogate markers for symptoms of cerebral SVD (e.g. cognitive and motor decline). It is 
thought that they might offer more sensitive outcome measures in future trials of disease-
modifying therapies than currently available clinical scales, and therefore will reduce the 
number of patients needed to demonstrate a treatment effect.20 However, the few studies 
investigating this issue mainly focused on cognitive decline,21,22 and did not take motor 
disturbances into account. 
Potential factors contributing to the variable 
association between cerebral small vessel disease 
and motor performance
There may be several explanations for the variable motor performance in subjects with SVD. 
Firstly, the severity of the WMLs and the number of lacunar infarcts could play a role. 
1
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Previous studies found an association between WMLs and motor performance14,23-26 and 
few studies investigated the association between lacunar infarcts and motor 
performance.24,27 Most of these studies did not investigate the relationship between WMLs 
and motor performance independent of the coexisting lacunar infarcts, and often used 
semi-quantitative estimates of WMLs rather than quantitative measures of WML volume. 
Furthermore, most previous studies used semi-quantitative clinical rating scales for the 
assessment of gait (thus measuring overall changes in global gait performance), whereas 
true quantitative assessment of various gait parameters could provide more insight into 
the different components of gait affected in SVD. 
Secondly, patients with motor disturbances could additionally have microbleeds, not 
visible on routine T1- and T2-weighted sequences. Although they were generally 
considered silent, some recent studies found an association between microbleeds and 
cognition.28-31 A potential relationship with gait performance has never been investigated. 
Thirdly, as mentioned earlier, SVD is often accompanied by cerebral atrophy. Although 
previous studies found that global cerebral atrophy is associated with gait disturbances 
in subjects with SVD,37 the specific role of cortical atrophy has only been investigated by 
one other research group in some regions-of-interest.38,39
Fourthly, not all WMLs are the same, but in fact reflect a wide spectrum of deficits in 
underlying white matter integrity.40,41 It could be that only WMLs with a high loss of micro-
structural integrity are related to gait disturbances. Furthermore, the microstructural 
integrity of the NAWM on conventional MRI, which is generally the largest part of the white 
matter,42 is damaged in some subjects with SVD.6 Damage to this part of the white matter 
could therefore contribute to the development of gait disturbances in some subjects with 
SVD. Only few recent studies, with relatively small sample sizes, have thus far investigated 
the association between the microstructural integrity of the white matter and gait.43,44 
Finally, the possible importance of the specific location of the abovementioned macro-
and microstructural abnormalities in the brain in the development of motor disturbances 
remains incompletely understood.
Novel MRI techniques
There has been substantial progress in the development of relatively new MRI techniques 
and post-processing methods to study the white and grey matter. An important step is the 
introduction of diffusion tensor imaging (DTI).45 DTI measures the magnitude and direction 
of water diffusion profiles, and, in this way, assesses the microstructural integrity of the 
white matter (Box 2), including the white matter appearing normal on conventional MRI. 
Chapter 1.1
17
1
General introduction
DTI is a MRI technique that measures the anisotropy (differences in the direction) in the 
self-diffusion of water molecules. In this way, it provides valuable information on the micro-
structural integrity of the white matter in the whole brain. Classical diffusion is the random 
(thermal) motion of molecules and is an intrinsic physical process that is totally independent 
of the MR effect of the magnetic field. It is a three-dimensional process (Figure A), which in 
vivo is limited by anatomical boundaries. Hence, molecular mobility in tissues may not be the 
same in all directions. In and around intact axons for example (Figure D), the diffusion of a 
water molecule (black line) will be mainly in one direction (i.e. anisotropic). Water diffusion at 
each voxel is modeled by a tensor, characterized by its three principal eigenvectors and their 
associated eigenvalues (λ1, λ2, λ3) (Figure B). The first is referred to as axial diffusivity, and 
represents the magnitude of diffusivity parallel to the white matter tracts. The average of λ2 
and λ3 is termed radial diffusivity, and reflects the magnitude of diffusivity perpendicular to 
these tracts.
Two different, but complementary, common DTI 
metrics can be derived from these eigenvalues: the 
mean diffusivity (MD), which is the average of the 
three eigenvalues and represents the overall 
magnitude of water diffusion, and the fractional 
anisotropy (FA), a normalized ratio of diffusion 
anisotropy.45 The FA ranges between 0 and 1. 
FA reflects the shape of the tensor, with more 
isotropic (spherical) tensors having a lower FA value and more anisotropic tensors a higher 
FA (Figure C). Tissues with intact axons (Figure D) will have a high FA, while tissues with 
axonal loss or the cerebrospinal fluid for example will have a low FA. The MD reflects the 
magnitude of water diffusion and is expressed in mm2/s. 
In intact axons, diffusion is restricted (Figure D) 
and the MD will therefore be low. In axonal loss, 
water molecules have more space to diffuse 
(Figure E), and the MD will be high. In tissues 
such as the cerebrospinal fluid, diffusion is not 
restricted to boundaries and the MD will even be 
higher. Loss of microstructural integrity is 
therefore typically reflected by a reduction in FA 
and increase in MD.46 
Box 2 Diffusion tensor imaging
FA map MD map
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Aim of the thesis and study design
The aim of this thesis was to investigate the association between several MRI parameters 
of cerebral SVD and motor performance, including gait disturbances and (other) 
parkinsonian signs, in subjects with cerebral SVD. We did so with several conventional 
MRI parameters of cerebral SVD (WMLs, lacunar infarcts, microbleeds) and recently 
added MRI parameters to the SVD spectrum (cortical thickness, the microstructural 
integrity of the WMLs and NAWM). Secondly, we wanted to investigate the (additional) 
value of new techniques such as DTI above conventional MRI sequences. 
The studies presented in this thesis are based on the Radboud University Nijmegen 
Diffusion tensor and Magnetic resonance imaging Cohort (RUN DMC) study; a prospective 
cohort study among 503 consecutive patients from the Department of Neurology, aged 
between 50 and 85 years, without dementia or parkinsonism, and with cerebral SVD. In 
this thesis, we use the term cerebral SVD to describe the ischemic consequences of SVD, 
and  hemorrhagic lesions only at the level of microbleeds. Patients with major hemorrhages 
were excluded. The study was designed to investigate the risk factors and cognitive, 
motor and mood consequences of functional and structural brain changes, as assessed 
by MRI. The baseline examination was carried out in 2006. In this thesis we present the 
studies based on these cross-sectional data.
Outline of the thesis
In the first part of this thesis (chapter 1) we describe the rationale and design of (the 
prospective part) of the RUN DMC study. In chapter 2 the relationships between macro-
structural abnormalities of the white and grey matter, assessed with conventional MRI 
sequences, and motor performance are reported. We describe the association between 
WMLs and lacunar infarcts and gait disturbances (chapter 2.1) as well as mild parkinsonian 
signs (chapter 2.2.). Next, gait was investigated in relation to microbleeds (chapter 2.3) 
and cortical thickness (chapter 2.4). In the third chapter of this thesis the association 
between loss of microstructural integrity within the WMLs and of the NAWM, assessed 
with DTI, and gait disturbances (chapter 3.1 and 3.3) and  mild parkinsonian signs 
(chapter 3.2) is presented. Chapter 4 reports on the possible (additional) clinical value of 
DTI above conventional MRI sequences with respect to gait disturbances. In the final part 
of this thesis (chapter 5), the main results are summarized and discussed. All findings are 
put into perspective and methodological aspects are discussed. In addition, possible 
clinical implications and suggestions for future research are put forward.
Chapter 1.1
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1.2
The Radboud University Nijmegen 
Diffusion tensor and Magnetic resonance 
imaging Cohort (RUN DMC) study: 
rationale and study design
Published as
van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, 
Esselink RA, Bloem BR, van Engelen BG, Zwarts MJ, Tendolkar I, Olde Rikkert MG, 
van der Vlugt MJ, Zwiers MP, Norris DG, de Leeuw F-E. Causes and consequences of 
cerebral small vessel disease. The RUN DMC study: a prospective cohort study. 
Study rationale and protocol. BMC Neurol 2011; 11: 29.
Abstract
Background 
Cerebral small vessel disease (SVD) is a frequent finding on CT and MRI scans of elderly 
people and is related to vascular risk factors and cognitive and motor impairment, 
ultimately leading to dementia or parkinsonism in some. In general, the relationships are 
weak, and not all subjects with SVD become demented or get parkinsonism. This might 
be explained by the diversity of underlying pathology of both white matter lesions (WMLs) 
and the normal-appearing white matter (NAWM). Both cannot be properly appreciated 
with conventional MRI. Diffusion tensor imaging (DTI) provides alternative information on 
microstructural white matter integrity. The association between SVD, the microstructural 
integrity of the white matter, and incident dementia and parkinsonism has never been 
investigated. 
Methods/design 
The RUN DMC study is a prospective cohort study on the risk factors and cognitive and 
motor consequences of brain changes among 503 non-demented older adults, aged 
between 50 and 85 years, with cerebral SVD. First follow-up is being prepared for July 
2011. Participants alive will be included and invited to the research center to undergo 
a structured questionnaire on demographics and vascular risk factors,  and a cognitive, 
and motor assessment, followed by a MRI protocol including conventional MRI, DTI and 
resting state functional MRI.  
Discussion 
The follow-up of the RUN DMC study has the potential to further unravel the causes and 
possibly better predict the consequences of changes in white matter integrity in older 
adults with SVD by using relatively new imaging techniques. When proven, these changes 
might function as a surrogate endpoint for cognitive and motor function in future 
therapeutic trials. Our data could furthermore provide a better understanding of the 
pathophysiology of cognitive and motor disturbances in older adults with SVD. The 
execution and completion of the follow-up of our study might ultimately unravel the role of 
SVD on the microstructural integrity of the white matter in the transition from “normal” 
aging to cognitive and motor decline and impairment and eventually to incident dementia 
and parkinsonism.
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Background
Cerebral small vessel disease (SVD) includes white matter lesions (WMLs) and lacunar 
infarcts and is a frequent finding on CT and MRI scans of older adults.1 It is associated 
with vascular risk factors, such as hypertension, atherosclerosis, diabetes mellitus and 
atrial fibrillation.10,47,48 In cerebral SVD, symptoms are due to either complete (lacunar 
syndromes) or incomplete infarction (WMLs) of subcortical structures leading to 
accompanying complaints including the lacunar syndromes, cognitive, motor (gait) and/
or mood disturbances.11 The prevalence of WMLs and lacunar infarcts varies considerably 
across studies from 5-95% and 8-28% respectively, depending on the population studied 
and the imaging technique used.1,49 There is evidence of an increased risk of cognitive 
decline, dementia, gait and balance disturbances and parkinsonism among individuals 
with SVD,23,50-52 although prospective studies are scarce. 
However, individuals with a virtually identical WML burden on conventional fLuid 
attenuated inversion recovery (FLAIR) imaging present with a wide variance in cognitive 
and motor performance ranging from no complaints at all to subjective cognitive 
complaints and mild parkinsonian signs to dementia and parkinsonism. Apparently there 
are other factors that determine whether identical-appearing WMLs on FLAIR  lead to for 
example cognitive or motor decline in one person, while leaving others unaffected. 
One of the other factors could be the presence of coexisting manifestations of cerebral 
SVD on conventional MRI, such as lacunar infarcts and microbleeds,4 which might 
influence the cognitive and motor performance.
As identical-appearing WMLs on conventional MRI are actually histopathologically 
heterogeneous,40 it could be that only the WMLs with a high loss of microstructural 
integrity are related to cognitive and motor impairment. It is also important to realize that 
only a small proportion of the white matter (usually less than a few percent) is affected by 
SVD, even among individuals with severe SVD.42 As conventional MRI is not sensitive to 
early loss of microstructural integrity in the normal-appearing white matter (NAWM), 
possible changes in this largest part of the white matter cannot be assessed. These 
limitations of conventional MRI can potentially be overcome with the use of diffusion 
tensor imaging (DTI), which allows us to assess the microstructural integrity of the whole 
wh ite matter.45 DTI, amongst others, provides two parameters; mean diffusivity (MD), a 
measure of the magnitude of diffusion of water in the white matter, and fractional 
anisotropy (FA), which provides information about the directionality of water diffusion. 
Damage to the white matter is supposedly accompanied roughly by an increase in MD 
and a decrease in FA.53
The RUN DMC study: rationale and study design
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Another explanation for the clinical diversity due to WMLs could be the efficiency of 
compensation mechanisms that prevent further cognitive and motor (gait) deterioration. 
Support for the existence of compensatory mechanisms comes from a study among 
young carriers of a pre-senilin mutation (at risk of genetically determined Alzheimers’ 
disease, but still without cognitive impairment) who showed altered functional connectivity 
(assessed with functional MRI) compared with controls.54 With innovative resting state 
functional MRI techniques the strength of functional connectivity between brain regions 
can be investigated.55 In that way it might be that these compensation mechanisms also 
play a role in the variety of clinical presentation of individuals with SVD. 
In the RUN DMC (Radboud University Nijmegen Diffusion tensor and Magnetic resonance 
imaging Cohort) study we prospectively investigate the effect of SVD on the transition 
from independently living older adults, without dementia or parkinsonism, with cerebral 
SVD and between 50 and 85 years, towards cognitive and motor (gait) decline, and 
ultimately dementia and parkinsonism. The primary objective of the RUN DMC study is to 
prospectively investigate the risk factors for and cognitive and motor (gait) consequences 
of longitudinal functional and structural changes in the integrity of the cerebral white 
matter as assessed by conventional MRI, DTI, resting state functional MRI. To the best of 
our knowledge there are no other prospective cohort studies investigating the development 
of incident dementia and parkinsonism using these novel imaging techniques. Here we 
describe the study design and protocol of the RUN DMC study. 
Methods/design
Study population
Cerebral SVD is characterized on neuroimaging by either WMLs or lacunar infarcts. 
Symptoms of SVD include acute symptoms, such as transient ischemic attack (TIA) or 
lacunar syndromes, but also subacute manifestations such as cognitive and motor (gait) 
disturbances.11 As the onset of cerebral SVD is often insidious, clinically heterogeneous, 
and typically with mild symptoms, it has been suggested that the selection of subjects 
with cerebral SVD in clinical studies should be based on the more consistent brain 
imaging features.12 
Accordingly, in 2006, consecutive individuals referred to the Department of Neurology 
between October 2002 and November 2006, were selected for possible participation. 
Inclusion criteria were: (a) age between 50 and 85 years; (b) cerebral SVD on neuroimaging 
[WMLs and/or lacunar infarct(s)]. Subsequently, the abovementioned acute and subacute 
clinical symptoms of SVD were assessed by standardized structured assessments (a 
Chapter 1.2
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questionnaire for TIA and stroke;56 for cognition the Cognitive Failures Questionnaire;57 for 
gait the Falls Questionnaire58 and the Freezing of Gait Questionnaire59). Subjects who 
were eligible because of a lacunar syndrome were included only >6 months after the 
event to avoid acute effects on the outcomes. 
To be able to detect incident dementia and parkinsonism we applied the following 
exclusion criteria: (a) presence of dementia60 and (b) parkinson(-ism).61,62 In addition, 
patients with (c) intracranial hemorrhage; (d) life expectancy <6 months; (e) intracranial 
space-occupying lesion; (f) (psychiatric) disease interfering with cognitive testing or 
follow-up; (g) recent or current use of acetylcholine-esterase inhibitors, neuroleptic 
agents, L-dopa or dopa-a(nta)gonists; (h) non-SVD-related WMLs (e.g. multiple sclerosis); 
(i) prominent visual or hearing impairment; (j) language barrier; (k) MRI contraindications 
or known claustrophobia were excluded. 
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
Follow-up
After 5 and 10 years all participants alive will be contacted for the prospective assessment 
of possible outcome events. This evaluation is currently being prepared for July 2011. 
Between 2006 and 2011 we contacted all participants every year by letter for an update 
on their address information and telephone number and for their survival status.
In 2011 all participants alive will be invited by letter and subsequently contacted by 
telephone to visit our research center. During their visit to the research center a cognitive, 
gait, balance and parkinsonian signs assessment, a structured interview, physical 
examination, neurological examination,  and an extensive MRI protocol, an electrocardio-
gram and an ultrasonography of the carotid arteries will be performed.  All tests will be 
performed by the same two trained neurology residents and all MRI scans will take place 
on the same scanner. 
Outcome events
Primary measures of outcome of the study are incident dementia and parkinsonism 
according to international diagnostic criteria,60,62 as well as all-cause mortality and  death 
from all vascular causes, non-fatal stroke, and non-fatal myocardial infarction. 
Secondary outcome measures are defined as change from baseline examination in 
cognitive function, gait and balance and parkinsonian signs.
Incident outcome events are to be identified by three different approaches:
1. During the follow-up a structured questionnaire on the possible occurrence on these 
The RUN DMC study: rationale and study design
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outcome events is administered to each participant. When an incident event is 
suspected, the treating physician will be contacted for the most recent information on 
that particular outcome event. 
2. When a participant died before follow-up, the general practitioner will be contacted 
for the most recent information on the cause of death and presence of primary 
outcome events. In case of presence of primary outcome events, the treating 
physician will be contacted for the most recent information available. 
3. When during follow-up assessment participants’ test results are suggestive for 
incident dementia or parkinsonism, subjects will be referred to our outpatient clinic. In 
case the diagnosis is established according to the international criteria, this will be 
considered an incident case.
All outcome events will be adjudicated independently by two specialised physicians, if the 
two classifications differ, the outcome event will be discussed and consensus will be made.
Assessment of cognitive and motor outcomes
Two trained residents in neurology will administer the complete outcome assessment.
Cognitive assessment. We will use an extensive neuropsychological test battery that 
encompasses items from other large scale epidemiological studies that cover virtually all 
cognitive domains.50,63 A measurement of global cognitive function will be assessed by 
the Mini Mental State Examination.64 The verbal memory function will be assessed by the 
three-trial version of the Rey Auditory Verbal Learning Test, a test used to evaluate the 
ability to acquire and retain new verbal information.65 Visuospatial memory will be 
administered by the Rey’s Complex Figure Test, that consists of three subtasks: the copy 
trial, the immediate recall trial within 3 minutes, and the delayed recall trial after 30 
minutes.66 To evaluate speed of mental processes 4 tests will be used; the Stroop test (3 
subtasks),67 the Paper and Pencil Memory Scanning Task (4 subtasks),68 the Symbol-Digit 
Substitution Task, which is a modified version of the Symbol Digit Modalities Test69 and a 
verbal fluency task in which as many animals as possible have to be named within 60 
seconds, followed by as many professions within 60 seconds. To evaluate attention, the 
verbal series attention test will be used.70 To register subjective cognitive failures we will 
administer the Cognitive failures questionnaire.57 The tests will be carried out in quiet 
rooms and a stopwatch will be used in timed tests.
Assessment of gait, balance and parkinsonian signs. All participants will perform a tandem 
walk by walking 10 steps heel to toe (registering: intact, one side step, more side steps, 
impossible). A quantitative gait analysis will be performed with a 5.6-meter long, 
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0.89-meter wide electronic walkway (GAITRite MAP/CIR Inc., Havertown, PA) with sensor 
pads (12.7 mm apart from each other) connected to a computer. This system has strong 
concurrent validity and test-retest reliability, also in older people.71 The participants walk 
twice at self-selected gait speed on low-heeled shoes. They start two meters before the 
carpet and walk until two meters behind it in order to measure steady-state walking.
We will use a widely used modified version of the original Tinetti test with 17 items: 9 for 
body balance (score 0-16) and 8 for gait (score 0-12), with a maximum score of 28.72 It 
grades balance while sitting, standing with eyes open and closed, nudging and turning, 
gait initiation, stride length and width and symmetry. Functional mobility will be classified 
by using the widely used Timed-Up-and-Go (TUG) test which is a timed test during which 
the participant is asked to rise from a standard armchair, walk 3 m, turn, walk back and sit 
down again.73 Each participant will perform the test 3 times. To evaluate parkinsonian 
signs we apply the Unified Parkinson’s Disease Rating Scale (UPDRS), the motor score.74 
Finally, disease severity will be assessed with the Hoenhn and Yahr stage assessing.75 
For the evaluation of gait and balance we will also administer the Freezing of gait 
questionnaire, a questionnaire consisting of 16 items regarding gait and falls and the 
Falls questionnaire.58,59
Assessment of other variables
Depressive symptoms. A standardized structured questionnaire used in previous large 
scale epidemiological studies will be used to assess the history of depressive symptoms; 
normal reactions to stressful events or normal grief will carefully be excluded.59,76 In case 
of a depressive episode, age of onset, the medical advice and medication use will be 
registered. We defi ned ‘depression’ as those depressive episodes that have required 
attention of a general practitioner, psychologist, or psychiatrist. This defi nition includes 
minor depression, as well as more severe depression syndromes such as major 
depression and bipolar depression.59,76
In addition, participants will be screened for depressive symptoms by means of the Mini 
International Neuropsychiatric Interview, part A, which is a short diagnostic structured 
interview based on the DSM IV.77 Additionally, presence of actual depressive symptoms 
will be assessed by two self-report questionnaires: the  Center of Epidemiologic Studies 
Depression Scale78 and the Hospital Anxiety and Depression Scale.79
Vascular risk factors and cardiovascular disease. With the aid a of structured, standardized 
questionnaire each participant will be asked for a history of: hypertension, diabetes 
mellitus, atrial fi brillation, TIA, stroke, myocardial infarction, coronary artery bypass graft, 
per-cutaneous transluminal coronary angiography, aortic prothesis, vascular prothesis, 
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carotid endartectomy10,47,48,56 and migraine.80 The presence of a family history of myocardial 
infarction, cerebrovascular disease and diabetes mellitus in next of kin will be recorded. 
Height and weight will be measured without shoes in light clothing. The body mass index 
is calculated as weight divided by height (in meters) squared. The maximal waist 
circumference will be measured without shirt, in standing position, between the lowest rib 
and the iliac crest, at the end of normal expiration.81 Blood pressure and pulse rate will be 
measured in triplicate in supine position after fi ve minutes rest. Subsequently one 
measurement is performed after one minute in upright position.10
Demographics and life style. Standardized questionnaires on demographics, education 
(classifi ed using 7 categories, 1 being less than primary school and 7 reﬂ ecting an 
academic degree),82 marital status, living conditions, and life style habits (alcohol 
consumption, smoking, exercise) will be administered. Alcohol consumption is defi ned as 
units per day and the age at which alcohol consumption had started (and if stopped) was 
noted. Cigarette smoking behavior is defi ned as the number of pack-years, calculated as 
the number of packs of cigarettes smoked per day multiplied by the number of years a 
participant had smoked. Exercise is expressed in the metabolic equivalent value 
according to accepted standards, where 1 metabolic equivalent value is proportional to 
the energy expended while sitting quietly.83 
Assessment of activities of daily living. As a measure of disability the Barthel Index will be 
used.84 The activities of daily living will be assessed by the instrumental activities of daily 
living questionnaire.85 
Current medication.  Current medication use will be noted and classifi ed according to the 
Anatomical therapeutic chemical classifi cation system. (World Health Organization, WHO 
Collaborating Centre for drug statistics and methodology, http://www.whocc.no/atcddd/)
Qualitity of life. The overall health status (quality of life) will be assessed with the Short 
Form 36 (SF-36).86,87
Sleep problems. For the assessment of sleep disorders we will use the SCOPA-Sleep 
scale88 and for fatigue the Checklist on Individual Strength.89 
Primary refl exes. The presence of the glabella, snout and grasp reﬂ ex, the applause sign90 
and the plantar response will be registered.
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Muscle strength. The strength of the biceps, hand grip, iliopsoas, quadriceps and foot 
extensor muscles on both sides will be measured by the medical research council scale 
and by a dynamometer (Citec hand-held dynamometer).91 
Sensory system. This will be assessed by a quantitative measurement by vibration tuning 
fork (Rydel-Seiffer) on both fi rst toes and both medial malleolus, also registering ankle 
oedema and ankle jerks. 
MRI scanning and processing
 MRI scanning will be performed on a 1.5 Tesla scanner (Magnetom Sonata, Siemens 
Medical Solutions, Erlangen, Germany). The scanning protocol includes whole brain 3D 
T1 magnetization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time 
(TE)/inversion time (TI) 2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm]; 
FLAIR pulse sequences (TR/TE/TI 9000/84/2200 ms; voxel size 1.0x1.2x5.0 mm, plus an 
interslice gap of 1.0 mm); transversal T2*-weighted gradient-echo sequence (TR/TE 
800/26 ms; voxel size 1.3x1.0x5.0 mm, plus an interslice gap of 1.0 mm); DTI (TR/TE 
10100/93ms; voxel size 2.5x2.5x2.5 mm; 4 unweighted scans, 30 diffusion-weighted 
scans, with non co-linear orientation of the diffusion-weighting gradient, and b-value 
900s/mm²) and resting state imaging using a gradient-echo EPI (TR/TE 2400/40ms; voxel 
size 3.5x3.5x4.0 mm, plus an interslice gap of 0.4 mm). During resting state, subjects will 
be told not to concentrate on any particular subject, but just to relax with their eyes closed. 
The complete scanning protocol takes 31 minutes.
White matter lesions. All images will be evaluated without prior notice of any clinical 
parameter. WMLs are defi ned as hyperintense lesions on FLAIR MRI without corresponding 
cerebrospinal fl uid like hypo-intense lesions on the T1-weighted image. Gliosis 
surrounding lacunar and territorial infarcts is not considered to be WMLs.33 Total WML 
volume is calculated by an in-house developed, validated technique. 
Brain volumetry. Automated segmentation on the T1 images was conducted using 
Statistical Parametric Mapping (SPM) 5 (http://www.fi l.ion.ucl.ac.uk/spm/) to obtain grey 
and white matter and cerebrospinal fl uid probability maps.92 These were binarized by 
applying a 0.5 treshold and summed to provide total volumes. Total brain volume was 
then calculated as the sum of total grey and white matter volumes. Co-registration 
parameters of the FLAIR image to the T1 image are computed (SPM5 mutual information 
co-registration) and used to bring both the FLAIR and WML segmentation images into the 
subject’s (anatomical) reference frame. Transformed images will visually be checked for 
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co-registration errors. Subsequently, the WML segmentations are resampled to and 
combined with the white matter maps to yield to a WML map (the intersection of WMLs 
and white matter) and NAWM map (the complement of WMLs in white matter) in the T1 
reference space. Total brain volume is taken as the sum of total grey and white matter. 
Lacunar and territorial infarcts. Lacunar infarcts are defi ned as hypo-intense areas >2 mm 
and ≤15 mm on FLAIR and T1, ruling out enlarged perivascular spaces (≤2 mm, except 
around the anterior commissure, where perivascular spaces can be large) and 
infraputaminal pseudolacunes.33 Territorial infarcts are defi ned as hypointense lesions on 
FLAIR and T1 images >15 mm. 
Microbleeds. Microbleeds are defi ned as small, homogeneous, round foci of low signal 
intensity on T2*-weighted images <10 mm in diameter.28  Microbleeds are counted per 
hemisphere separately. In addition, they are classifi ed as cortical/subcortical including 
the periventricular white matter and deep portions of the centrum semiovale (frontal, 
parietal, occipital and temporal separately); in the basal ganglia, including caudate 
nucleus, internal and external capsule, globus pallidus, thalamus and putamen; 
infratentorial including the cerebellar hemispheres, pons and medulla oblongata.28 
Lesions are not considered to be microbleeds when they are symmetric hypointensities in 
the globus pallidus, most likely calcifi cations or iron deposits, fl ow voids artifacts of the 
pial blood vessels or hyposignals on T2* inside a lesion compatible with an infarct, likely 
to be hemorrhagic transformation.28 
Diffusion tensor imaging. The diffusion-weighted images of each participant are realigned 
on the unweighted image using mutual information based Matlab (The Mathworks, Inc.) 
routines from SPM5. Then, the diffusion tensor and its eigenvalues are computed using 
an SPM5 add-on (http://sourceforge.net/projects/spmtools).93 Unphysical spurious 
negative eigenvalues of the diffusion tensor were set to zero, after which the tensor 
derivatives the FA and MD are calculated.94 The mean unweighted image is used to 
compute the co-registration parameters to the anatomical T1 image (SPM5 mutual 
information co-registration), which are then applied to all diffusion-weighted images and 
results. All images are visually checked for motion artefacts and co-registration errors.
Electrocardiogram
An electrocardiogram will be performed and evaluated using a standardized assessment 
by an experienced cardiologist, registering frequency, cardiac rhythm, cardiac ectopias, 
cardiac axis, conduction time over the PQ, QRS and QTC intervals, conduction 
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disturbances, left ventricle hypertrophy, pathologic Q’s, infarction, repolarisation 
disturbances and acute ischemia. A fi nal diagnosis is defi ned as normal, abnormal 
without clinical signifi cance, abnormal with clinical consequences or pathologic electro-
cardiogram with immediate consultation of a cardiologist when necessary.
Ultrasonography of the carotid arteries 
All ultrasound measurements will be performed by three experienced and specifi c trained 
clinical neurophysiology technicians. A carotid ultrasound assessment at which the intima 
media thickness is measured in the distal left and right carotis communis, near the 
bulbus, will be performed. All measurements will be performed using a phased array 
real-time scanner (Philips i-u22, The Netherlands) with a 17- 5 MHz broadband linear 
transducer. Two-dimensional ultrasound imaging of the carotid artery will be performed to 
measure the intima media thickness. The intima media thickness will be automatically 
measured by QLab qualifi cation software (V. 4.2.1.). An edge detection algorithm identifi es 
the lumen/intima and the media/adventitia interfaces within a region-of-interest over a 10 
mm long segment and calculates the average thickness.95 
The same cognitive, motor, gait and balance assessment, structured interview and 
assessment of other variables and the same ancillary investigation were performed at 
baseline in 2006. 
Statistical analysis
Sample size calculation.  Based on the literature we expect about 60 incident dementia 
cases during the 5-year follow-up (absolute risk 4-5%/year), as about half of our study 
population has a relatively high degree of WMLs.96 We expect that each standard deviation 
increase in MD increases this absolute risk of dementia by 2% per year. To detect this 
increased risk with a high probability of 90% at the 5% signifi cance level, we will need 380 
participants at the end of the follow-up. We therefore included 500 participants at baseline 
and hope to end up with 400 participants at follow-up protocol (taking into account an 
expected loss to follow-up of about 20%).
Analysis of primary outcome measures. We will analyze mean baseline MD and FA and 
change in MD and FA on follow-up imaging in relation to incident dementia and 
parkinsonism by Cox proportional hazard models adjusted for age, sex, education, 
depressive symptoms, total brain volume, WML volume and lacunar infracts, where 
appropriate.
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Discussion
The RUN DMC study is a large prospective cohort study on causes and consequences of 
structural and functional changes in the integrity of the cerebral white matter (in both the 
WMLs and the NAWM) as assessed by conventional MRI as well as new techniques, such 
as DTI and resting state functional MRI, among older adults with cerebral SVD, starting to 
include participants for the follow-up protocol in July 2011.
Numerous studies have shown that WMLs observed on conventional MRI are related to 
vascular risk factors10,47 and have reported associations with cognitive and motor decline 
and found these relations to be rather weak.23,50 To the best of our knowledge there are no 
prospective cohort studies on individuals with cerebral SVD investigating the development 
of incident dementia and parkinsonism in relation to white matter changes assessed by 
DTI and resting state functional MRI. 
Strengths of the RUN DMC study include the prospective fashion of the study in which all 
vascular risk factors, clinical and imaging measures will be followed-up after 5 years, and 
the large and well-established protocol used to explore demographics, vascular risk 
factors, and cognitive function and motor performance. The tests chosen are furthermore 
widely accepted and have been proven specifi c and sensitive in this population with 
structural brain changes. 
Another strength is the fact that it is a single-center study. Moreover, the complete study 
protocol will take place in one research center with the use of a single scanner and only 2 
investigators performing all investigations. 
In conclusion, the RUN DMC study has the potential to further unravel the causes and 
consequences of changes in white matter integrity in older adults with cerebral SVD by 
using new imaging techniques, DTI and resting state functional MRI. When proven, 
changes in white matter integrity assessed by these techniques might function as a 
surrogate endpoint for cognitive and motor function in future therapeutic trials of vascular 
risk factors in SVD. 
The execution and completion of the follow-up of our study will ultimately unravel the role 
of SVD on the microstructural integrity of the white matter in the transition from “normal” 
aging to cognitive and motor decline and impairment and eventually to incident dementia 
and parkinsonism.
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Abstract
Background and objectives
Gait disturbances are common in older adults and are related to loss of functional 
independence and death. White matter lesions (WMLs) may be related, but only a minority 
of individuals with WMLs have gait disturbances. Probably other factors are involved, 
including location and the independent effect of frequently coinciding lacunar infarcts, 
the other aspect of cerebral small vessel disease (SVD). The aim of our study was to 
investigate the effect of both the severity and location of both WMLs and lacunar infarcts 
on gait. 
Methods
431 individuals with SVD, aged between 50 and 85 years, without dementia or 
parkinsonism, were included in this analysis and underwent MRI scanning. The number 
and location of lacunar infarcts were rated and WML volume was assessed by manual 
segmentation with automated delineating of different regions. Gait was assessed 
quantitatively with an electronic walkway as well as the semi-quantitatively Tinetti and 
Timed-Up-and-Go test. 
Results
WMLs and lacunar infarcts were both independently associated with most gait parameters, 
with stride length as the most sensitive parameter related to WMLs. WMLs in the sublobar 
(basal ganglia/internal capsule) and limbic areas and lacunar infarcts in the frontal lobe 
and thalamus were related to a lower velocity.
Conclusions
Cerebral SVD is related to gait disturbances. As SVD may, in part, be preventable, it 
should be regarded as a potentially important target for postponing gait impairment.
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Introduction
Gait disturbances are common in older adutls and are associated with loss of functional 
independence, institutionalization and death.19 Proper gait is the result of automated 
spinal motor programs under supraspinal control. The integrity of connections between 
the cortical areas and between these areas and the spinal cord can be disrupted by small 
vessel disease (SVD), including white matter lesions (WMLs) and lacunar infarcts. WMLs 
are recognized as a possible cause of gait impairment,14,23-26,97 but not all individuals with 
WMLs have gait disturbances.14 It may be that the severity of WMLs or the frequent 
coinciding lacunar infarcts play a role. Remarkably, there was no statistical control for the 
presence of lacunar infarcts in most of these studies and they did not investigate the 
independent effect of these lesions on gait.23-25,97 Moreover, the site of SVD in relation to 
gait could be another important factor in the variability of gait disturbances, but was 
usually not taken into account. Only few studies with small sample size investigated the 
effect of WML location on gait.98-100
Quantitative gait analysis, providing insight into the different components of gait, has 
been performed in patients with extensive SVD with severe gait disorders.14 However, 
most studies among independently living elderly people with SVD used semi-quantitative 
clinical rating scales,23,25 a composite gait score26 or measured only gait velocity.23,25 
Hence, it is not clear how SVD alters the different parameters of the gait pattern in the early 
stages of the disease and which parameter is a sensitive indicator for underlying SVD.
The aim of our study was therefore to investigate the individual contribution of WML 
volume and lacunar infarcts, overall and by specifi c location, on different gait parameters 
using quantitative gait analysis. 
Patients and methods
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging 
Cohort (RUN DMC) study is a prospective cohort study that was designed to investigate 
risk factors and cognitive, motor and mood consequences of functional and structural 
brain changes in older adutls with cerebral SVD. 
In subjects with cerebral SVD symptoms are due to either complete (lacunar infarcts) or 
incomplete infarction (WMLs) of subcortical structures, that might lead to acute symptoms 
as transient ischemic attacks (TIAs) or lacunar syndromes, or subacute manifestations as 
cognitive, motor and/or mood disturbances.11 As the onset of cerebral SVD is often 
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insidious, clinically heterogeneous and with mild symptoms, it has been suggested that 
the selection of subjects with cerebral SVD in clinical studies should be based on the 
more consistent brain imaging features.12 Accordingly, in 2006, consecutive patients from 
the Department of Neurology between October 2002 and November 2006, were selected 
for participation.
Inclusion criteria were: (a) age between 50 and 85 years; (b) cerebral SVD on neuroimaging 
and (c) acute (n=219) or subacute (n=284) clinical symptoms of SVD as assessed by 
standardized structured assessments. Patients who were eligible because of a lacunar 
syndrome were included only >6 months after the event to avoid acute effects on the 
outcomes. 
Exclusion criteria were: (a) dementia60 and (b) parkinson(ism);61,101 (c) life expectancy <6 
months; (d) intracranial space-occupying lesion; (e) (psychiatric) disease interfering with 
cognitive testing or follow-up; (f) recent or current use of acetylcholine-esterase inhibitors, 
neuroleptic agents, L-dopa or dopa-a(nta)gonists,; (g) non-SVD-related WMLs (e.g. 
multiple sclerosis and irradiation induced gliosis); (h) prominent visual or hearing 
impairment; (i) language barrier; (j) MRI contraindications or known claustrophobia.
From 1004 invited individuals by letter, 727 were eligible after contact by phone and 525 
agreed to participate. In 22 subjects exclusion criteria were found during their visit to our 
research center, yielding a response of 71.3% (503/705). These 503 individuals had 
symptoms of TIA or lacunar syndrome (n=219), cognitive disturbances (n=245), motor 
disturbances (n=97), depressive symptoms (n=100) or a combination thereof. A motor 
disturbance was defi ned, in accordance with operationalization as used in other large 
scale studies on cerebral SVD and gait,102 as follows: a reported history of ≥1 fall(s) during 
the past year or a self-reported slowing of gait. All participants signed an informed 
consent form. The Medical Review Ethics Committee region Arnhem-Nijmegen approved 
the study.
MRI scanning and processing
Imaging was performed on a 1.5 Tesla scanner (Magnetom Sonata, Siemens Medical 
Solutions, Erlangen, Germany). The protocol included T1 3D magnetization-prepared 
rapid gradient-echo imaging [repetition time (TR)/echo time (TE)/inversion time (TI) 
2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm] and fl uid-attenuated inversion 
recovery (FLAIR) sequences (TR/TE/TI 9000/84/2200 ms; voxel size 1.0x1.2x50 mm, plus 
an interslice gap of 1 mm). All scans were performed on the same scanner.
White matter signal hyperintensities on FLAIR scans, which were not, or only faintly, 
hypo-intense on T1-weighted images, were considered WML, except for gliosis 
surrounding infarcts. WMLs were manually segmented on the FLAIR images by two 
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trained raters. All imaging analyses were performed by raters blinded to clinical 
information. Also the WML volume of predefi ned volumes of interest, taken from an 
inversely normalized (parameters taken from the T1 normalization) Talairach-based 
atlas103 (WFU Pickatlas, v2.3), was computed. They included the frontal, parietal, occipital, 
temporal lobes and sublobar (basal ganglia, thalamus, internal and external capsule, 
insula) and limbic (cingulate gyrus) area, brainstem and cerebellum. Lacunar infarcts 
were defi ned as areas with a diameter >2 mm and ≤15 mm with low signal intensity on T1 
and FLAIR, ruling out enlarged perivascular spaces and infraputaminal pseudolacunes.33 
In a random sample of 10% inter-rater variability for WML yielded an intra-class correlation 
coeffi cient of 0.99; intra- and inter-rater reliability for lacunar infarctions a weighted kappa 
of 0.80 and 0.88.
Automated segmentation on the T1 images was conducted using Statistical Parametric 
Mapping (SPM5) (http://www.fi l.ion.ucl.ac.uk/spm/) to obtain grey and white matter and 
cerebrospinal fl uid maps.92 Total brain volume was calculated as the sum of total grey and 
white matter volumes. 
Measurement of gait
Quantitative gait analysis was performed with a 5.6-m electronic portable walkway 
(GAITRite, MAP/CIR Inc., Havertown, PA). We measured velocity (m/s), consisting of the 
stride length (m) (the distance between the heel points of two consecutive footprints of 
the same foot) and cadence (number of steps per minute); stride width (cm) (the distance 
between one midpoint of a footprint to the line of progression of the opposite foot); double 
support percentage (percentage of the gait cycle time during which both feet are on the 
fl oor) and variability of stride length, stride time and stride width, two times at self-selected 
speed. Variability was expressed as coeffi cients of variation (CV): standard deviation 
(SD)/mean x 100%. 
Semi-quantitative assessment existed of the modifi ed Tinetti test with 17 items: 9 for body 
balance (score 0-16) and 8 for gait (score 0-12), with a maximum score of 28,72 as well as 
the Timed-Up-and-Go (TUG) test,73 which was executed 3 times. Inter-rater reliability was 
calculated in a random sample of 15% with an intra-class correlation coeffi cient of 0.99. 
Other measurements
We considered age, sex, height and total brain volume as possible confounders. We used 
the Mini Mental State Examination score (range 0–30) to assess global cognitive status.64 
Functional independence was assessed using the Barthel Index (range 0–20).84 
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Statistical analysis
The mean quantitative GAITRite and semi-quantitative TUG measures were calculated as 
the mean of the two and three walks. When one trial was missing, the remaining measures 
were used (n=5 for quantitative and n=2 for semi-quantitative gait assessment). 
The relationship between SVD and gait was analyzed using three different approaches. 
Firstly, we used age, sex, height and total brain volume adjusted multiple linear regression 
to investigate the relationship between WML volume or number of lacunar infarcts and 
gait. Subsequently we adjusted for either the number of lacunar infarcts (with WMLs as 
independent variable) or WML volume (with lacunar infarcts as independent variable). 
This analysis was also repeated in subjects without lacunar infarcts. The same analyses 
were also done by location of the WMLs and presence of lacunar infarcts. In positively 
skewed distributions the log transformation was used. Regression coeffi cients are 
presented as standardized beta-values. 
Secondly, a possible independent dose-effect relationship of WML and number of lacunar 
infarcts with gait velocity was investigated by means of analysis of covariance with WMLs 
in quintiles or number of lacunar infarcts in three groups and the abovementioned 
covariates. 
Thirdly, the risk of impaired gait (velocity <1 m/s104 or TUG test >12 s105) by the severity of 
WMLs (in quintiles) or the number of lacunar infarcts was assessed with logistic regression 
analysis. As no impaired TUG test was observed in the fi rst quintile, the fi rst and second 
quintile together were considered as the reference group.
All analyses were performed using SPSS v16.0.
Results
Characteristics
All gait variables were available for 488 participants. Fifteen individuals could not 
participate because of walking aids (n=4), current levodopa use (n=1), drop foot (n=1), 
lower extremity amputation (n=1), joint fusion (n=2), severe arthritis (n=1), severe vascular 
problems of the lower extremity (n=2) or a functional gait disturbance (n=3). Territorial 
infarcts were considered as confounder and therefore individuals with these infarcts were 
excluded (n=56). One subject had to be excluded because of technical problems with the 
calculation of the total brain volume, yielding a fi nal sample size of 431 subjects.
Table 1 represents the characteristics of these 431 subjects. The mean age was 65.2 
years with 45% being women. Eighty-four subjects were classifi ed as having a motor 
disturbance. Of these 84, none had a mild or severe hemiplegia (Medical Research 
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Table 1 Characteristics of the study population
Characteristics n=431
Demographic and clinical characteristics
Age, yrs 65.2 (8.9)
Female, no. 195 (45.2)
Height, m 1.7 (0.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Neuroimaging characteristics
Total brain volume, ml 1098.9 (119.5)
White matter volume, ml 467.5 (64.9)
White matter lesion volume, ml† 6.5 (3.2; 17.7)
Frontal, ml† 2.1 (0.9; 6.1)
Parietal, ml† 0.2 (0.0; 1.1)
Occipital, ml† 0.6 (0.3; 1.1)
Temporal, ml† 0.4 (0.1; 1.6)
Sublobar, ml† 2.5 (1.2; 4.5)
Limbic, ml† 0.4 (0.2; 1.1)
Infratentorial, ml† 0.2 (0.1; 0.6)
Subjects with lacunar infarct(s), no. 132 (30.6 )
Frontal, no. 47 (10.9)
Parietal, no. 23 (5.3)
Occipital, no. 14 (3.2)
Temporal, no. 11 (2.6)
Sublobar (basal ganglia/internal capsule), no. 74 (17.2)
Limbic, no. 0 (0)
Infratentorial, no. 25 (5.8)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 112.1 (10.8)
Stride width, cm 10.8 (3.1)
Double support percentage, % 25.8 (4.2)
Stride length variability, % 1.7 (1.2; 2.5)
Stride time variability, % 1.6 (1.2; 2.3)
Stride width variability, % 17.1 (12.4; 24.0)
Tinetti  test 28.0 (28.0; 28.0)
Timed-Up-and-Go test, s 8.7 (7.7; 10.3)
Timed-Up-and-Go test, no. steps 12.4 (3.4)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range).
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Council Scale ≤4). Furthermore, of all subjects with a history of a TIA or lacunar syndrome, 
4 participants were still having a mild hemiplegia of one of their legs at the time of 
enrolment. All analyses were repeated excluding these 4 subjects. This did not markedly 
change the magnitude of the association. We therefore present the results for the 
group as a whole. Of all the participants, 11.6% had a gait velocity <1 m/s and 10.4% 
a TUG test >12 s. 
Severity of small vessel disease and gait 
WML and lacunar infarcts were both independently associated with most of the 
spatiotemporal gait parameters (Table 2) and borderline signifi cant with variability in 
stride length (standardized β=0.10; P=0.055 and standardized β=0.10; P=0.066). 
Regarding the clinical rating scales, there was an association between WML volume and 
the number of steps needed during the TUG test, but not with the duration of the test. 
Lacunar infarcts were related with both tests (Table 2). In analyses restricted to subjects 
without lacunar infarcts, WMLs were only associated with a shorter stride length 
(standardized β=-0.13; P=0.006) and not with other parameters or clinical rating scales. 
Figure 1 shows a dose-effect relationship between the severity of WML and gait velocity 
(Ptrend=0.003). Those with severe (fi fth quintile) WMLs were 4 times more likely to have 
an abnormal gait velocity or an abnormal TUG test than the reference group. Subjects 
with >2 lacunar infarcts had an OR of 4.5 (95% CI 1.7-12.0) for impaired gait velocity and 
3.1 (95% CI 1.1-8.7) for an impaired TUG test (Table 3). 
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Figure 1   Association between cerebral small vessel disease and gait velocity
Adjusted for age, sex, height, total brain volume and number of lacunar infarcts (panel A) or WML volume 
(panel B) (± standard errors).
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Location of small vessel disease and gait
As gait velocity is dependent on stride length and cadence, we examined these three 
parameters separately. WMLs in all regions were associated with gait velocity, with the 
strongest association in the sublobar and limbic region and to a lesser extent in the frontal 
lobe, due to a reduction in stride length. Lacunar infarcts in the frontal lobe were related 
to both a shorter stride length (standardized β=-0.08; P=0.042) and lower step frequency 
(standardized β=-0.11; P=0.025), resulting in a lower gait velocity. Those subjects with 
thalamic infarcts walked slower (standardized β=-0.13; P=0.005) due to a shorter stride 
length. Cadence was also related with the presence of lacunar infarcts in the brainstem 
(standardized β=-0.13; P=0.005) (Table 4).
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Table 3   Association between severity of cerebral small vessel disease and 
impaired gait
Severity of cerebral 
small vessel disease
Impaired gait 
velocity†
Impaired TUG test‡
OR (95% CI) OR (95% CI)
WML volume in quintiles (range in ml)
1st+2nd (0.5-5.1) 1.0 (reference) 1.0 (reference)
3rd (5.1-8.9) 4.1 (1.3-12.5)* 2.7 (0.8-9.8)
4th (8.9-20.6) 2.0 (0.6-6.6) 2.5 (0.7-8.9)
5th (20.6-139.7) 4.3 (1.3-14.1)* 4.4 (1.2-15.8)*
Lacunar infarcts
0 1.0 (reference) 1.0 (reference)
1 or 2 1.4 (0.6-3.1) 1.0 (0.4-2.4)
>2 4.5 (1.7-12.0)* 3.1 (1.1-8.7)*
Adjusted for age, sex, height, total brain volume and number of lacunar infarcts or WML volume
†Defi ned as <1 m/s in gait velocity; ‡defi ned as a TUG test of >12 s; *P<0.05
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Table 4 Association between location of cerebral small vessel disease and gait
Gait parameters
Cerebral small 
vessel disease 
Gait velocity 
(m/s)
Stride length
(m)
Cadence 
(steps/min)
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Frontal lobe
WML volume -0.17** -0.06 -0.19** -0.09 -0.04 0.05
Lacunar infarcts -0.11* -0.11* -0.09* -0.08* -0.11* -0.11*
Parietal lobe
WML volume -0.17** 0.06 -0.19** 0.02 -0.04 0.09
Lacunar infarcts 0.01 0.04 0.04 0.07 -0.03 -0.01
Occipital lobe
WML volume -0.12* 0.02 -0.12* 0.04 -0.08 -0.05
Lacunar infarcts -0.05 -0.03 -0.05 -0.03 -0.03 -0.02 
Temporal lobe
WML volume -0.16* 0.14 -0.18** 0.06 -0.04 0.18
Lacunar infarcts 0.02 0.04 -0.02 -0.01 0.07 0.08
Sublobar areas
WML volume -0.19** -0.14 -0.18** -0.09 -0.10* -0.13
Lacunar infarcts -0.09* -0.06 -0.10* -0.08 -0.04 -0.01
Limbic areas
WML volume -0.20** -0.13 -0.22** -0.14 -0.08 -0.06
Lacunar infarcts - - - - - -
Infratentorial
WML volume -0.18** -0.03 -0.19** -0.03 -0.07 -0.05
Lacunar infarcts -0.05 -0.02 -0.01 0.01 -0.11* -0.10*
Brainstem
WML volume -0.15* -0.01 -0.16** -0.00 -0.06 -0.03
Lacunar 
infarcts
-0.08 -0.06 -0.04 -0.02 -0.14* -0.13*
Cerebellum
WML volume -0.21** -0.11 -0.22** -0.14 -0.08 -0.06
Lacunar 
infarcts
-0.03 -0.01 -0.02 -0.00 -0.05 -0.04
Data are standardized beta-values.
Model 1 represents the independent association between WML volume in ml, presence of lacunar infarcts 
and gait adjusted for age, sex, height and total brain volume; model 2 is with additional adjustment for 
WML volume and presence of lacunar infarcts in the other regions.
*P<0.05; **P<0.001
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Discussion
Both WMLs and lacunar infarcts were independently associated with several gait 
parameters. WMLs particularly in the sublobar (basal ganglia, thalamus, internal and 
external capsule, insula), limbic area and frontal lobe seemed to be related to a lower gait 
velocity, due to a shorter stride length, and lacunar infarcts in the thalamus and frontal 
lobe to a lower gait velocity, due to respectively a shorter stride length and both a reduced 
stride length and cadence. 
Some methodological issues need to be considered. Firstly, we here report on cross-
sectional data, which prevent causal inference. Furthermore, in the examination of the 
inﬂ uence of the location of SVD, a potential confounder could be the presence of SVD in 
other regions related to gait, which are highly correlated to each other. We tried to 
overcome this problem by analyzing the relationships in two separate models; one with 
and one without taking into account the possible confounding effect of SVD in the other 
regions. As a major advantage of our study, WML volume was obtained by manual 
segmentation, with automated delineating of different regions. Gait was also assessed in 
a quantitative manner as well as with semi-quantitative rating scales, because these test 
are frequently used and easy to apply in everyday clinical practice. Another strong 
element of our study was the fact that we were able to investigate the effect of SVD on gait, 
independent of possible confounders such as total brain volume and lacunar infarcts (and 
WML volume with lacunar infarcts as independent variable). We intentionally did not 
correct for vascular risk factors as hypertension or diabetes as they were considered part 
of the causal chain between SVD and gait. Finally, our study was large, with a high 
response and with all subjects examined by only two investigators in a single center.
Gait velocity is determined by both the stride length and cadence and was found to be 
associated with both aspects of SVD in our study. No studies discriminated between 
these two components of velocity. We showed that cadence was only reduced in 
association with lacunar infarcts. In analyses restricted to subjects without lacunar 
infarcts, WML volume was signifi cantly related to stride length, but not to velocity or 
other parameters. We therefore suggest that stride length is a more sensitive indicator for 
(subclinical) SVD than velocity. This is also reﬂ ected by more steps needed during the 
TUG test in subjects with a higher WML volume, without a signifi cant effect on the duration 
of the test. The same is observed in other gait disorders such as Parkinson’s disease and 
normal pressure hydrocephalus.106 In conclusion, these results suggest that measuring 
stride length instead of velocity could lead to an early detection of gait abnormalities in 
SVD.
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Apart from the lower velocity, due to smaller steps and in the presence of lacunar infarcts 
also due to a lower step frequency, we found that gait in subjects with more severe SVD 
was characterized by a broader base, more shufﬂ ing, reﬂ ected by increased double 
support percentage, and with a higher variability in stride time and trend to a higher stride 
length variability. Rosano et al. did not detect an effect of SVD on stride width in contrast 
to our fi nding of a clear relationship with both aspects of SVD.4 The association of lacunar 
infarcts with double support percentage is also a novel fi nding. Gait variability, which is 
suggested to be more sensitive to fall risk than other gait parameters,107 has not been 
extensively studied in the early stages of SVD. Although the effect of WMLs on overall gait 
variability was recently reported,26 our data provide insight into the different components 
as we showed an association between variability in stride time and to a lesser extent in 
stride length and SVD.
Because the presence of >2 lacunar infarcts was signifi cantly associated with gait 
velocity, our fi ndings suggested a threshold- rather than a dose-effect. However, those 
with >4 lacunar infarcts were limited and could therefore not be investigated separately. 
In contrast, the relationship between WML and gait suggested a dose-dependent effect 
relationship.  A similar fi nding was reported by two other studies.23,26 One study showed a 
threshold-effect, but the median WML volume in this study was lower than in our study.25 
They found a signifi cant lower gait velocity with WML volume >5-10 ml as we did. Hence, 
it seems that gait impairment only occurs when WMLs are moderate or (in the combination) 
with more lacunar infarcts. 
The exact cerebral networks impaired in gait disorders due to SVD have not been identifi ed 
yet. In previous studies in subjects with gait impairment and extensive SVD the basal 
ganglia-thalamo-frontal cortical circuit was considered to be involved.14 Our fi ndings 
support this hypothesis, even during the early stages of SVD as we showed that lacunar 
infarcts in the frontal lobe were related to a lower gait velocity. Furthermore, we found 
WMLs in the sublobar region and thalamic infarcts to be related to gait velocity. Rosano 
et al. also suggested that lacunar infarcts in the basal ganglia are related to gait velocity 
as most of the infarcts in their population were located in the basal ganglia, but their 
sample size was too small for subanalyses.24 A remarkable fi nding in our study was the 
relevance of WMLs in the limbic area for gait velocity. This is in accordance with an 
functional MRI study that showed, except for activation of the dorsal premotor cortex and 
supplementary motor area, also activation of the cingulate motor area and the parahippo-
campal gyri.108 These latter two areas are part of the limbic area and believed to be 
required for spatial navigation. Finally, we found that lacunar infarcts in the brainstem 
were associated with a lower cadence. This suggests that cadence is regulated, among 
others, by regions in the brainstem (and cerebellum), such as the mesencephalic 
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locomotor regions. One other study also demonstrated that persons with WMLs in the 
brainstem walked more slowly.100 Our fi ndings support the notion that gait relies on 
widespread cerebral networks that are vulnerable to the disruption by SVD resulting in 
impaired gait. Further studies, for example with the aid of diffusion tensor imaging, may 
be useful to investigate the disruption of these networks by cerebral SVD more precisely. 
In conclusion, cerebral SVD contributes to disturbances in gait even at a preclinical level 
that currently cannot be identifi ed properly with the standard semi-quantitative clinical 
tests. Stride length may be a useful measure for the early detection of gait abnormalities 
due to SVD. Follow-up studies are needed to study possible gait deterioration in those 
patients. A clinical rule of thumb could be that gait disturbances should only be attributed 
to SVD in patients with moderate or severe WMLs and/or the presence of >2 lacunar 
infarcts, especially at specifi c locations. This provides an explanation why only a part of 
patients with SVD suffers from gait disturbances. As cerebral SVD may, in part, be 
preventable, it should be regarded as a potentially therapeutic target for postponing gait 
impairment.
Chapter 2.1
51
White matter lesions and lacunar infarcts and gait disturbances
2

2.2
Severity and location of white matter 
lesions and lacunar infarcts are associated 
with mild parkinsonian signs
Submitted as
de Laat KF, van Norden AG, Gons RA, van Uden IW, van Oudheusden LJ, van Dijk EJ, 
Bloem BR, Zwiers MP, de Leeuw F-E. Severity and location of cerebral small vessel 
disease are associated with mild parkinsonian signs.
Abstract
Background and objectives
Mild parkinsonian (MPS) signs are common in older adults, and may be an early stage of 
parkinson(ism). They might be related to cerebral small vessel disease (SVD), including 
white matter lesions (WMLs) and lacunar infarcts. It may be of great importance to identify 
and subsequently treat (i.e. vascular risk factors) subjects at early stages of the disease, 
as it may be expected that this might halt or delay conversion to parkinsonism. However, 
as SVD is far more prevalent than MPS, other factors than the mere presence of SVD 
presumably contribute to the presence of MPS. We therefore investigated the association 
between severity and location of WMLs and lacunar infarcts and the presence of MPS.
Methods
430 individuals, with SVD, aged between 50 and 85 years and without dementia or 
parkinsonism, were included in this analysis and underwent MRI scanning. The number 
and location of lacunar infarcts were rated. WML volume was assessed by manual 
segmentation, with automated delineating of different regions. Presence of MPS was 
based on the motor section of the Unifi ed Parkinson’s Disease Rating Scale. Associations 
were determined using logistic regression analysis, adjusted for age, sex and total brain 
volume. 
Results
Severe WMLs and the presence of lacunar infarcts were independently associated with 
the presence of MPS (OR 2.8; 95% CI 1.5-5.3 and OR 1.8; 95% CI 1.0-3.1). Frontal and 
parietal WMLs and, to a lesser extent, lacunar infarcts in the thalamus were associated 
with a higher risk of MPS. The presence of lacunar infarcts was independently related to 
the bradykinesia category of parkinsonian signs. 
Conclusions
This study shows that SVD, especially at certain locations, is associated with MPS in older 
adults. Our fi ndings suggest that SVD interrupts basal ganglia-thalamocortical circuits 
involving both the frontal and parietal lobes and hence may result in parkinsonian signs.
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Introduction
Individuals with small vessel disease (SVD), including white matter lesions (WMLs) and 
lacunar infarcts, may not only exhibit cognitive impairment, but also motor disturbances, 
including mild parkinsonian signs (MPS), such as bradykinesia, rigidity, tremor and gait/
balance disturbances51,109,110 They are common in elderly people with a prevalence in 
20-30%,15 and are associated with increased morbidity and mortality.15,111,112 As isolated 
MPS usually progress,113 they could be considered a prodromal stage of more full-blown 
parkinsonism.
In contrast to the well-studied association between vascular risk factors and lesions and 
(mild) cognitive impairment,50,114 much less attention has been paid to the association 
between these factors and motor performance. If these associations will also be 
demonstrated for MPS and parkinsonism, the identifi cation of SVD-related MPS and 
subsequent management of vascular risk factors might be an important strategy for 
preventing and delaying progression to (vascular) parkinsonism, as is demonstrated for 
cognitive decline and dementia.115 As not all older adults with SVD (prevalence >80%2) 
have similar risks of MPS, it is important to know which factors other than the mere 
presence of SVD play a role in the development of MPS. We hypothesized that the severity 
of WMLs or lacunar infarcts is one of these factors. Secondly, the specifi c location of 
these lesions could be related to the presence of MPS. To date, most studies on the 
relationship between severity or location of SVD and MPS focused on gait/balance 
disturbances.25,98,116 The association between the severity of lacunar infarcts and presence 
of (other) MPS, and that between the location of SVD and MPS has never been investigated.
We therefore investigated the independent association between both WMLs and lacunar 
infarcts, their severity and location, and the risk of MPS and the different categories.
Methods
Study population
This study is embedded in the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort study that 
was designed to investigate risk factors and cognitive, motor and mood consequences of 
functional and structural brain changes as assessed by MRI among older adults with 
cerebral SVD. The primary outcome of the longitudinal part of the RUN DMC study is the 
development of dementia or parkinsonism.117
Recruitment methods and other details of the RUN DMC design are described elsewhere.117 
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In short, in 2006, 503 consecutive individuals referred to the Department of Neurology 
between October 2002 and November 2006, were selected for participation. Inclusion 
criteria were (a) age between 50 and 85 years, (b) WMLs and/or lacunar infarct(s) on 
neuroimaging. Subsequently, acute (transient ischemic attack or lacunar syndromes) or 
subacute symptoms were assessed by standardized structured assessments. As 
suggested for clinical studies, patients were primarily selected on brain imaging features, 
since clinical symptoms of SVD are more heterogeneous and typically mild at the onset 
of cerebral SVD.12
Because we wanted to study the association between SVD and parkinsonian signs in the 
earliest symptomatic manifestation of parkinson(ism) (i.e. MPS), we excluded patients 
with (a) parkinsonism61,101 and (b) dementia.60 Other exclusion criteria were: (c) intracranial 
hemorrhage; (d) life expectancy of <6 months; (e) intracranial space-occupying lesion; (f) 
(psychiatric) disease interfering with cognitive testing or follow-up; (g) recent or current 
use of acetylcholine-esterase inhibitors, neuroleptic agents, L-dopa or dopa-a(nta)
gonists; (h) non-SVD-related WML (e.g. multiple sclerosis); (i) prominent visual or hearing 
impairment; (j) language barrier; (k) MRI contraindications or claustrophobia. Additional 
exclusion criteria for this study were: (l) conditions not related to SVD that affected 
assessment of MPS with the motor section of the Unifi ed Parkinson’s Disease Rating 
Scale (UPDRSm)74 (e.g. joint fusion, amputation, severe arthritis, psychogenic gait 
disturbance) (n=16); (m) territorial infarcts, because they were considered potential 
confounders (n=56). Tissue segmentation was not possible in 1 scan, yielding a fi nal 
sample size of 430 subjects for this study.
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
MRI scanning and processing
All MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom 
Sonata, Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 
magnetization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time 
(TE)/inversion time (TI) 2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm], and 
a fl uid-attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 9000/84/2200 ms; 
voxel size 1.0x1.2x5.0 mm, plus an interslice gap of 1.0 mm).
All imaging analyses were performed by raters blinded to clinical information. White 
matter signal hyperintensities on FLAIR scans, which were not, or only faintly, hypo-intense 
on T1-weighted images, were considered WMLs, except for gliosis surrounding infarcts. 
WMLs were manually segmented on the FLAIR images by two trained raters. The 
inter-rater variability for total WML volume, obtained in a random sample of 10%, was 
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good (intra-class correlation coeffi cient 0.99). In addition, we computed WML volume of 
predefi ned volumes-of-interest, taken from an inversely normalized (parameters taken 
from the T1 normalization) Talairach-based atlas103 (WFU Pickatlas, v2.3), including the 
frontal, parietal, occipital, temporal lobe and sublobar (basal ganglia, thalamus, internal 
and external capsule, insula) and limbic area (cingulate gyrus), brainstem and cerebellum.
Lacunar infarcts were rated and defi ned as areas with a diameter >2 mm and ≤15 mm 
with low signal intensity on T1 and FLAIR, ruling out enlarged perivascular spaces and 
infraputaminal pseudolacunes.33 Intra- and inter-rater reliability for the number of lacunar 
infarcts in a random sample of 10% yielded a weighted kappa of 0.80 and 0.88.
Automated segmentation on the T1 images was conducted using Statistical Parametric 
Mapping (SPM5) (http://www.fi l.ion.ucl.ac.uk/spm/) to obtain grey and white matter and 
cerebrospinal fl uid probability maps.92 These were binarized by applying a 0.5 treshold 
and summed to provide total volumes. Total brain volume was then calculated as the sum 
of total grey and white matter volumes.
Measurement of mild parkinsonian signs
MPS were assessed by two trained residents in neurology, using the items of the UPDRSm 
(27 items, score 0-4).74 The inter-rater variability, assessed in a random sample of 17%, 
yielded an intra-class correlation coeffi cient of 0.90. MPS were defi ned as present when the 
participant had either: (a) ≥2 items with a score of 1 or (b) 1 item with a score of ≥2.109 
Subsequently, we divided the UPDRSm into four categories: bradykinesia (based on 9 
items), tremor (based on 7 items), rigidity (based on 5 items), and gait/balance/axial function 
(based on 6 items). A category was considered present when the participant had in that 
category either: (a) ≥2 items with a score of 1 or (b) 1 item with a score of ≥2.109 Parkinsonism 
was considered present when the following condition was met: ≥2 items with a score of ≥2 
in at least 2 different categories.101 These patients were excluded from this part of the study.
Other measurements
We considered age, sex and total brain volume as possible confounders. Because SVD 
is correlated with the total brain volume42 and cerebral atrophy is a predictor of MPS,110 this 
was also considered a potential confounder. We used the Mini Mental State Examination 
score (range 0–30) to assess global cognitive status.64 Functional independence was 
assessed using the Barthel Index (range 0–20).84 
Statistical analysis
Baseline characteristics were summarized as mean with standard deviation (SD), median 
with interquartile range or absolute numbers with percentages. 
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Firstly, the proportion of MPS (dependent variable) was analyzed in quintiles of the WML 
distribution (independent variable) by analysis of covariance with adjustment for age, sex, 
total brain volume and the number of lacunar infarcts. Based on this analysis, the upper 
quintile of the WML volume distribution was considered severe (>20.6 ml). In another model 
the same was done with lacunar infarcts divided into fi ve groups with adjustment for age, 
sex, total brain volume and WML volume. Secondly, the risk of the presence of MPS 
(dependent variable) in subjects with severe WMLs (independent variable) was assessed 
with logistic regression analysis, with the other four quintiles as reference, adjusting for age, 
sex and total brain volume. The same was done for the presence of lacunar infarcts (model 
1). Subsequently we adjusted either for the number of lacunar infarcts (with WMLs as 
independent variable) or WML volume (with lacunar infarct as independent variable) (model 
2). These analyses were repeated for the four categories of parkinsonian signs. Data are 
presented as odds ratios (OR) with 95% confi dence intervals (CI). Finally, the association 
between the location of severe WMLs or presence of lacunar infarcts on MPS was assessed 
by means of logistic regression analysis, adjusted for the former mentioned variables 
(model 1). In each region, WML volume in the upper quintile was considered as severe. The 
subsequent model was additionally adjusted for the presence of severe WMLs and lacunar 
infarcts in the other regions than the one under study (model 2).
All data were analyzed using SPSS statistical software, v16.0.
Results
Characteristics
Table 1 shows the characteristics of the study population (n=430). Mean age was 65.2 
years (SD 8.9) with 45.1% being women. MPS were present in 92 (21.4%) participants 
[bradykinesia in 40 (9.3%), rigidity in 38 (8.8%), tremor in 20 (4.7%) and gait/balance 
disturbances in 17 (4.0%)]. The median WML volume was 6.4 ml (interquartile range 
3.2-17.7). Lacunar infarcts were present in 30.7% of all subjects [38 participants (8.8%) 
had a lacunar infarct in the basal ganglia, 25 (5.8%) in the thalamus]. 
Small vessel disease and mild parkinsonian signs
The proportion of subjects with MPS was only signifi cantly higher in those with severe 
WMLs (>20.6 ml; 37.7% MPS) compared to all other quintiles [e.g. to mild WMLs (<2.8 ml) 
18.3%; P=0.005]. A possible threshold-effect was also found with regard to the number 
of lacunar infarcts: the proportion of subjects with MPS in the group patients with >3 
lacunar infarcts was higher (44.7%) than that for example in the group without an infarct 
(18.3%; P=0.004) (Figure 1). 
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When expressed as ORs, subjects with severe WMLs were almost three times more likely 
to have MPS than the reference group (OR 2.8; 95% CI 1.5-5.3), independent of the 
number of lacunar infarcts. They had an increased risk of bradykinesia (OR 3.1; 95% CI 
1.5-6.5), rigidity (OR 2.4; 95% CI 1.1-5.1) and gait/balance disturbances (OR 3.7; 95% CI 
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Table 1 Characteristics of the study population
Characteristics n=430
Demographic and clinical characteristics
Age, yrs 65.2 (8.9)
Female, no. 194 (45.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Subjects with mild parkinsonian signs, no. 92 (21.4)
Bradykinesia, no. 40 (9.3)
Rigidity,  no. 38 (8.8)
Tremor, no. 20 (4.7)
Gait/balance disturbance, no. 17 (4.0)
Neuroimaging characteristics
Total brain volume, ml 1099.1 (119.6)
White matter volume, ml 467.5 (64.9)
White matter lesion volume, ml† 6.4 (3.2; 17.7)
Frontal, ml† 2.1 (0.9; 6.1)
Parietal, ml† 0.2 (0.0; 1.1)
Occipital, ml† 0.6 (0.3; 1.1)
Temporal, ml† 0.4 (0.1; 1.6)
Sublobar, ml† 2.5 (1.2; 4.5)
Limbic, ml† 0.4 (0.2; 1.1)
Infratentorial, ml† 0.2 (0.1; 0.6)
Subjects with lacunar infarct(s), no. 132 (30.7)
Frontal, no. 47 (10.9)
Parietal, no. 23 (5.3)
Occipital, no. 14 (3.3)
Temporal, no. 11 (2.6)
Sublobar, no. 72 (16.7)
Limbic, no. 0 (0.0)
Infratentorial, no. 25 (5.8)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range).
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1.3-10.9). These associations disappeared after additional adjustment for the number of 
lacunar infarcts. The presence of lacunar infarcts was independently associated with an 
increased risk of MPS (OR 1.8; 95% CI 1.0-3.1) due to a higher risk of bradykinesia (OR 
2.7; 95% CI 1.3-5.7) (Table 2).
When analyzing according to lesion location, severe WMLs in the frontal (OR 2.7; 95% CI 
1.2-6.2) and parietal (OR 2.4; 95% CI 1.1-5,4) lobe appeared most strongly related to MPS, 
even after additional adjustment for WMLs and lacunar infarcts in the other parts of the 
brain (Table 3). Subjects with lacunar infarcts in the sublobar area (basal ganglia, 
thalamus, internal and external capsule) had a higher risk of MPS (OR 2.0; 95% CI 1.1-3.8), 
which was mainly driven by infarcts in the thalamus (OR 3.5; 95% CI 1.4-8.9). This risk 
disappeared after adjusting for WMLs and lacunar infarcts in the other regions.
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Figure 1   Association between cerebral small vessel disease and presence of 
mild parkinsonian signs
Adjusted for age, sex, total brain volume and number of lacunar infarcts (panel A) or WML volume (panel 
B) (± standard error). Quintiles of WML volume represent 0.5-2.8; 2.8-5.1; 5.1-8.9; 8.9-20.6; 20.6-140.0 ml 
WMLs respectively.
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Table 3   Association between location of cerebral small vessel disease and 
presence of mild parkinsonian signs
Severe
cerebral small vessel 
disease†
Presence of mild parkinsonian signs‡
Model 1
OR (95% CI)
Model 2
OR (95% CI)
Frontal
WML volume 3.4 (1.9-6.1)** 2.7 (1.2-6.2)*
Lacunar infarcts 1.5 (0.7-3.2) 1.4 (0.6-2.9)
Parietal
WML volume 3.3 (1.9-6.0)** 2.4 (1.1-5.4)*
Lacunar infarcts 1.3 (0.5-3.5) 1.0 (0.4-2.9)
Occipital
WML volume 1.9 (1.1-3.4)* 1.2 (0.6-2.3)
Lacunar infarcts 1.5 (0.4-5.4) 1.4 (0.4-4.7)
Temporal
WML volume 2.8 (1.6-4.9)** 1.7 (0.8-3.7)
Lacunar infarcts 1.1 (0.2-4.9) 1.0 (0.2-4.5)
Sublobar
WML volume 2.0 (1.1-3.7)* 1.2 (0.6-2.9)
Lacunar infarcts 2.0 (1.1-3.8)* 1.1 (0.5-2.4)
Limbic
WML volume 2.5 (1.4-4.4)* 1.1 (0.5-2.6)
Lacunar infarcts - -
Infratentorial
WML volume 3.1 (1.7-5.4)** 2.0 (0.9-4.5)
Lacunar infarcts 1.1 (0.4-3.0) 0.9 (0.3-2.3)
Model 1 is with adjustment for age, sex, total brain volume and presence of lacunar infarcts or severe 
WML volume; model 2 is with additional adjustment for severe WML volume and presence of lacunar 
infarcts in the other regions.
Sublobar = basal ganglia, thalamus, internal and external capsule, insula
†Defi ned as the upper quintile of the WML volume distribution  or presence of lacunar infarcts; 
‡defi ned as UPDRSm ≥2; *P<0.05; **P<0.001
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Discussion
We found that severe WMLs, especially in the frontal and parietal lobe, were associated 
with an increased risk of MPS. Lacunar infarcts, particularly in the thalamus, were also 
independently associated with an increased risk of MPS, mainly due to the presence of 
bradykinesia. 
Some limitations of this study need to be considered. MPS were assessed by clinical 
examination by means of the UPDRSm score, which has a subjective nature. It is 
sometimes diffi cult to distinguish between rigidity, spasticity or paratonia and between 
bradykinesia and pyramidal or non-neurological slowing, especially in subjects with 
minimal impairment.118 We tried to overcome this problem by rating all subjects by two 
experienced residents in neurology with a high inter-rater agreement. Secondly, we here 
report on cross-sectional data, which prevents us from making causal inferences. The 
RUN DMC study has a longitudinal design and follow-up is already planned to evaluate 
the effect of progression of SVD on (changes in) MPS. Strengths of this study are the large 
sample size, the high response rate and the recruitment of subjects in a single research-
center. Other strengths are the quantitative assessment of WML volume, and the fact that 
we were able to investigate the effect of SVD independent of possible confounders such 
as total brain volume and WMLs (and lacunar infarcts with WMLs as independent variable). 
However, adjustment for concomitant SVD present in a different region or from a different 
kind (WMLs and lacunar infarcts) could also have resulted in overcorrection and hence 
underestimation of effect sizes. For example, WMLs could be considered an external 
confounding factor in the relationship between lacunar infarcts and MPS, but also as part 
of the same causal chain. Therefore, we present both the adjusted and unadjusted 
estimates. We intentionally did not correct for vascular risk factors such as hypertension 
or diabetes, as they were considered part of the causal chain between SVD and MPS. 
Finally, using almost the same defi nitions of MPS as other studies, the prevalence (21.4%) 
in our study is in accordance with those in community-dwelling people without dementia 
ranging from 15.7-21.9%,109,111 indicating a high generalizibility of our study.
The association between severe WMLs and the presence of MPS, independent of lacunar 
infarcts, is consistent with that found in another large study,109 but our fi nding of an 
independent higher risk of MPS in subjects with lacunar infarct(s) is novel. Although data 
from previous smaller-sized studies reporting on the relationship between lacunar infarcts 
and bradykinesia were conﬂ icting,51,110 we found that the increased risk of MPS in subjects 
with lacunar infarct(s) was mainly due to a higher risk of bradykinesia. Moreover, we found 
that only those with several lacunar infarcts or severe WMLs had MPS more often. This 
suggests that a certain amount of damage to the structural integrity of the white matter is 
White matter lesions and lacunar infarcts and mild parkinsonian signs
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needed before disconnection and subsequently MPS occur. The increased risk of MPS in 
subjects with severe WMLs seemed to be explained by the presence of bradykinesia, 
rigidity or gait/balance disturbances, although the signifi cance disappeared after 
adjustment for lacunar infarcts. This may be due to a lack of power (type II error) as the 
size of the groups with bradykinesia, rigidity or gait/balance was small (17-40 subjects). 
In addition, the UPDRSm is not the most sensitive way to investigate gait/balance as it 
only addresses some aspects in a semi-quantitative way. 
Another important factor leading to an increased risk of MPS in our study was the 
anatomical location of these WMLs and lacunar infarcts. Severe WMLs in the parietal and 
frontal lobe, and to a lesser extent thalamic infarcts were associated with an increased 
risk of MPS. SVD in the latter two regions is suggested to interrupt the basal ganglia-
thalamo-frontal cortical circuits leading to a reduction in the thalamo-cortical drive and 
subsequently parkinsonism,62 but this concept is still somewhat controversial. Our 
fi ndings provide additional evidence for this hypothesis, interestingly even at a preclinical 
level of parkinsonism. Other small-sized studies supporting this hypothesis are among 
subjects in the more severe part of the spectrum, i.e. overt vascular parkinsonism.62,119-122 
An intriguing fi nding in our study was the association between severe WMLs in the parietal 
lobe and MPS. This may suggest that altered somatosensory processing and sensorimotor 
integration contributes to the development of parkinsonian signs in patients with SVD. Our 
fi nding is indirectly supported by recent studies in patients with Parkinson’s disease. A 
diffusion tensor imaging study showed loss of integrity of the superior longitudinal 
fasciculus,123 connecting frontal with parietal areas and a resting-state functional MRI 
study showed decreased coupling between basal ganglia and the inferior parietal cortex 
in these patients.124
In conclusion, these fi ndings support the hypothesis of a vascular contribution to MPS in 
older adults, especially in those with severe WMLs or several lacunar infarcts. Future 
studies are needed to investigate to what extent MPS are a marker of the subsequent 
development of vascular parkinsonism and to provide more insight in causality of the 
found associations. If so, control of risk factors for SVD, such as hypertension, could halt 
progression of these lesions and hence prevent the development of (vascular) 
parkinsonism. This study also indicates that damage to the basal ganglia-thalamocortical 
circuits of both the frontal and parietal lobe are important in the development of MPS. 
Diffusion tensor imaging may be useful in future studies to investigate the disruption of 
these networks by SVD more precisely. 
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2.3
Severity and location of microbleeds are 
associated with gait disturbances
Published as
de Laat KF, van den Berg HA, van Norden AG, Gons RA, Olde Rikkert MG, de Leeuw F-E. 
Microbleeds are independenlty related to gait disturbances in elderly individuals with 
cerebral small vessel disease. Stroke 2011; 42: 494-497.
Abstract
Background and objectives 
Cerebral small vessel disease (SVD), including white matter lesions (WMLs) and lacunar 
infarcts, is related to gait disturbances. Microbleeds are another manifestation of SVD, but 
their clinical impact remains unclear. We therefore investigated the relationship between 
the number and location of microbleeds and gait, independent of WMLs and lacunar 
infarcts.
Methods
485 older adults, without dementia or parkinsonism, with cerebral SVD underwent MRI 
scanning. The number and location of microbleeds was rated. Gait was assessed with a 
GAITRite system and the Tinetti and Timed-Up-and-Go (TUG) test. Microbleeds were 
related to gait parameters by age, height, total brain volume, WML volume and number of 
lacunar infarcts adjusted linear regression.
Results
A higher number of microbleeds was independently related to a shorter stride length, and 
poorer performance on the Tinetti and TUG test. These relationships seemed to be 
explained by microbleeds in the temporal and frontal lobe and basal ganglia, including 
the thalamus.
Conclusions
This study offers the fi rst indication that microbleeds may be associated with gait 
disturbances, independent of other coexisting markers of SVD. 
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Introduction
Cerebral small vessel disease (SVD), including white matter lesions (WMLs) and lacunar 
infarcts, adversely affects gait.116 Cerebral microbleeds are increasingly being recognized 
as another manifestation of cerebral SVD.3 However, the consequences of microbleeds 
are largely unknown. They are generally considered clinically silent, although some recent 
studies showed a relationship between microbleeds and cognitive disturbances.28-31 
Whether these associations can be attributed to a direct effect of microbleeds or to the 
accompanying WMLs and lacunar infarcts, remains incompletely understood. As far as 
we know, the relationship between microbleeds and gait disturbances has never been 
studied. We hypothesized that microbleeds are associated with gait disturbances, 
preferentially in regions related to the control of gait, such as the frontal lobe and basal 
ganglia.116 We therefore cross-sectionally investigated the association between 
microbleeds, their location, and gait in older adults with cerebral SVD.
Subjects and methods
Study population
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging 
Cohort (RUN DMC) study is a prospective cohort study that investigates risk factors and 
clinical consequences of brain changes as assessed by MRI among non-demented older 
adults with cerebral SVD, referred to our the Department of Neurology.117 A total of 503 
participants, aged between 50 and 85 years, were enrolled in the original cohort. For the 
present study, those with inability to walk 6 m unaided (n=4), current levodopa use (n=1), 
conditions that affected gait performance (n=10)116 or an uninterpretable MRI (n=3) were 
additionally excluded, yielding a fi nal sample size of 485 subjects. 
MRI scanning and processing
Standardized T1 and T2-weighted116 and gradient-echo T2*-weighted sequences 
[repetition time (TR)/echo time (TE) 800/26 ms: voxel size 1.3x1.0x5.0 mm, plus an 
interslice gap of 1.0 mm], were acquired. WMLs (ml), lacunar infarcts (no.), territorial 
infarcts (no.) (diameter >15 mm in known arterial territories) and total brain volume (ml) 
were assessed according to a standardized protocol.117 The number of microbleeds were 
rated by two trained raters according to recently formulated criteria36 and categorized into 
a lobar, deep or infratentorial location.28,125 In a random sample of 10%, intra- and inter-rater 
reliability for the total number of microbleeds yielded an intraclass correlation coeffi cient 
of 0.79 and 0.99; inter-rater reliability for the number in individual locations 0.94-1.00.
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Measurement of gait
As reported previously,116 we measured gait velocity, stride length, cadence, stride width 
and double support percentage using the 5.6m GAITRite system (MAP/CIR Inc., 
Havertown, PA). In addition, we used the Tinetti and Timed-Up-and-Go (TUG) test.
Statistical analysis 
Statistical analysis was performed using SPSS v16.0. As the number of microbleeds were 
positively skewed, we changed the two highest scores (15 and 32) into the next highest 
score (10) to reduce the skewness to some extent. Other methods to reduce the skewness, 
such as log transformation, did not change the presented associations. The association 
between the number of microbleeds and gait was investigated using multiple linear 
regression analysis, adjusted for age, sex, height, total brain volume and number of 
territorial infarcts. We subsequently adjusted for WML volume (log transformed) and the 
number of lacunar infarcts. Secondly, the effect of the location of microbleeds was studied 
adjusted for the above-mentioned covariates and in the second model also for the 
remaining microbleeds at other locations. Bonferroni correction was applied by adjusting 
the signifi cance level to P=0.05/9=0.0056. The location was furthermore studied in four 
groups (no microbleeds, strictly lobar, deep/infratentorial and mixed) using analysis of 
covariance, adjusted for age, sex, height, total brain volume, number of territorial and 
lacunar infarcts and WML volume. Finally, we studied whether results changed when we 
additionally excluded subjects with territorial infarcts.
Results
Characteristics
Characteristics of the study population are shown in Table 1. The prevalence of micro - 
bleeds was 10.7% (52/485). Of those with microbleeds, 48.1% (95% CI 43.7-52.5) had 
1 microbleed, 21.1% (95% CI 17.5-24.7) had 2 microbleeds, 15.4% (95% CI 12.2-18.6) 
had 3-5 microbleeds and 15.4% (95% CI 12.2-18.6) had >5 microbleeds. 31 (59.6%) 
individuals exhibited microbleeds only in lobar areas and 7 (13.5%) in a strictly deep/
infratentorial location. 
The number of microbleeds and territorial infarcts were not signifi cantly related to each 
other (Pearson correlation coeffi cient=0.02) and additional exclusion of subjects with 
territorial infarcts did not change the presented associations.
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Table 1 Characteristics of the study population
Characteristics n=485
Demographic and clinical characteristics
Age, yrs 65.6 (8.8)
Female, no. 209 (43.1)
Height, m 1.7 (0.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Subjects with hypertension, no.‡ 359 (74.0)
Subjects with diabetes mellitus, no.§ 73 (15.1)
Subjects with hypercholesterolemia, no.# 230 (47.4)
Smokers, current, no. 72 (14.8)
Smokers, former, no. 267 (55.1)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 111.5 (10.8)
Stride width, cm 11.0 (3.1)
Double support percentage 26.0 (4.2)
Tinetti  test† 28.0 (28.0; 28.0)
Timed-Up-and-Go test, s† 8.9 (7.7; 10.5)
Neuroimaging characteristics
Subjects with microbleed(s), no. 52 (10.7)
Lobar, no. 45 (9.3)
Frontal, no. 23 (4.7)
Parietal, no. 20 (4.1)
Occipital, no. 13 (2.7)
Temporal, no. 16 (3.3)
Deep, no. 13 (2.7)
Basal ganglia, no. 8 (1.6)
Thalamus, no. 8 (1.6)
External capsule, no. 2 (0.4)
Infratentorial, no. 10 (2.1)
Total brain volume, ml 1093.5 (121.5)
White matter volume, ml 464.1 (66.8)
White matter lesion volume, ml† 7.2 (3.4; 18.1)
Subjects with lacunar infarct(s), no. 166 (34.2)
Subjects with territorial infact(s), no. 56 (11.5)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range).
‡Blood pressure ≥ 140/90 mmHg and/or use of antihypertensive drugs; §using oral glucose-lowering 
drugs or insulin; #using lipid-lowering drugs
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Microbleeds and gait 
A higher number of microbleeds was associated with a lower gait performance (Table 2). 
After additional adjustment for WML volume and lacunar infarcts, microbleeds were still 
related to a shorter stride length (standardized β=-0.09; P=0.016) and borderline 
signifi cant to a longer double support percentage (standardized β=0.08; P=0.067). The 
independent relationship between microbleeds and gait disturbances was even more 
pronounced for the clinical rating scales (Table 2).
Location of microbleeds and gait
Microbleeds in the frontal and temporal lobe and basal ganglia were signifi cantly related 
to a shorter stride length and in the temporal lobe also to a lower gait velocity (Table 3), 
even after adjustment for the number of microbleeds at other sites. A lower score on both 
clinical rating scales was also signifi cantly related to microbleeds in the thalamus.
When subjects with microbleeds were divided into three groups (strictly lobar, deep/
infratentorial and mixed), subjects with mixed microbleeds had a signifi cantly shorter 
stride length (mean 1.25 m; P=0.007) and a longer TUG test (mean 10.86 s; P=0.005) 
than those without microbleeds (mean 1.39 m and 9.08 s) as was true for persons with 
strictly deep/infratentorial microbleeds (mean 1.30 m; P=0.189 and 10.59 s; P=0.071) 
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Table 2   Association between number of microbleeds and gait
Number of 
microbleeds
Gait parameters
GAITRite parameters Clinical rating 
scales
Gait 
velocity
(m/s)
Stride 
length
(m)
Cadence 
(steps/
min)
Stride 
width
(cm)
Double 
support 
percentage
(%)
Tinetti 
test
TUG 
test† 
(s)
Model 1 -0.16* 0.17** -0.08 0.12* 0.16** -0.23** 0.21**
Model 2 -0.12* 0.14*  -0.05 0.11* 0.14* -0.21** 0.17** 
Model 3 -0.07 -0.09* -0.01 0.05 0.08 -0.17** 0.14* 
Data are standardized beta-values.
Model 1 represents the unadjusted relationship between the number of microbleeds and gait; model 2 is 
with adjustment for age, sex, height, total brain volume and the number of territorial infarcts; model 3 is 
with additional adjustment for WML volume and the number of lacunar infarcts.
†For skewed variables the logarithm is presented; *P<0.05; **P<0.001
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although not signifi cant. In contrast, subjects with strictly lobar microbleeds, the largest 
group, did not differ from those without microbleeds. 
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Table 3   Association between location of microbleeds and gait
Number of 
microbleeds
Gait parameters
GAITRite parameters Clinical rating scales
Gait 
velocity
(m/s)
Stride 
length
(m)
Cadence
(steps/
min)
Tinetti TUG test†
(s)
Lobar -0.05 -0.07 0.00 -0.16* 0.11* 
Frontal -0.09 -0.12* -0.01 -0.23* 0.17* 
Parietal 0.01 0.00 0.02 -0.05 0.03 
Occipital 0.04 0.04 0.03 0.05 -0.04 
Temporal -0.12* -0.15* -0.06 -0.26* 0.20* 
Deep -0.08 -0.11* 0.03 -0.20* 0.14*
Basal 
ganglia
-0.07 -0.11* 0.02  -0.20* 0.15*
Thalamus -0.03 -0.05 0.02  -0.17* 0.10* 
Infratentorial -0.02 -0.03 0.01 -0.01 0.07
Data are standardized beta-values.
Adjusted for age, sex, height, total brain volume, the number of territorial and lacunar infarcts and WML 
volume. 
†for skewed variables the logarithm is presented; *signifi cant after Bonferroni correction (P<0.006)
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Discussion
We found that the number of microbleeds, especially those located in the frontal, temporal 
lobe and basal ganglia (and thalamus), interfered with gait, independent of coexisting 
WMLs and lacunar infarcts. 
Strengths of our study include the large sample size and quantitative assessment of gait. 
Moreover, we were able to investigate the effect of microbleeds on gait independent of 
WMLs, segmented manually, infarcts and total brain volume. We intentionally did not 
adjust for vascular risk factors such as hypertension, as they were considered an earlier 
part of the causal chain between microbleeds and gait. On the other hand, interpretation 
of our results regarding cause and effect is limited because of the cross-sectional design. 
Secondly, since recent MRI techniques have improved the detection of microbleeds,36 we 
may have underestimated the actual number of microbleeds. This may probably have led 
to a systematic measurement error that may have affected the effect size, but not our 
observation of an association between microbleeds and gait.
Microbleeds were independently related to a shorter stride length and poorer scores on 
the clinical rating scales. We furthermore found that their location played a role in these 
associations, independent of coexisting WMLs or lacunar infarcts. These fi ndings, 
together with results from pathological studies showing that microbleeds are frequently 
characterized by surrounding microstructural damage,126 suggest that they have a direct 
effect on motor performance rather than simply reﬂ ecting the presence of other markers 
of SVD. 
We found that microbleeds in the basal ganglia, the thalamus and frontal lobe, areas 
involved in the control of gait,13 were related to gait disturbances. This is in line with our 
earlier report on the relationship between the presence of other markers of SVD, WMLs 
and lacunar infarcts, in these regions and gait disturbances.116 The association between 
microbleeds in the temporal lobe, involved in processing visual and vestibular signals, 
and gait is also in accordance with functional imaging studies of normal gait.130 This 
fi nding is interesting, as the temporal lobe is not a predilection site for WMLs,127 and 
therefore may indicate much more widespread disruption of neuronal networks in subjects 
with SVD and gait disturbances than previously thought based on conventional 
T2-weighted images. 
It is suggested that strictly lobar located microbleeds are attributable to amyloid 
angiopathy, while microbleeds in deep/infratentorial regions (with or without lobar 
microbleeds) rather represent hypertensive microangiopathy.125 Our fi ndings are therefore 
suggestive of hypertensive SVD as the underlying etiology, although we have to note that 
these results should be interpreted with caution (the mean number of microbleeds in the 
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mixed group was higher than in the other two groups with equal number of microbleeds). 
In conclusion, this study offers the fi rst indication that cerebral microbleeds may contribute 
to gait disturbances, independent of other coexisting markers of SVD. Other studies are 
needed to replicate these fi ndings.
Microbleeds and gait disturbances
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Abstract
Background and objectives 
Although gait disturbances are present in a substantial portion of patients with cerebral 
small vessel disease (SVD), their pathogenesis has not been clarifi ed as they are not 
entirely explained by the white matter lesions (WMLs) and lacunar infarcts. The role of 
cortical thickness in these patients remains largely unknown. We aimed to assess the 
regions of cortical thickness associated with distinct gait parameters in patients with SVD, 
and whether these associations were dependent on WMLs and lacunar infarcts.
Methods
MRI data were obtained from 415 subjects with SVD, aged between 50 and 85 years. We 
assessed cortical thickness using surface-based cortical thickness analysis, and gait 
using the GAITRite system.
Results
Cortical thickness of predominantly the orbitofrontal and ventrolateral prefrontal cortex, 
the inferior parietal lobe, cingulate areas and visual association cortices was positively 
related to stride length. Thickness of the primary and supplementary motor cortices and 
the cingulate cortex was positively related to cadence, while thickness of the orbitofrontal 
and ventrolateral prefrontal cortex, anterior cingulate cortex and especially the inferior 
parietal lobe and superior temporal gyrus was negatively related to stride width. The 
associations with stride length and width were partially explained by the subcortical 
WMLs and lacunar infarcts. 
Conclusions
Cortical thickness may be important in gait disturbances in individuals with SVD, with 
different cortical patterns for specifi c gait parameters. We suggest that cortical atrophy is 
part of the disease processes in patients with SVD.
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Introduction
Cerebral small vessel disease (SVD), including white matter lesions (WMLs) and lacunar 
infarcts, is very common in elderly persons.1 SVD is not only associated with cognitive 
impairment but also with gait disturbances,116 an often neglected, but nevertheless 
important consequence of SVD. However, the anatomical and pathophysiological 
mechanisms underlying these gait disturbances in SVD remain poorly understood. WMLs 
and lacunar infarcts have been found to be important factors.116 A number of studies have 
furthermore demonstrated that measures of global cerebral atrophy are strongly and 
independently related to these gait disturbances.37-39,128
Less is known about the specifi c role of cortical atrophy in gait disturbances in individuals 
with SVD, its spatial distribution and association with subcortical WMLs and lacunar 
infarcts. Only two studies have investigated the relationship between cortical atrophy and 
gait performance.38,39 Using volumetric morphometry, they found that cortical volume in 
some frontoparietal regions was positively related to gait performance. An alternative 
MR-based morphometric approach is that of cortical thickness analysis.129 Cortical 
thickness methods have been shown to be more sensitive in detecting alterations in 
cortical morphology than the former volumetric approach,130,131 and have been proven to 
be reliable, in terms of spatial localization and magnitude of absolute cortical thickness 
measurement.132 Moreover, cortical volumetric approaches typically require an a priori 
defi nition of a small number of regions-of-interest (ROIs), limiting the possibility of 
exploratory analyses of cortical regions, whereas surface representations allow a 
landmark-based assignment of cortical regions to the entire cortex. Because the networks 
involved in gait are scattered throughout the entire brain in healthy individuals,13 a more 
comprehensive and data-driven analysis, such as is provided by this latter approach, is 
desirable.
It is furthermore not clear whether and to what extent this relationship is (in)dependent of 
the coexisting WMLs and lacunar infarcts. It could be hypothesized that cortical atrophy 
in subjects with SVD, and subsequently gait disturbances, may partly be due to WMLs 
and lacunar infarcts. These lesions may cause disruption of axons traversing the white 
matter with secondary neuronal degeneration of networks connecting relevant cortical 
regions, involved in the control of gait. Rosano et al. found that WMLs and lacunar infarcts 
did not substantially change the regression coeffi cients of these associations, but they 
assessed WMLs only semi-quantitatively.38,39
Using surface-based cortical thickness analysis, we aimed to identify the association 
between  regional cortical thickness and several spatiotemporal gait parameters in a 
large group of older adults with cerebral SVD. A secondary objective of this study was to 
Cortical thickness and gait disturbances
2
80
examine whether these associations were dependent on SVD, including WMLs and 
lacunar infarcts.
Methods
Study population
This study is embedded in the RUN DMC study, a prospective cohort study that 
investigates risk factors and clinical consequences of brain changes as assessed by MRI 
among older adults with cerebral SVD, with the development of dementia or parkinsonism 
as the primary study outcome.117 Participants were recruited from the Department of 
Neurology. Recruitment methods and other details of the RUN DMC design are described 
elsewhere.117 The RUN DMC cohort consists of 503 people, aged between 50 and 85 
years, with WMLs and/or lacunar infarct(s) on neuroimaging and acute (transient ischemic 
attack or lacunar syndrome) or subacute (cognitive, motor or depressive) symptoms of 
SVD. As suggested for clinical studies, patients were primarily selected on brain imaging 
features, since clinical symptoms of SVD are more heterogeneous and typically mild at 
the onset of cerebral SVD.12 Exclusion criteria were: (a) dementia;60 (b) parkinson(ism);61,101 
(c) intracranial hemorrhage; (d) life expectancy of <6 months; (e) brain tumor; (f) 
(psychiatric) disease interfering with cognitive testing or follow-up; (g) recent or current 
use of acetylcholine-esterase inhibitors, neuroleptic agents, L-dopa or dopa-a(nta)
gonists; (h) non-SVD-related WMLs (e.g. multiple sclerosis) (i) prominent visual or hearing 
impairment; (j) language barrier; (k) MRI contraindications or known claustrophobia. 
Additional exclusion criteria for this study were: (l) inability to walk 6 m unaided across the 
GAITRite carpet as this measured 5.6 m (n=4); (m) conditions not related to SVD that 
affected gait (e.g. joint fusion, severe arthritis or psychogenic gait disorder) (n=11) and (n) 
territorial infarcts, because they were considered potential confounders and because of 
methodological issues during the cortical thickness analysis (n=55). Assessment of 
cortical thickness was furthermore not possible in 18 scans, because of failures in the 
cortical surface generation process, yielding a sample size of 415 for this study.
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
MRI techniques
All MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom 
Sonata, Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 
magnetization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time 
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(TE)/ inversion time (TI) 2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm] and 
a fl uid-attenuated inversion recovery sequence (TR/TE/TI 9000/84/2200 ms; voxel size 
1.0x1.2x5.0 mm, plus an interslice gap of 1 mm).
MRI analysis
WMLs were manually segmented, and the number of lacunar infarcts rated according to 
a standardized protocol.117 Subsequently, WML volume was calculated.
Cortical thickness was estimated using the Civet pipeline, because this method has proven 
to be more valid than other used techniques like Freesurfer.133 Firstly, structural T1 images 
were aligned to the Montreal Neurological Institute 152 template using a multi-scale, 
9-parameter transformation,134 and corrected for nonuniformities using the nonparametric 
nonuniformity intensity normalization (N3) method.135 Secondly, the image was segmented 
into discrete tissue compartments representing grey matter, white matter, and cerebrospinal 
fl uid, with partial volume estimates being additionally applied to defi ne deep sulci.129 Thirdly, 
deformable surfaces meshes, isomorphic to a sphere, were optimized to fi t the boundaries 
between white/grey matter and grey matter/cerebrospinal fl uid, respectively, using a 
multi-scale method called Constrained Laplacian Automated Segmentation with 
Proximities.129,136 Finally, cortical thickness was calculated as the distance between two 
corresponding vertices (i.e. individual spatial points) on the two boundary surfaces. To 
facilitate intersubject comparisons, individual surfaces were registered to a population 
template surface obtained through an iterative group template registration algorithm.137
Each cortical surface was parcellated into Brodmann areas (BAs), by a deformation from 
its representation on the Population-Average, Landmark- and Surface-based atlas 
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Figure 1   Surface parcellation into Brodmann areas
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(PALS-B12)138 (Figure 1) to the template Civet surface. Since all individual surfaces were 
previously coregistered to this surface, only one such deformation was necessary. In this 
parcellation, BAs were derived from manual delineations according to the original cyto-
architectonic map of Brodmann.139 Using this scheme, the vascular territories were not 
taken into account.
Measurement of gait
As reported previously,116 we measured gait velocity (m/s), stride length (m), cadence 
(steps/minute) and stride width (cm) using the 5.6m GAITRite system (CIR Systems Inc., 
Havertown, PA). For this study, we choose velocity, stride length and width, because our 
previous study demonstrated a clear relationship between these gait parameters on the 
one hand and WMLs or lacunar infarcts on the other116 and the known association of 
velocity with risk of falls.140  As velocity is determined by stride length and cadence, this 
latter gait parameter was also included.
Other measurements
For assessment of vascular risk factors, structured questionnaires were used and an 
experienced research nurse measured the blood pressure three times in the supine 
position after fi ve minutes of rest. The risk factors used were presence of hypertension 
(mean blood pressure ≥140/90 mmHg and/or use of antihypertensive medications),141 
diabetes (treatment with antidiabetic medications), hypercholesterolemia (treatment with 
lipid-lowering medications) and smoking status. The body mass index was also recorded. 
We used the Mini Mental State Examination score (range 0 – 30) to assess global cognitive 
status.64 Functional independence was assessed using the Barthel Index (range 0 – 20).84
Statistical analysis
The baseline characteristics are presented as mean ± standard deviation (SD) and for the 
positively skewed WML volume, the median and interquartile range was calculated (SPSS 
statistical software, version 16.0). The quantitative GAITRite parameters were averaged over 
two walks. When one trial was missing (n=3), the remaining measures were used.
Statistical analysis of cortical thickness was performed using the SurfStat Matlab library,142 
by obtaining independent general linear models for cortical thickness values averaged 
within each subject, for each BA ROI. P-values obtained from these models were corrected 
for family-wise error (FWE) using the Holm-Bonferroni method. There was one comparison 
for each BA, and the hemispheres were considered separately (i.e., corrected for the 
number of areas in one hemisphere rather than both). Also the corrections were made 
separately for each gait measure. The critical P-values we used were 0.05; these are 
corrected P-values. The associations between cortical thickness (independent variable) 
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and the gait parameters of interest (gait velocity, stride length, cadence, or stride width) 
(dependent variable) were tested in two models. The fi rst model was adjusted for age, sex 
and height. The second model was additionally adjusted for total WML volume (log 
transformed) and number of lacunar infarcts. We present both regression coeffi cients, to 
assess the effect size per unit, and standardized beta-values, to compare the associations 
for the different gait parameters to each other. Cortical maps are presented on the 
 population-based template brain used in the Civet pipeline.
Results
Characteristics
Table 1 shows the demographic, clinical, imaging, and gait characteristics of the study 
population (n=415). Mean age was 65.1 (SD 8.8) years and 192 (46.3%) were women. The 
mean cortical thickness was 3.3 (SD=0.2, range 1.8-4.9) mm. Primary motor and 
somatosensory cortices (BA 1-4) were thinnest (mean thickness 2.2-2.6 mm), whereas 
the temporal pole and medial temporal lobe were thickest (mean thickness 3.8-4.0 mm).
Cortical thickness and gait
Table 2 shows the regression coeffi cients and Figure 2 illustrates the standardized 
beta-values of the signifi cant associations between the cortical thickness per BA ROI and 
the different gait parameters. All these regions showed a positive association with gait 
velocity, stride length, and cadence, and a negative association with stride width, 
indicating a lower velocity and cadence, a shorter stride length and broader stride width 
by a decrease of cortical thickness in this study population. Overall, relationships were 
comparable between both hemispheres. For velocity, signifi cant regions were found 
bilaterally in BA ROIs involving almost the entire cortex. As expected (since gait velocity is 
the product of stride length and cadence), these regions correspond to those found for 
stride length plus cadence.
We found associations between stride length and the cortical thickness of virtually the 
entire frontal lobe, except for the bilateral primary motor cortices (precentral gyrus, BA 4). 
The most prominent associations were found in the orbitofrontal (BA 11) and ventrolateral 
prefrontal cortex (BA 44, 45, 47). For the parietal and temporal lobes these areas were 
located in the inferior parietal lobe (BA 39, 40), superior temporal gyrus (BA 22, 41, 42), 
and on the left side the fusiform gyrus (BA 37). A thinner cortical thickness of the visual 
areas (BA 17-19), as well as the anterior and posterior cingulate areas of the limbic region 
(BA 23-25, 31-33), was also associated with a shorter stride length.
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The most prominent associations between a thinner cortical thickness and a lower 
cadence were located in the left cingulate areas (BA 23-25, 31-33), the bilaterally visual 
areas (BA 18), and left fusiform gyrus (BA 37). Other signifi cant associations were found 
in the primary (BA 4) and premotor cortices (BA 6, 8).
Regression analysis between cortical thickness and stride width revealed a signifi cant 
negative association in both hemispheres in regions largely corresponding to the 
Chapter 2.4
Table 1 Characteristics of the study population
Characteristics n=415
Demographic and clinical characteristics
Age, yrs 65.1 (8.8)
Female, no. 192 (46.3)
Height, m 1.7 (0.1)
Body Mass Index, kg/m2 27.1 (4.1)
Subjects with hypertension, no. 296 (71.3)
Subjects with diabetes mellitus, no. 59 (14.2)
Subjects with hypercholesterolemia, no. 184 (44.3)
Smokers, current, no. 61 (14.7)
Smokers, former, no. 226 (54.5)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Neuroimaging characteristics
Cortical thickness, mm 3.3 (0.2)
Grey matter volume, ml 632.9 (69.3)
White matter volume, ml 467.6 (66.7)
WML volume, ml† 6.4 (3.3; 17.7)
Subjects with lacunar infarct(s), no. 122 (29.4)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 112.1 (10.9)
Stride width, cm 10.8 (3.1)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range).
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Table 2 Regions of cortical thickness associated with gait
Cortical thickness 
(mm)
Stride length
(m)
Cadence
(steps/min)
Stride width
(cm)
Region (Brodmann area) Regression 
coefficients
Regression 
coefficients
Regression 
coefficients
Left Right Left Right Left Right
Frontal lobe
Precentral gyrus (4) - - 7.33 8.23 - -
Superior frontal gyrus (6) 0.16 0.16 8.71 8.67 - -
Superior frontal gyrus (8) 0.14 0.12 8.91 7.57 - -
Superior/middle frontal gyrus (9) 0.17 0.15 7.89 - - -
Superior/middle frontal gyrus (10) 0.17 0.17 - - - -2.22
Middle frontal gyrus (46) 0.16 0.21 - - - -
Inferior frontal gyrus (44) 0.19 0.26 - - -2.47 -3.50
Inferior frontal gyrus (45) 0.17 0.20 - - -2.80 -2.72
Inferior frontal gyrus (47) 0.11 0.17 - - - -.287
Orbital gyrus (11) 0.22 0.22 - - -2.99 -3.53
Parietal lobe
Postcentral gyrus (2) 0.15 0.15 - - - -
Postcentral gyrus (3) 0.13 - 8.76 - - -
Post-/precentral gyrus (43) 0.15 0.16 - - -2.39 -2.57
Supramarginal gyrus (40) 0.20 0.18 - - -2.79 -3.12
Angular gyrus (39) 0.22 0.13 - - - -
Occipital lobe
(Peri-)calcarine sulcus (17) 0.15 0.18 - - - -2.66
Lingual gyrus / cuneus (18) 0.15 0.19 9.28 8.97 - -
Lateral occipital gyrus (19) 0.19 0.21 - - - -
Temporal lobe
Transverse temporal gyrus (41) 0.22 0.24 8.45 8.17 -3.03 -3.66
Transverse temporal gyrus (42) 0.25 0.20 - - -3.83 -3.46
Superior temporal gyrus (22) 0.20 0.15 - - -3.15 -2.97
Middle temporal gyrus (21) 0.11 - - - - -
Inferior temporal gyrus (20) - - - - -2.47 -2.69
Fusiform gyrus (37) 0.21 - 9.27 - -2.84 -
Limbic system
Subgenual cortex (25) 0.20 0.20 - - - -2.71
Anterior cingulate gyrus (24) 0.18 0.23 10.15 - - -
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orbitofrontal (BA 11) and ventrolateral prefrontal cortex (BA 44, 45, 47), the cortical areas 
adjacent to the posterior insula (inferior parietal lobe, superior temporal gyrus, BA 22, 
39-42), the inferior temporal gyrus (BA 20) and the left fusiform gyrus (BA 37). Of the limbic 
lobe, only the dorsal anterior cingulate cortex (BA 32) showed a signifi cant association.
As shown in Figure 2, the strength of the associations with stride length (and subsequently 
velocity) and stride width weakened or even disappeared after adjustment for the 
subcortical lesions (WMLs and lacunar infarcts), but in most cases a signifi cant 
association remained. In contrast, the associations between cortical thickness in the 
frontal lobe and cadence did not markedly change.
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Table 2 Continued
Cortical thickness 
(mm)
Stride length
(m)
Cadence
(steps/min)
Stride width
(cm)
Region (Brodmann area) Regression 
coefficients
Regression 
coefficients
Regression 
coefficients
Left Right Left Right Left Right
Limbic system
Anterior cingulate cortex (32) 0.23 0.21 8.30 9.51 -2.99 -2.78
Anterior cingulate cortex (33) - 0.13 - - - -
Posterior cingulate gyrus (23) 0.22 0.18 9.54 - - -2.17
Posterior cingulate cortex (31) 0.20 0.21 11.42 - - -
Cingulate cortex (26) - 0.11 - - - -
Cingulate cortex (29) 0.11 0.14 - - - -
Cingulate cortex (30) 0.15 0.19 - - - -2.82
Parahippocampal gyrus (35) 0.13 - - - - -
Parahippocampal gyrus (36) 0.10 0.10 6.41 - - -
Regression coeffi cients represent change in units of the dependent variable by 1 mm decrease of cortical 
thickness. Only cortical regions with statistically signifi cant associations are presented (P<0.05, FWE-
corrected). Adjusted for age, sex and height.
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Figure 2   Regions of cortical thickness associated with gait 
Brain regions demonstrating signifi cant (P<0.05, FWE-corrected) associations between cortical thinning 
and lower gait velocity, stride length, cadence and broader stride width. Effect sizes are illustrated with 
color-labelled standardized beta-values with scaling from 0.10 to 0.30. Panel A shows models adjusted 
for age, sex and height. Panel B shows models additionally adjusted for total WML volume and number of 
lacunar infarcts. Maps are presented on a population template brain. The medial wall and corpus 
callosum are masked.
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Discussion
The main fi nding of this study among patients with cerebral SVD was that individuals with 
a thin cortex performed worse on gait tasks than those with a thicker cortex. There were 
specifi c anatomical patterns for the various gait parameters. These relationships, with the 
exception of those observed in the frontal areas with respect to cadence, were partially 
attributable to subcortical WMLs and lacunar infarcts.
The present study has a number of advantages, including its large sample size, high 
response rate, and the collection of data from a single scanner and research center. In 
addition, we used quantitative assessment of cortical atrophy, WMLs, and several gait 
parameters. Moreover, surface-based cortical thickness analysis provides a more 
sensitive measure of cortical atrophy than previous approaches130,131 and the use of 
surface-based cortical parcellation into BAs permits a more detailed anatomical reference 
set.138 These advantages allowed us to pursue an approach which was largely data-driven, 
employing regional analyses of cortical thickness and gait, rather than hypothesis-driven, 
necessitating the identifi cation of a small number of pre-defi ned ROIs. As a result, we 
were able to investigate the relationship of cortical thickness with gait disturbances 
across the entire cerebral cortex. Finally, we were able to investigate the attribution of SVD 
in these relations by controlling for WMLs and lacunar infarcts.
At present, our study is cross-sectional, which limits conclusions regarding causality. We 
cannot prove that a lower cortical thickness precedes gait impairment due to this design. 
However, future longitudinal studies, such as ours, are needed to examine changes in 
cortical thickness over time and how they relate to gait. Other markers for cortical neuronal 
loss could also be used for this purpose, such as the amount of benzodiazepine receptors 
using positron-emission-tomography.143 Furthermore, the parcellation of the cortical 
surface into BAs areas has a number of limitations which are important to consider when 
interpreting the results described here. Firstly, the use of anatomical landmarks – 
particularly major sulci – to delineate BAs has been challenged by histological evidence 
showing that some BAs vary substantially between individuals, both in surface area and 
location relative to major sulci.144 While this variance is problematic, and can possibly be 
addressed through the use of probabilistic atlases, functional localization, or alternate 
parcellation schemes, the BA parcellation does appear to be highly accurate for some 
areas, and overlaps substantially with probabilistic representations in more problematic 
areas.138 Secondly, being derived from cytoarchitectonic criteria, BAs do not necessarily 
have a strong correspondence with vasculature. Because SVD, in contrast to large vessel 
disease, is generally not restricted to these vascular territories, we feel that this has not 
greatly inﬂ uenced our results. Moreover, we preferred the Brodmann parcellation scheme 
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as it is widely used. In addition, the schemes considering the vascular supply defi ne large 
territories, which we feel have insuffi cient spatial resolution for our present analyses. 
Thirdly, given the high variance and apparently unreliable delineation of the insula, this 
potentially important cortical region was also excluded from our analyses. We furthermore 
only investigated the cortical thickness of supratentorial structures, although gait is a 
result of complex networks of both supra- and infratentorial structures.
We found the different gait parameters related to the cortical thickness each at different 
regions (Figure 2). As gait velocity is calculated from stride length and cadence, we do 
not separately discuss the results for velocity. Some of the cortical regions – located in the 
frontal and parietal lobe – of which the thickness  related to a shorter stride length and 
broader stride width, are consistent with that found in another study.39 However, an 
interesting difference with this study was observed with regard to the frontal lobe. We 
could not replicate their fi nding of involvement of the primary motor cortex in a shorter 
stride length. Instead, we found the strongest associations with stride length and width in 
the prefrontal cortex, in particular BA 11 and 44. This suggests that defi cits in attention 
and executive function (i.e. the cognitive control of motor performance145) may explain 
gait disturbances in SVD, rather than defi cits in (the planning and) execution of movements. 
In contrast, we found only modest associations between cortical thickness and cadence, 
and in other parts of the frontal lobe: the primary motor cortex and premotor areas. This 
is in line with a functional near-infrared spectroscopy-study among independently living 
elderly, which showed that a change in cadence was related to the degree of activation in 
the same motor areas, and not in the prefrontal cortex.146 We found furthermore signifi cant 
relationships between all three gait parameters and cortical thickness of the anterior 
cingulate cortex, encompassing the cingulate motor areas.147 This region was also found 
to be involved in the locomotion network in a positron-emission-tomography study 
showing deactivation in this area during normal gait.13
Although SVD in the frontal lobe is generally regarded as the most important cause of gait 
disturbances,148 we also found strong associations between gait and cortical thickness of 
other lobes, which receive or integrate multisensory information. Individuals with a thinner 
cortex of the left fusiform gyrus or the regions adjacent to the posterior insula, including 
the supramarginal gyrus, transverse and superior temporal gyrus, known to be involved 
in vestibular, somatosensory and visual information processing, had a shorter stride 
length and broader stride width than those with a thicker cortex. Furthermore, associations 
were found in the posterior cingulate areas for stride length and cadence and in the visual 
areas for stride length, both believed to be involved in spatial orientation.147 Interestingly, 
all these regions showed (de)activations during walking in functional MRI and positron-
emission-tomography studies.13,149 To the best of our knowledge, this is the fi rst study 
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investigating thickness of the entire cerebral cortex in gait disturbances in SVD, showing 
that a thin cortex in areas implicated in the control of normal gait is related to poorer gait 
performance with specifi c patterns for the three gait parameters.
Our fi nding that WMLs and lacunar infarcts weakened most of the associations between 
cortical thickness and gait velocity, stride length, and width, was similarly as observed in 
a previous study in relation to cognitive function among patients with cerebrovascular 
disease.150 However, Rosano et al. did not fi nd a substantial change in regression 
coeffi cients of the association between cortical volume and gait when WMLs were added 
to the model, but WMLs were assessed semi-quantitatively in their study.38,39 At this stage, 
we are unable to unravel the individual contribution, and the moment during which this 
takes places, of cortical thickness and WMLs and lacunar infarcts to gait. In theory, WMLs 
and lacunar infarcts may play a role as antecedent, intermediate or confounder in the 
association between cortical thickness and gait, or a combination thereof. As mediation 
and confounding are identical statistically, they can be distinguished only on conceptual 
grounds. Firstly, it may be that cortical thinning was, at least in part, secondary to the 
subcortical WMLs and lacunar infarcts, possibly through antero- or retrograde neuronal 
degeneration of fi bers traversing these lesions. This hypothesis is indirectly supported by 
a study among patients with subcortical vascular dementia.151 The BA ROIs showing a 
modifi cation by WMLs and lacunar infarcts in our study matched the pattern of cortical 
thinning in these patients, indicating that specifi c cortical areas are affected in patients 
with SVD. Moreover, a post-mortem study has indeed shown neuronal apoptosis in the 
cerebral cortex related to the burden of subcortical ischemic lesions among patients with 
cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencepha-
lopathy (CADASIL) and with Binswanger disease.152 Other studies reporting on a 
correlation between the burden of WMLs or lacunar infarcts and cortical morphology9,153-
156 provide further support for this hypothesis. It is less likely that WML volume and lacunar 
infarcts acted as an intermediate between cortical thickness and gait performance. An 
alternative explanation would be that WML volume and the number of lacunar infarcts 
were (purely or partially) a confounding factor.
Even more importantly, we found that cortical thickness contributed signifi cantly to gait 
performance, independent of subcortical cerebrovascular pathology. This may be 
explained for example by direct ischemic damage to the cortex, such as cortical 
microinfarcts, although fi ndings about their clinical role (e.g. in cognition) in patients with 
cerebrovascular pathology remain controversial in previous studies.8,152,157 Another 
explanation would be that subcortical lesions and cortical atrophy develop independently, 
as other processes (e.g. degenerative) often co-occur with SVD.158 So, we hypothesize 
that cortical thickness, at least in part, has a direct effect on gait disturbances, whereby a 
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thinner cortex is caused by degenerative processes and/or (direct or indirect) ischemic 
damage. Future longitudinal studies are needed to explore these mechanisms in more 
detail.
In conclusion, our study adds to the understanding of the pathogenesis of gait 
disturbances in SVD. In SVD, a thinner cortical thickness is associated with poorer gait, 
partially dependent on the subcortical cerebrovascular lesions. Therefore, cerebral SVD 
should no longer be regarded as a disease restricted to the white matter, and future 
studies of SVD should include the cortical grey matter in their analyses. Moreover, various 
gait parameters are associated with distinct anatomical regions, suggesting that different 
cerebral networks are involved. Additional and follow-up studies are needed to further 
investigate the mechanisms underlying cortical atrophy in SVD and the magnitude and 
regional patterns of these cortical changes related to gait performance in these patients.
Cortical thickness and gait disturbances
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Association between cerebral small 
vessel disease and motor performance: 
a diffusion tensor imaging approach

3.1
Loss of white matter integrity is associated 
with gait disturbances
Published as
de Laat KF, van Norden AG, Gons RA, van Oudheusden LJ, van Uden IW, Norris DG, 
Zwiers MP, de Leeuw F-E. Diffusion tensor imaging and gait in elderly persons with 
cerebral small vessel disease. Stroke 2011; 42: 373-379.
Abstract
Background and objectives
Although cerebral small vessel disease (SVD), including white matter lesions (WMLs) and 
lacunar infarcts, is associated with gait disturbances, not all individuals with SVD have 
these disturbances. Identical-appearing WMLs on MRI could reﬂ ect different degrees of 
microstructural integrity. Moreover, conventional MRI does not assess the integrity of the 
normal-appearing white matter (NAWM). We therefore investigated the relationship 
between white matter integrity, assessed by diffusion tensor imaging (DTI), in WMLs, 
NAWM, several regions-of-interest and gait. 
Methods
A total of 484 older adults between 50 and 85 years, without dementia or parkinsonism, 
with cerebral SVD were included in this analysis and underwent MRI and DTI scanning.
Mean diffusivity (MD) and fractional anisotropy (FA) within WMLs, NAWM and regions-of-
interest were related to quantitative and semi-quantitative gait parameters. 
Results
MD in the WMLs was inversely related with gait [standardized β (for velocity)=-0.15; 
P=0.002]. For the FA this association was less evident. The same was found in the NAWM 
[standardized β (for velocity)=-0.21; P<0.001]; for some parameters also after additional 
adjustment for WMLs and lacunar infarcts.
Conclusions
This study indicates that integrity of both WMLs and NAWM, beyond the detection limit of 
conventional MRI, is associated with gait disturbances. 
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Introduction 
Cerebral small vessel disease (SVD), including white matter lesions (WMLs) and lacunar 
infarcts, is related to gait disturbances,116 an often neglected but nevertheless serious 
consequence of SVD as it is associated with increased morbidity and mortality.19 However, 
not everyone with SVD suffers from gait disturbances as its prevalence is about 35%,19 
which is far below the 90% prevalence of SVD in elderly.1 Although we demonstrated 
earlier that the different severity of WMLs and lacunar infarcts could partially account for 
this discrepancy,116 even subjects with a similar degree of WMLs may have a different 
degree of gait impairment.14 
As identical-appearing WMLs on conventional MRI actually are histopathologically 
heterogeneous,40 it could be that only WMLs with the highest loss of microstructural 
integrity are related to gait disturbances. Moreover, MRI is not sensitive to early loss of 
microstructural integrity of the normal-appearing white matter (NAWM). Abnormalities in 
this part of the white matter may nevertheless well be present6 and therefore may 
contribute to the development of gait disturbances. As previous studies have demonstrated 
that WMLs in the frontal lobe are most related to gait performance,148 the location of 
damage to the white matter may also be important. On the other hand, studies of normal 
gait have found that networks involved in its control are widespread in the entire brain.149 
In addition, conventional MRI parameters other than WMLs or lacunar infarcts, such as 
total brain volume, may play a role in the development of gait disturbances. Total brain 
volume has found to be a strong predictor for cognitive dysfunction in subjects with 
SVD,150 but the association with gait disturbances has only been studied sparsely.370
Diffusion tensor imaging (DTI)93 allows to assess the microstructural integrity of the whole 
white matter.45 A reduction in fractional anisotropy (FA) and increase in mean diffusivity 
(MD) are believed to represent reduced microstructural integrity in SVD.53 Only two studies 
reported on the association between a low FA or high MD in the corpus callosum and gait 
impairment, but they did not investigate43 or failed to demonstrate44 an association in the 
white matter outside the corpus callosum. The aim of this study was therefore to investigate 
the association between the microstructural integrity of both WMLs and NAWM and gait 
in older adults with cerebral SVD. Secondly, we assessed whether this association in the 
NAWM was independent of  WML volume and lacunar infarcts. We furthermore investigated 
this relationship in several scattered regions-of-interest (ROIs). Finally, we examined the 
association between total brain volume and gait.
White matter integrity and gait disturbances
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Patients and methods
Study population
This study is embedded in the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort study that 
was designed to investigate risk factors and cognitive, motor and mood consequences of 
functional and structural brain changes among older adults with cerebral SVD. The 
primary study outcome of the longitudinal part of the RUN DMC study is the development 
of dementia or parkinsonism. 
Cerebral SVD is characterized on neuroimaging by either WMLs or lacunar infarcts. 
Symptoms of SVD include acute symptoms, such as transient ischemic attacks (TIAs) or 
lacunar syndromes, or subacute manifestations, such as cognitive disturbances, motor 
(gait) disturbances and/or depressive symptoms.11 As the onset of cerebral SVD is often 
insidious, clinically heterogeneous, and typically with mild symptoms, it has been 
suggested that the selection of subjects with cerebral SVD in clinical studies should be 
based on the more consistent brain imaging features.12 Accordingly, in 2006, consecutive 
patients referred to the Department of Neurology between October 2002 and November 
2006, were selected for participation. 
Inclusion criteria were: (a) age between 50 and 85 years; (b) cerebral SVD on neuroimaging 
[WMLs and/or lacunar infarct(s)]. Subsequently, the abovementioned acute or subacute 
clinical symptoms of SVD were assessed by standardized structured assessments (a 
questionnaire for TIA and stroke;56 for cognition the Cognitive Failures Questionnaire, 
which also includes executive functions;57 for gait the Falls Questionnaire58 and the 
Freezing of Gait Questionnaire;59 for depressive symptoms the Center of Epidemiologic 
Studies-Depression scale78 and use of antidepressive medication). Patients who were 
eligible because of a lacunar syndrome were included only >6 months after the event to 
avoid acute effects on the outcomes. 
Exclusion criteria were: (a) dementia;60 (b) parkinson(ism);61,101 (c) intracranial hemorrhage; 
(d) life expectancy <6 months; (e) intracranial space-occupying lesion; (f) (psychiatric) 
disease interfering with cognitive testing or follow-up; (g) recent or current use of acetyl-
choline-esterase inhibitors, neuroleptic agents, L-dopa or dopa-a(nta)gonists; (h) non-
SVD-related WMLs (e.g. multiple sclerosis); (i) prominent visual or hearing impairment; (j) 
language barrier; (k) MRI contraindications or known claustrophobia.
From 1004 individuals invited by letter, 727 were eligible after contact by phone and 525 
agreed to participate. In 22 subjects exclusion criteria were found during their visit to our 
research centre [dementia (n=4), Parkinson’s disease (n=1), current levodopa use (n=1), 
multiple sclerosis (n=1), language barrier (n=1), death before MRI scanning (n=1) or 
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unexpected claustrophobia (n=14)], yielding a response rate of 71.3% (503/705). 
The reasons for referral in this group included those corresponding to symptoms of SVD: 
e.g. TIA/minor stroke, cognitive and motor complaints. Based on the former assessments, 
these 503 individuals had acute symptoms such as TIA or lacunar syndrome (n=219), or 
subacute symptoms such as cognitive disturbances (n=245), motor disturbances (n=97), 
depressive symptoms (n=100) or a combination thereof. A motor disturbance was 
defi ned, in accordance with operationalization as used in other large scale studies on 
cerebral SVD and gait,102 as follows: a reported history of ≥1 fall(s) during the past year, or 
a self-reported slowing of gait. 
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
MRI scanning
All MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom 
Sonata, Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 
magnetization-prepared rapid gradient-echo sequence [time repetition (TR)/time echo 
(TE)/ time interval (TI) 2250/3.68/850ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm], a fl uid-
attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 9000/84/2200 ms; voxel size 
1.0x1.2x5.0 mm, plus an interslice gap of 1mm) and a DTI sequence (TR/TE 10100/93 ms, 
voxelsize 2.5x2.5x2.5 mm, 4 unweighted scans, 30 diffusion-weighted scans with b-value 
of 900 s/mm2). During the study period there were no changes in scanner hard or software 
or in the scanning protocol. 
Conventional MRI analysis
White matter signal hyperintensities in both supra- and infratentorial regions on FLAIR 
scans, which were not, or only faintly, hypo-intense on T1-weighted images, were 
considered WMLs, except for gliosis surrounding infarcts. WMLs were manually 
segmented on the FLAIR images by two trained raters. Total WML volume was calculated 
by summing the segmented areas multiplied by slice thickness. Lacunar infarcts were 
rated and defi ned as areas with a diameter >2 mm and ≤15 mm with low signal intensity 
on T1 and FLAIR, ruling out enlarged perivascular spaces and infraputaminal 
pseudolacunes.33 All imaging analyses were performed by raters blinded to clinical 
information. In a random sample of 10%, inter-rater variability for total WML volume 
yielded an intra-class correlation coeffi cient of 0.99; intra- and inter-rater reliability for the 
number of lacunar infarcts a weighted kappa of 0.80 and 0.88. 
Automated segmentation on the T1 images was conducted using Statistical Parametric 
Mapping (SPM5) (http://www.fi l.ion.ucl.ac.uk/spm/) to obtain grey and white matter and 
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cerebrospinal fl uid probability maps.92 These maps were tresholded at 0.5 to provide total 
volumes. Total brain volume was calculated as the sum of total grey and white matter 
volumes. Mutual information co-registration (SPM5) was used to align WML maps to the 
T1 image and to yield a NAWM map (the complement of WMLs in white matter). 
DTI analysis
The diffusion-weighted images of each subject were realigned on the mean of the 
realigned unweighted images using the mutual information co-registration routines 
(SPM5). The diffusion tensor93 and its eigenvalues were computed using an SPM5 add-on 
(http://sourceforge.net/projects/spmtools). Spurious negative eigenvalues were set to 
zero, after which the FA and MD were calculated.94 The mean unweighted image was 
used to compute the co-registration parameters to the T1 image, which were then applied 
to all diffusion-weighted images and results. All images were visually checked for motion 
artifacts and co-registration errors. 
The volume averaged FA and MD were calculated in the WMLs, NAWM and in ROIs. ROIs 
were spherical (diameter 10 mm) and placed on three axial slices of the Montreal 
Neurological Institute 152 T1 template (Figure 1). Two slices including the anterior horns 
(frontal lobe) and posterior horns (temporal/occipital lobes) of the lateral ventricles were 
chosen for assessment of periventricular white matter and one slice through the centrum 
semiovale was chosen for assessement of subcortical white matter (frontal and parietal 
lobes). The non-linear transformation parameters were used to map the ROIs onto the 
corresponding FA and MD images.
Chapter 3.1
Figure 1   Regions-of-interest
The Montreal Neurological Institute 152 T1 template showing the ROIs in periventricular (panel A+B) and 
subcortical (panel C) regions.
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Measurement of gait
Quantitative gait analysis was performed with a 5.6-m electronic portable walkway 
(GAITRite®, MAP/CIR Inc., Havertown, PA). All subjects walked two times at a self-selected 
normal speed. We measured velocity (m/s), consisting of both the stride length (m) (the 
distance between the heel points of two consecutive footprints of the same foot) and 
cadence (number of steps per minute); stride width (cm) (the distance between one 
midpoint of a footprint and the line of progression of the opposite foot); double support 
percentage (percentage of the gait cycle time during which both feet are on the fl oor) and 
the variability of stride length, stride time and stride width. Variability was expressed as 
coeffi cients of variation (CV): standard deviation/mean x 100%. Semi-quantitative assessment 
existed of the modifi ed Tinetti test with 17 items: 9 for body balance (score 0-16) and 8 for 
gait (score 0-12), with a maximum score of 28,72 as well as the Timed-Up-and-Go (TUG) 
test,73 which was executed three times. Inter-rater reliability was calculated in a random 
sample of 15% with an intra-class correlation coeffi cient of 0.99. 
Other measurements
We considered age, sex, height and total brain volume as possible confounders. Because 
SVD is correlated with total brain volume42 and cerebral atrophy is a predictor of gait 
disturbance,128 this was also considered a possible confounder. We used the Mini Mental 
State Examination score (range 0–30) to assess global cognitive status.64 Functional 
independence was assessed using the Barthel Index (range 0–20).84 
Statistical analysis
The baseline characteristics were presented as mean ± standard deviation (SD) and for 
the skewed distributed parameters the median and interquartile range were calculated. 
The quantitative GAITRite and semi-quantitative TUG measures were averaged over two 
and three walks. When one trial was missing (n=5 for quantitative and n=2 for semi-
quantitative assessment), the remaining measures were used. 
The relationship between DTI parameters and gait was analyzed in two ways. Firstly, we 
used multiple linear regression to investigate the relationship between FA and MD in both 
the WMLs and NAWM and gait, with adjustment for age, sex, height and total brain 
volume. To investigate whether DTI parameters in the NAWM were associated with gait 
regardless of WMLs and number of lacunar infarcts, we additionally adjusted analyses for 
these parameters. We furthermore examined the association between total brain volume 
and gait, adjusted for age, sex, height, WML volume and number of lacunar infarcts. 
Secondly, we investigated the relationship between DTI parameters and gait velocity in six 
bilateral ROIs, using the same analyses. In positively skewed distributions the log 
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transformation was used. Regression coeffi cients are presented as standardized 
beta-values. All data were analyzed using SPSS statistical software, version 16.0.
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Table 1 Characteristics of the study population
Characteristics n=484
Demographic and clinical characteristics
Age, yrs 65.6 (8.9)
Female, no. 210 (43.4)
Height, m 1.7 (0.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Neuroimaging characteristics
Total brain volume, ml 1093.3 (121.5)
White matter volume, ml 464.3 (66.5)
WML volume, ml† 7.2 (3.4; 18.1)
NAWM volume, ml 450.2 (70.3)
Subjects with lacunar infarct(s), no. 165 (34.1)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 111.5 (10.8)
Stride width, cm 11.0 (3.2)
Double support percentage, % 25.9 (4.2)
Stride length variability, %† 1.8 (1.3; 2.6)
Stride time variability, %† 1.9 (1.2; 2.3)
Stride width variability, %† 16.7 (12.2; 23.8)
Tinetti  test† 28.0 (28.0; 28.0)
Timed-Up-and-Go test, s† 8.9 (7.7; 10.5)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range).
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Results 
Characteristics
Gait assessment was available for 488 participants. Fifteen individuals could not 
participate because of walking aids (n=4), current levodopa use (n=1), drop foot (n=1), 
lower extremity amputation (n=1), joint fusion (n=2), severe arthritis (n=1), severe vascular 
problems of the lower extremity (n=2) or a psychogenic gait disturbance (n=3). Four 
subjects had to be excluded because of uninterpretable MRI sequences, yielding a fi nal 
sample size of 484 subjects for this study.
Table 1 shows the characteristics of the study population. Mean age was 65.6 years (SD 
8.9) with 43% being women. Median percentage NAWM of the whole white matter volume 
was high: 98.5% (interquartile range 96.0-99.2%). 
MRI parameters and gait
Subjects with a higher MD within the WMLs walked signifi cantly slower (standardized 
β=-0.15; P=0.002), due to both smaller steps (standardized β=-0.14; P=0.001) and a 
lower cadence (standardized β=-0.13; P=0.011), with a larger step width (standardized 
β=0.24; P<0.001), a longer double support percentage (standardized β=0.11; P=0.039), 
a reduced stride width variability (standardized β=-0.14; P=0.010) and a trend to an 
increased stride time variability (standardized β=0.09; P=0.081). There was also a 
signifi cant relationship between MD within WMLs and the Tinetti (standardized β=-0.14; 
P=0.008) and TUG test (standardized β=0.14; P=0.004). However, a lower FA in the 
WMLs was only associated with a lower score on the Tinetti test (standardized β=0.10; 
P=0.035) (Table 2).
The relationship between microstructural integrity and gait was not restricted to the 
WMLs, as there was also a signifi cant relationship between both DTI parameters in the 
NAWM and various quantitative and semi-quantitative parameters of gait (Table 2). After 
additional adjustment for WML volume and number of lacunar infarcts, the association 
between MD in the NAWM and gait remained present, although weaker, for various 
parameters, whereas this association disappeared for FA. 
Table 3 shows the results of the association between DTI parameters and gait velocity in 
six bilateral ROIs. Despite the fact that the median percentage WMLs was much higher in 
the periventricular than in the subcortical ROIs, we found in almost all ROIs a signifi cant 
association between a high MD and low gait velocity and to a lesser extent between a low 
FA and low gait velocity, also after Bonferroni correction. These relations disappeared 
after additional adjustment for WMLs and number of lacunar infarcts.
White matter integrity and gait disturbances
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Apart from DTI parameters, conventional MRI parameters, such as total brain volume 
were also found to be independently related to gait performance, with the exception of 
stride width variability (Table 2).
Discussion
In this large cohort of patients with cerebral SVD, we found that the microstructural 
integrity of both WMLs and NAWM, at multiple locations, was associated with gait. 
Major strengths of this study include its large sample size and use of novel imaging 
techniques as DTI. Furthermore, our study is a single-center study, with a high response 
rate and all subjects examined by only two investigators. We measured MD and FA using 
a whole brain voxel-based analysis differentiating between WMLs and NAWM, as well as 
ROI analysis, to provide both global and regional information of the microstructural 
integrity in relation to gait. Another strength is the manual segmentation of WMLs and 
quantitative assessment of gait. Moreover, we were able to investigate the effect of micro-
structural integrity on gait independent of total brain volume and in the NAWM also of 
WML volume and lacunar infarcts. We intentionally did not correct for vascular risk factors 
such as hypertension or diabetes, as they were considered part of the causal chain 
between SVD and gait. Another methodologic issue is the term SVD, which is used in 
different contexts (i.e., pathological, neuroimaging, and clinical aspects). As mentioned 
earlier, neuroimaging has a central role in defi ning SVD. WMLs and lacunar infarcts are 
widely accepted signs of cerebral SVD. However, WMLs may also be caused by other 
diseases. Lacunar infarcts may furthermore also result from non-SVD-related mechanisms, 
such as embolism from the heart or proximal arteries.159 We therefore cannot rule out 
some misclassifi cation of lacunar infarcts as SVD-related in our study. As the majority of 
lacunar strokes are SVD-related159 and the lacunar infarcts in our study were all 
accompanied by some degree of WMLs, favouring an underlying SVD-related 
mechanism,160 we feel that this misclassifi cation would be rather small and did not greatly 
inﬂ uenced our results. Finally, an important limitation is the cross-sectional nature of our 
study, which prevents us from proving causality. The RUN DMC study has a longitudinal 
design to evaluate the effect of progression of SVD on (changes in) gait.
Within the WMLs, we found a relationship between a high MD and worse score on almost 
all gait parameters. This may indicate that otherwise identical-appearing WMLs on FLAIR 
imaging reﬂ ect different microstructural abnormalities and subsequently have different 
consequences for gait performance. It should be noted that we did not account for the 
spatial distribution of WMLs, which was not entirely comparable between all subjects. 
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Because the networks involved in the control of gait are considered to be widespread,149 
which is in line with our fi ndings in the ROI analysis (loss of microstructural integrity at 
multiple locations was related to a lower gait velocity), we feel that this has not greatly 
inﬂ uenced our results. However, we have to note that another recent study, using partial 
least square regression, has shown that not all locations are equally important in relation 
to gait. They found the frontal WMLs to be most related to poorer gait.148 It would be 
interesting to apply this technique in DTI analysis in future studies.
The MD, which reﬂ ects the magnitude of the diffusion of water, within the WMLs was 
found to be more strongly related to gait than the FA, which measures the directionality of 
the diffusion of water. One explanation could be that both parameters reﬂ ect different 
pathophysiology with different consequences for gait performance. The disparity in 
associations could also be explained by the differences in WML location between 
subjects, as FA values vary widely across the whole white matter in the normal brain.45 
Multiple fi bers are present within a single voxel and may have all different destinations. 
Due to this intravoxel fi ber incoherence the measured FA within a given voxel may be low 
and does not necessarily reﬂ ect an underlying lower microstructural integrity. In contrast, 
MD is not so much affected by fi ber crossing and remains relatively constant throughout 
the white matter.45 
We furthermore found that the association between loss of microstructural integrity of the 
white matter and gait extended even in the NAWM, which constituted the largest part of 
the white matter in our study. Hence, our fi ndings imply that the microstructural integrity 
of the NAWM should also be taken into account when investigating the relation between 
SVD and gait. This is in line with two other smaller studies, fi nding the microstructural 
integrity of the corpus callosum, a structure typically free from SVD, associated with 
gait.43,44 The contribution of damage to the NAWM was recently also found in relation to 
cognitive impairment,161 another symptom of SVD. 
As most associations in the NAWM disappeared or weakened after additional control for 
WMLs and lacunar infarcts, it seems plausible that SVD is one of the underlying 
pathological mechanisms in the relation between microstructural integrity of NAWM and 
gait. When interpreting these results, it is important to consider that the severity of damage 
in the NAWM is positively associated with the WML load.162 Several explanations could 
therefore be proposed by which SVD may be related to the associations between the 
microstructural integrity of the NAWM and gait. Firstly, it may be that these association 
are, at least in part, explained by the coexisting WMLs, and not so much by the loss of the 
microstructural integrity of the NAWM. Secondly, it could be that WMLs and DTI changes 
in the NAWM share similar risk factors for SVD, such as hypertension;163 additional control 
for WMLs and lacunar infarcts will therefore reduce the magnitude of the association 
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between DTI-parameters in NAWM and gait. Finally, WMLs may lead to axonal loss in 
areas (i.e. the NAWM) connected by these axons that travel through these WMLs, by 
antero- (Wallerian) or retrograde neuronal degeneration. On the other hand, some 
associations in the NAWM (e.g. with cadence) did not alter after additional control for 
WMLs and lacunar infarcts. This indicates that also other factors than SVD may play a 
role. Future studies are needed to explore these processes and hence the relevance of 
damage to the NAWM in gait disturbances in SVD in more detail. 
Finally, we found that a smaller total brain volume was associated with poorer gait 
performance, suggesting that patients with SVD may also be more vulnerable to gait 
disturbances related to global brain atrophy.
In conclusion, this study indicates that loss of microstructural integrity not only within 
WMLs, but also of the NAWM contributes to gait disturbances. DTI leads to considerable 
insight into the pathogenesis of gait disturbances in persons with SVD. Whether 
DTI-derived metrics are a better marker for gait disturbances in patients with SVD than 
those of conventional MRI (WMLs, lacunar infarcts, total brain volume), should be 
investigated in future studies. Future studies are needed to establish the regional 
correlates of white matter integrity and gait more specifi cally, using whole brain analysis 
with region-specifi c information such as Tract-Based Spatial Statistics. Furthermore, they 
should be prospective in order to assess causality and to investigate if changes in the 
microstructural integrity of the NAWM are treatable and preventable by treatment of risk 
factors for SVD, such as with blood pressure-lowering agents. 
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3.2
Loss of white matter integrity is associated 
with mild parkinsonian signs
Published as
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Zwiers MP, de Leeuw F-E. Diffusion tensor imaging and mild parkinsonian signs in elderly 
with cerebral small vessel disease. Neurobiol Aging 2011;
doi: 10.1016/j.neurobiolaging.2011.09.001.
Abstract
Background and objectives
Mild parkinsonian signs (MPS) are common and can be considered as a prodromal stage 
of full-blown parkinsonism. Although the role of cerebral small vessel disease (SVD), 
including white matter lesions (WMLs) and lacunar infarcts, is increasingly being 
recognized, not all individuals with SVD have MPS. We hypothesized that the presence of 
MPS is dependent on the microstructural integrity underlying WMLs, the possible early 
loss of integrity of the normal-appearing white matter (NAWM) and the location of this 
damage. We therefore investigated these relationships with the aid of diffusion tensor 
imaging (DTI).
Methods
In 483 persons with SVD, between 50 and 85 years, without dementia or parkinsonism, 
we measured the fractional anisotropy and mean diffusivity in WMLs, NAWM and several 
regions-of-interest. MPS were based on the motor section of the Unifi ed Parkinson’s 
Disease Rating Scale. 
Results
Subjects with severe loss of integrity within their WMLs had a higher risk of MPS, 
regardless of WML volume (fractional anisotropy OR=1.9; 95% CI 1.1-3.4). The same was 
found in the NAWM, but this association disappeared after adjustment for WMLs and 
lacunar infarcts. The integrity of the periventricular frontal regions-of-interest was 
signifi cantly lower in subjects with MPS than without, independent of WMLs and lacunar 
infarcts.
Conclusions
This study indicates that integrity of WMLs, especially in the frontal lobe, is associated 
with MPS. DTI may be of added value in investigating the underlying mechanisms of 
parkinsonian signs in subjects with SVD.
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Introduction
Mild parkinsonian signs (MPS) occur in 20-30% of elderly people15 and can be considered, 
to some extent, as a prodromal stage of full-blown parkinsonism. Moreover, they are 
associated with increased morbidity and mortality.15,111,164 
The role of cerebral small vessel disease (SVD), including white matter lesions (WMLs) 
and lacunar infarcts, in MPS is increasingly being recognized.51,109,110 However, these 
lesions do not fully account for the variability in presence of MPS in subjects with cerebral 
SVD. Although WML volume plays a role,109,110 even individuals with severe WMLs have no 
invariable identical expression with regard to parkinsonism.122,165 One factor could be the 
heterogeneity in the underlying microstructure of these lesions, as found in histopatho-
logical studies.40 Moreover, abnormalities in the normal-appearing white matter (NAWM) 
on MRI may contribute to the development of MPS. Finally, as disruption of specifi c 
networks such as the basal ganglia-thalamocortical networks are believed to be involved 
in vascular parkinsonism,62 the location of damage to the white matter may be important.
Diffusion tensor imaging (DTI)93 allows to assess the microstructural integrity of the whole 
white matter.45 Common DTI-derived metrics include the fractional anisotropy (FA) and 
the mean diffusivity (MD). The FA refl ects the directionality of the diffusion of water, 
whereas MD refl ects the magnitude of the diffusion. We hypothesized that individuals with 
SVD with severe loss of microstructural integrity, indicated by a low FA and high MD, have 
a higher risk of MPS than those with a more intact integrity of the white matter. We therefore 
investigated the association between FA and MD in WMLs and NAWM and the presence 
of MPS in subjects with SVD and whether this was independent of the WMLs and lacunar 
infarcts. Secondly, we examined the infl uence of the location of this loss of integrity.
Methods
Study population
This study is embedded in the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort study that 
investigates risk factors and clinical consequences of brain changes as assessed by MRI 
among older adults with cerebral SVD, with the development of dementia or parkinsonism 
as the primary study outcome. Participants were recruited from the Department of 
Neurology of the Radboud University Nijmegen Medical Center. Recruitment methods 
and other details of the RUN DMC design are described elsewhere.117 In 2006, 503 
consecutive individuals referred to the Department of Neurology between October 2002 
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and November 2006, were selected for participation. Inclusion criteria were (a) age 
between 50 and 85 years, (b) WMLs (of any degree) and/or one or more lacunar infarct(s) 
on neuroimaging. Subsequently, acute [transient ischemic attack (TIA) or lacunar 
syndrome] or subacute (cognitive, motor or depressive) symptoms of SVD were assessed 
by standardized structured assessments. As suggested for clinical studies, patients were 
primarily selected on brain imaging features, since clinical symptoms of SVD are more 
heterogeneous and typically mild at the onset of cerebral SVD.12 Exclusion criteria were: 
(a) dementia;60 (b) parkinson(ism);61,101 (c) intracranial hemorrhage; (d) life expectancy of 
<6 months; (e) intracranial space-occupying lesion; (f) (psychiatric) disease interfering 
with cognitive testing; (g) use of acetylcholine-esterase inhibitors, neuroleptic agents, 
L-dopa or dopa-a(nta)gonists; (h) non-SVD-related WMLs (e.g. multiple sclerosis) (i) 
prominent visual or hearing impairment; (j) language barrier; (k) MRI contraindications or 
known claustrophobia. Additional exclusion criteria for this study were: (l) inability to walk 
6 m unaided (n=4), (m) conditions not related to SVD that affected gait (e.g. joint fusion, 
severe arthritis, psychogenic gait disturbance) (n=12). Tissue segmentation or DTI 
postprocessing was not possible in 4 scans, yielding a fi nal sample size of 483 subjects. 
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
MRI techniques
MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom Sonata, 
Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 magnet-
ization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time (TE)/
inversion time (TI) 2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm], a fl uid-
attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 9000/84/2200 ms; voxelsize 
1.0x1.2x5.0 mm, plus an interslice gap of 1.0mm) and a DTI sequence (TR/TE 10100/93 
ms, voxelsize 2.5x2.5x2.5 mm, 4 unweighted scans, 30 diffusion-weighted scans, b-value 
900 s/mm2). 
Conventional MRI analysis
WMLs were manually segmented, and the number of lacunar infarcts rated according to 
a standardized protocol.117 Grey and white matter and cerebrospinal fl uid probability 
maps were obtained by automated segmentation on the T1 images using Statistical 
Parametric Mapping (SPM5) (http://www.fi l.ion.ucl.ac.uk/spm/).92 Total brain volume was 
calculated as the sum of total grey and white matter volumes. Mutual information co-
registration (SPM5) was used to align WML maps to the T1 image and to yield a NAWM 
map (the complement of WMLs in white matter). Finally, SPM5 routines were used to 
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compute the non-linear transformation parameters that map the T1 image to the Montreal 
Neurological Institute 152 T1 template (and vice versa).
DTI analysis
The diffusion-weighted images of each subject were realigned on the mean of the 
realigned unweighted images using mutual information co-registration (SPM5). The 
diffusion tensor93 and its eigenvalues were computed using a SPM5 add-on (http://
sourceforge.net/projects/spmtools). Spurious negative eigenvalues were set to zero, after 
which the FA and MD were calculated.94 The mean unweighted image was used to 
compute the co-registration parameters to the T1 image, which were then applied to all 
diffusion-weighted images and results. We checked all images visually for motion artifacts 
and co-registration errors. 
The volume averaged MD and FA were calculated in the WMLs, NAWM and in selected 
regions-of-interest (ROIs). ROIs were spherical (diameter 10mm) and placed on three 
axial slices of the Montreal Neurological Institue 152 T1 template (Figure 1). We chose two 
slices including the anterior horns (frontal lobe) and posterior horns (temporal/occipital 
lobes) of the lateral ventricles for assessment of periventricular white matter and one slice 
through the centrum semiovale  for assessment of subcortical white matter (frontal and 
parietal lobes). To minimize partial volume effects, we positioned ROIs at a certain 
distance from the edge of the ventricles and the cortical grey matter. The non-linear 
transformation parameters were used to map the ROIs onto the corresponding FA and 
MD images. 
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Figure 1   Regions-of-interest
The Montreal Neurological Institute 152 T1 template showing  the ROIs in periventricular (panel A+B) and 
subcortical (panel C) regions.
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Measurement of mild parkinsonian signs
MPS were assessed by two trained residents in neurology, using the items of the motor 
section of the Unifi ed Parkinson’s Disease Rating Scale (UPDRSm) (27 items, score 0-4).74 
The inter-rater variability, assessed in a random sample of 17%, yielded an intra-class 
correlation coeffi cient of 0.90. MPS were defi ned as present when the participant had either: 
(a) ≥2 items with a score of 1 or (b) 1 item with a score of ≥2.109 Subsequently, we divided the 
UPDRSm into four categories: bradykinesia (based on 9 items), tremor (7 items), rigidity (5 
items), and gait/balance (6 items). A category was considered present when the participant 
had in that category either (a) ≥2 items with a score of 1 or (b) 1 item with a score of ≥2.109 
Parkinsonism was considered present when the following condition was met: ≥2 items with 
a score of ≥2 in at least 2 different categories.101
Other measurements
For assessment of vascular risk factors, structured questionnaires were used and an 
experienced research nurse measured the blood pressure three times in the supine 
position after fi ve minutes of rest. The risk factors included presence of hypertension 
(mean blood pressure ≥140/90 mmHg and/or use of antihypertensive medications),141 
diabetes (treatment with antidiabetic medications), hypercholesterolemia (treatment with 
lipid-lowering medications) and smoking status. Body mass index was also recorded. We 
used the Mini Mental State Examination score (range 0–30) to assess global cognitive 
status.64 Functional independence was assessed using the Barthel Index (range 0–20).84
Statistical analysis
For normal distributions, baseline characteristics were summarized by the mean and 
standard deviation (SD); for skewed distributions the median and interquartile range were 
calculated.
Firstly, we analyzed the proportion of MPS in quintiles of the FA and MD distribution in 
WMLs and NAWM by analysis of covariance with adjustment for age, sex and total brain 
volume.
Based on this analysis, severe loss of microstructural integrity was defi ned as the lowest 
quintile of the FA and highest quintile of the MD distribution. Secondly, the risk of MPS and 
their subtypes in subjects with severe loss of microstructural integrity of WMLs and NAWM 
with regard to the reference group (other four quintiles) was assessed with logistic 
regression analysis, adjusting for age, sex and total brain volume. Subsequently, we 
adjusted for WML volume and number of lacunar infarcts. Risks were presented as odds 
ratios (OR) with confi dence intervals (CI). Finally, in six bilateral ROIs, signifi cant 
differences in DTI parameters between subjects with and without MPS were estimated 
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using analysis of covariance, adjusting for age, sex, total brain volume, WML volume and 
number of lacunar infarcts. 
All data were analyzed using SPSS statistical software, v16.0.
Results
Characteristics
Table 1 shows the characteristics of the study population. The mean age was 65.6 (SD 
8.9) years with 43.3% being woman. MPS were present in 114 (23.6%) of the 483 
participants. Median percentage NAWM of the whole white matter volume was high: 
98.5% (interquartile range 96.0-99.3%).
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3Table 1 Characteristics of the study population
Characteristics n=483
Demographic and clinical characteristics
Age, yrs 65.6 (8.9)
Female, no. 209 (43.3)
Body mass index, kg/m2 27.0 (4.0)
Subjects with hypertension, no. 357 (73.9)
Subjects with diabetes mellitus, no. 72 (14.9)
Subjects with hypercholesterolemia, no. 228 (47.2)
Smokers, current, no. 72 (14.9)
Smokers, former, no. 266 (55.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Subjects with mild parkinsonian signs, no. 114 (23.6)
Bradykinesia, no. 54 (11.2)
Rigidity, no. 48 (9.9)
Tremor, no. 24 (5.0)
Gait/balance disturbance, no. 26 (5.4)
Neuroimaging characteristics
Total brain volume, ml 1093.4 (121.6)
White matter volume, ml 464.3 (66.6)
White matter lesion volume, ml† 7.1 (3.4;18.1)
Normal-appearing white matter volume, ml 450.1 (70.4)
Subjects with lacunar infarct(s), no. 164 (34.0)
Data are number of subjects (%), means (standard deviation) or †medians (interquartile range).
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DTI parameters and mild parkinsonian signs
The association between FA in the WMLs and presence of MPS suggested a threshold-
effect as in the lowest quintile of FA 38% of all subjects had MPS, while this was between 
16-23% in the other quintiles (Figure 2). This association was less clear for the MD, 
although a positive association was found with the percentage of subjects having MPS, 
in both WMLs (Ptrend=0.047) and NAWM (Ptrend=0.003). 
Subjects with a low FA within their WMLs had a higher risk of having MPS than the 
reference group (OR=2.6; 95% CI 1.5-4.3), even independent of the WML volume (Table 2). 
This association was mainly driven by the presence of rigidity (OR=2.8; 95% CI 1.4-5.4). 
Individuals with a low FA or high MD in the NAWM had a two-fold increased risk of the 
presence of MPS (FA OR=1.9; 95% CI 1.1-3.2; MD OR=2.1; 95% CI 1.2-3.7), but this 
disappeared after adjustment for WML volume and lacunar infarcts. These patients had 
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Figure 2   Association between microstructural integrity of the white matter and 
mild parkinsonian signs
Adjusted for age, sex and total brain volume. Presence of MPS represents the percentage of subjects with 
MPS (± standard error).
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also a higher risk of rigidity (FA OR=3.4; 95% CI 1.7-6.8; MD OR=2.5; 95% CI 1.2-5.2), 
which persisted after adjustment for WML volume and lacunar infarcts. The presence of 
all other symptoms belonging to the spectrum of parkinsonian signs were not signifi cantly 
associated with a low FA or high MD.
Table 3 shows the results of the ROI analyses. The periventricular ROIs included both 
WMLs and NAWM with a median percentage WMLs of 5-15% in the frontal and 1-20% in 
the temporal/occipital ROIs. The subcortical ROIs represented mainly NAWM. In these 
subcortical ROIs, no difference was found between subjects with or without MPS. In 
contrast, in the periventricular frontal ROIs the FA was signifi cantly lower in subjects with 
MPS than without and the mean MD signifi cantly higher, independent of WML volume and 
lacunar infarcts in the whole white matter. We did not fi nd such difference in the periven-
tricular temporal/occipital ROIs after applying Bonferroni correction. 
Discussion
We found that severe loss of microstructural integrity of WMLs, and to a lesser extent of 
NAWM, was associated with a higher risk of MPS, especially rigidity. This association was 
mainly found  in the periventricular frontal regions, and could not be explained by the 
severity of WMLs and lacunar infarcts visible on conventional MRI.
To the best of our knowledge, this is the fi rst study investigating the relationship between 
DTI parameters of the white matter and MPS. Strengths of our study include the large 
sample size and high response rate. All patients were recruited in a single center and 
examined by only two investigators. The relationship between DTI parameters and MPS 
was investigated with extensive adjustment for possible confounders such as total brain 
volume and in the NAWM with additional adjustment for quantitative assessed WMLs and 
number of lacunar infarcts. We intentionally did not adjust for vascular risk factors such as 
hypertension or diabetes, as they were considered part of the causal chain between SVD 
and MPS. A methodological issue we should consider is the cross-sectional nature of our 
study, limiting interpretation of our results regarding causality. Secondly, we intentionally 
derived the mean FA and MD in the WMLs and NAWM, and as such obtained a global 
estimate of the loss of microstructural integrity, not taking into account the neuroana-
tomical location of this damage in the white matter. We did so because we considered DTI 
parameters in ROIs alone not a valid representation of the whole white matter. To verify 
differences between the global and ROI-based approach and to investigate the impact of 
the location of affected white matter in relation to the presence of MPS, we additionally 
used ROI analysis in WMLs (periventricular ROIs) as well as in NAWM (subcortical ROIs). 
White matter integrity and mild parkinsonian signs 
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By combining these two techniques we aimed to provide global as well as local estimates 
of loss of microstructural integrity of the white matter in relation to MPS. 
We found that severe loss of microstructural integrity within the WMLs was related to the 
presence of MPS, also after adjustment for WML volume and lacunar infarcts. This 
indicates that the effect of cerebral SVD on MPS not only depends on severity of SVD 
visible on conventional MRI, but also on severity of loss of microstructural integrity within 
these lesions. Although the role of white matter integrity of WMLs with regard to MPS has 
not been reported before, our fi ndings are in line with a study on the cognitive 
consequences of SVD.161 They found among 860 community-dwelling people that 
subjects with a higher MD or lower FA within their WMLs performed worse on tests 
measuring cognitive function.
As expected, the NAWM constituted in all subjects a much larger portion of the white 
matter than the WML volume. Also in this part of the white matter we found that severe 
loss of integrity was related to a higher risk of the presence of MPS and rigidity, although 
the association with MPS disappeared after adjustment for WMLs and lacunar infarcts. 
When interpreting these fi ndings, it is important to realize that in patients with SVD severity 
of the microstructural damage of the NAWM is related to the volume of WMLs.162 Whether 
the association in the NAWM is therefore in fact driven by the coexisting WMLs or whether 
the WML volume serves as an indirect marker of SVD-related damage to the NAWM 
integrity, could not be resolved with this study but should be explored in the future. The 
higher risk of rigidity in subjects with severe loss of microstructural integrity of the NAWM 
in our study persisted after additional adjustment for WMLs and lacunar infarcts. This 
suggests that also other than SVD-related mechanisms contribute to the clinically relevant 
microstructural changes in the NAWM. 
Finally, damage to the white matter integrity and the subsequent effect on MPS could be 
more pronounced when occurring in specifi c regions. We found that a low FA and high 
MD in periventricular regions, especially in the frontal lobe, were associated with MPS. 
Involvement of the frontal lobe is in accordance with studies among patients with vascular 
parkinsonism, supporting the idea that frontal lesions reduce the thalamocortical drive.62 
Furthermore, our fi ndings suggest that disruption of periventricular tracts in the frontal 
lobe rather than subcortical tracts are associated with MPS. This suggestion is supported 
by studies demonstrating an association between periventricular but not subcortical 
WMLs and gait/balance disturbances,25 one of the parkinsonian signs. Because the 
mean MD in the subcortical ROIs was signifi cantly lower than in periventricular ROIs, 
another explanation could be that subcortical frontal tracts are important but were 
relatively spared in our subjects. 
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Although we can speculate about the underlying histopathological substrate of the found 
associations between FA and MD and MPS, it is extremely diffi cult to univocally associate 
them with specifi c pathophysiological processes. We found that both a low FA and high 
MD within WMLs and NAWM were related to MPS. Studies have suggested that FA is a 
somewhat specifi c measure of axonal integrity,46 while the MD has been suggested to be 
altered more selectively by changes in the amount of extra-axonal ﬂ uid and membrane 
density,46 e.g. by damage to myelin.166 However, this is an oversimplifi ed view since 
multiple pathological processes occur simultaneously in cerebral SVD, inﬂ uencing the 
fi nal diffusion pattern. Inferring histopathological characteristics from a given diffusion 
pattern is therefore problematic.
In conclusion, the deleterious effect of cerebral SVD on the presence of motor disturbances 
not only depends on the WML volume, but also on the microstructural integrity of these 
lesions. In addition, our data underscores the importance of neuroanatomical location 
and suggest that MPS may be related to disruption of specifi c deep white matter tracts of 
the frontal lobe. Thus, DTI may be of added value in investigating the underlying 
mechanisms of parkinsonian signs in subjects with SVD. Longitudinal studies are needed 
to determine the predictive value of DTI parameters for the development of parkinsonism. 
In future studies it would also be interesting to investigate the involved networks in more 
detail, for example with other DTI analysis methods such as Tract-Based-Spatial-Statistics. 
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Loss of white matter integrity 
is associated with gait disturbances: 
a Tract-Based Spatial Statistics study
Published as
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white matter integrity is associated with gait disorders in cerebral small vessel disease. 
Brain 2011; 143: 73-83.
 Abstract
Background and objectives
Gait disturbances are common in elderly people. Cerebral small vessel disease (SVD), 
including white matter lesions (WMLs) and lacunar infarcts, is thought to disrupt white matter 
tracts connecting important motor regions, hence resulting in gait disturbances. Pathological 
studies have demonstrated abnormalities in white matter that may appear normal on brain 
imaging. The loss of integrity in such normal-appearing white matter (NAWM) may partly be 
due to small vessel disease and may play a role in causing gait disturbances. The white 
matter regions involved in these gait disturbances, both in WMLs and NAWM, remain unclear. 
We therefore aimed to investigate the relationship between the location of WMLs and gait 
using voxel-based morphometry analysis, as well as between white matter integrity and gait 
by applying Tract-Based Spatial Statistics to diffusion tensor imaging (DTI) parameters. 
Methods
429 individuals with cerebral SVD, aged between 50 and 85 years, without dementia or 
parkinsonism, were included and underwent MRI scanning. Gait was assessed quantitatively. 
Results
WMLs, especially in the centrum semiovale and periventricular frontal lobe, were related 
to a lower gait velocity, shorter stride length and broader stride width. Loss of white matter 
integrity, as indicated by a lower fractional anisotropy and higher mean diffusivity, in 
numerous regions was related to a lower gait performance. Most of these regions were 
located in the NAWM. The strongest signifi cant association was found in the corpus 
callosum, particularly the genu. Most of the associations in the NAWM disappeared after 
controlling for WMLs and lacunar infarcts, except for some in the corpus callosum. 
Conclusions
In conclusion, our study showed that using a combination of voxel-based morphometry 
analysis of the WMLs and DTI is of added value in investigating the pathophysiology of gait 
disturbances in subjects with small vessel disease. Our data demonstrated that in older 
adults with SVD widespread disruption of white matter integrity, predominantly in the NAMW, 
is involved in gait disturbances. Particularly loss of fi bers interconnecting bilateral cortical 
regions, especially the prefrontal cortex, which is involved in cognitive control on motor 
performance, may be important. The most important mechanism underlying this affected 
NAWM is probably by a direct effect of SVD or indirectly by remote effects of WMLs and 
lacunar infarcts.
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Introduction
Gait disorders are common in elderly people and are associated with functional impairment, 
institutionalization and death.19,167 Gait is a complex function that depends on multiple 
factors, including spinal locomotor pattern generators under supraspinal control. Multiple 
brain regions, connected by white matter tracts, are involved in this supraspinal control of 
gait.13 These tracts are vulnerable to lesions, for example caused by cerebral small vessel 
disease (SVD), including white matter lesions (WMLs) and lacunar infarcts.53 Previous 
studies have shown that cerebral SVD is related to gait disturbances,116 which is 
supposedly due to the disruption of these white matter tracts. To date, the involvement of 
white matter tracts has generally been studied at the level of white matter regions affected 
by SVD visible on conventional MRI, showing the frontal98,99,116,148,168 and in several studies 
also the parieto-occipital and brain stem regions to be important.98,100,116,169 However, 
these studies did not investigate the whole brain white matter, including the normal-ap-
pearing white matter (NAWM) (the white matter with exclusion of T2-weighted WMLs), 
although pathological studies have demonstrated that abnormalities in this part of the 
white matter may nevertheless well be present.6
Diffusion tensor imaging (DTI) measures local water diffusion profi les and, in this way, 
provides valuable information on the microstructural integrity of the whole brain white 
matter. The diffusion tensor has three eigenvalues: the fi rst is referred to as axial diffusivity, 
and represents the diffusivity parallel to the white matter tracts. The average of the second 
and third eigenvalues is termed radial diffusivity, and reﬂ ects the diffusivity perpendicular 
to these tracts. Two different, but complementary, common DTI metrics can be derived 
from these eigenvalues: the mean diffusivity (MD), which is the average of the three 
eigenvalues and represents the overall magnitude of water diffusion, and the fractional 
anisotropy (FA), a normalized ratio of diffusion directionality.45 Loss of microstructural 
integrity is typically reﬂ ected by a reduction in FA and/or increase in MD,46 which can 
result from different combinations of changes in axial and radial diffusivity. Investigating 
these four measures conjointly provides more information about the possible changes of 
white matter microstructure than FA and MD alone. 
DTI studies in patients with cerebral SVD and gait disturbances are scarce. Two studies 
showed an association between the loss of microstructural integrity of the corpus 
callosum and gait impairment43,44 One of these studies used a region-of-interest (ROI) 
approach,43 which has the disadvantage of revealing changes only in pre-selected areas 
that might not necessarily correspond with areas that are affected in gait disturbances. 
Whole brain white matter information can be obtained with voxel-based DTI methods as 
used by Della Nave et al.44 However, potentially important limitations of this analysis are 
White matter integrity and gait disturbances: a TBSS study
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the spurious effects of the smoothing170 and the possible misalignment due to the spatial 
normalization procedure.171 Especially the latter is a common problem in elderly people 
because of atrophy and ventricular enlargement. Tract-Based Spatial Statistics (TBSS) is 
a relatively new method that mitigates these two problems.171 The rationale behind the 
TBSS method is that the analysis is restricted to those white matter voxels that constitute 
the skeleton (core) of the brain’s connectional architecture and that this skeleton can be 
matched more accurately (compared to whole brain normalization) across subjects. 
We hypothesized that gait disturbances in older adults with cerebral SVD would not only 
be related to loss of microstructural integrity of the white matter within the WMLs, but also 
of the NAWM. Moreover, we suggested that this loss of integrity of the NAWM would be 
related to the concurrent SVD, rather than to degenerative processes such as general 
brain atrophy. Firstly, we examined the association between WML location and gait 
disturbances using voxel-based morphometry analysis. Secondly, we conducted TBSS to 
investigate the location of white matter with loss of microstructural integrity related to gait 
disturbances. Finally, we examined whether the associations in the white matter were 
primarily explained by SVD or general brain atrophy by appropriate adjustment for these 
two factors. 
Methods
Study population
This study is embedded within the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort study that 
was designed to investigate risk factors and cognitive, motor and mood consequences of 
functional and structural brain changes as assessed by MRI among older adults with 
cerebral SVD. The primary study outcome of the longitudinal part of this study is the 
development of dementia or parkinsonism. 
Cerebral SVD is characterized on neuroimaging by either WMLs or lacunar infarcts. 
Symptoms of SVD include acute symptoms, such as transient ischemic attacks (TIAs) or 
lacunar syndromes, or subacute manifestations, such as cognitive, motor (gait) and/or 
mood disturbances.11 As the onset of cerebral SVD is often insidious, clinically 
heterogeneous, and typically with mild symptoms, it has been suggested that the 
selection of subjects with cerebral SVD in clinical studies should be based on these more 
consistent brain imaging features.12 Accordingly, in 2006, consecutive patients referred to 
the Department of Neurology between October 2002 and November 2006, were selected 
for participation. 
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Inclusion criteria were (a) age between 50 and 85 years and (b) cerebral SVD on 
neuroimaging [WMLs and/or lacunar infarct(s)]. Subsequently, the abovementioned acute 
or subacute clinical symptoms of SVD were assessed by standardized structured 
assessments. Patients who were eligible because of a lacunar syndrome were included 
only >6 months after the event to avoid acute effects on the outcomes. 
Exclusion criteria were: (a) dementia;60 (b) parkinson(ism),61,101 (c) intracranial hemorrhage; 
(d) life expectancy of <6 months; (e) intracranial space-occupying lesion; (f) (psychiatric) 
disease interfering with cognitive testing or follow-up; (g) recent or current use of acetyl-
choline-esterase inhibitors, neuroleptic agents, L-dopa or dopa-a(nta)gonists; (h) WML 
mimics; (i) prominent visual or hearing impairment; (j) language barrier; (k) MRI contrain-
dications or known claustrophobia. Additional exclusion criteria for this study were: (l) 
inability to walk 6 m unaided; (m) conditions not related to SVD that affected gait (e.g. joint 
fusion, severe arthritis or psychogenic gait disturbance) and (n) territorial infarcts, 
because they were considered as a confounder and because of methodological issues 
such as misalignment during normalization procedure.
Patients were selected for participation in the study by a three step approach. After 
reviewing the medical records, we invited 1004 individuals by letter. Of these 1004, 727 
were eligible after contact by phone and 525 agreed to participate. During their visit to our 
research center, we found exclusion criteria in 22 subjects [dementia (n=4), Parkinson’s 
disease (n=1), multiple sclerosis (n=1), language barrier (n=1), death before MRI scanning 
(n=1), unexpected claustrophobia (n=14)], yielding a response of 71.3% (503/705) for the 
original cohort of the study. During these three steps, patients excluded because of 
dementia were diagnosed according to the Diagnostic and Statistical Manual for Mental 
Disorders, version IV,60 with formal cognitive assessment. Firstly, patients were excluded 
based on the clinical information and cognitive assessment obtained by reviewing their 
medical records. Secondly, during contact by phone, patients were excluded if a close 
informant told us that the eligible person was admitted to a nursing home because of 
dementia, diagnosed by a neurologist or geriatrician. Thirdly, during their visit to our 
research center, all subjects underwent extensive cognitive assessment and 
questionnaires about their social functioning, and were excluded because of dementia if 
they fulfi lled the previously mentioned criteria. For the present study, 74 subjects were 
additionally excluded: inability to walk 6 m unaided (n=4); conditions not related to the 
risk factor that affected gait (n=11), such as drop foot, lower extremity amputation, joint 
fusion, severe arthritis, severe vascular problems of the lower extremity, or a psychogenic 
gait disturbance; territorial infarcts (n=55), and inadequate quality of the MRI image 
(n=4), yielding a sample size of 429 for the this study. These 429 individuals had acute 
symptoms such as TIA or lacunar syndrome (n=166), or subacute symptoms such as 
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cognitive disturbances (n=227), motor disturbances (n=84), depressive symptoms 
(n=89) or a combination of these subacute symptoms. A motor disturbance was defi ned, 
in accordance with operationalization as used in other large scale studies on cerebral 
SVD and gait,102 as follows: a reported history of ≥1 fall(s) during the past year or a 
self-reported slowing of gait. All participants signed an informed consent form. The 
Medical Review Ethics Committee region Arnhem-Nijmegen approved the study.
MRI techniques
All MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom 
Sonata, Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 
magnetization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time 
(TE)/interval time (TI) 2250/3.68/850 ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm], a fl uid-
attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 9000/84/2200 ms; voxel size 
1.0x1.2x5.0mm, plus an interslice gap of 1 mm) and a DTI sequence (TR/TE 10100/93 ms; 
voxelsize 2.5x2.5x2.5 mm, 4 unweighted scans, 30 diffusion-weighted scans with b-value 
of 900 s/mm2). 
Conventional MRI analysis
White matter signal hyperintensities on FLAIR scans, which were not, or only faintly, 
hypo-intense on T1-weighted images, were considered WMLs, except for gliosis 
surrounding infarcts. We rated WMLs visually on FLAIR images using the Age-Related 
White Matter Changes scale, which grades WML severity on a 4-point scale (0-3).172 
WMLs were also manually segmented on the FLAIR images by two trained raters. Total 
WML volume was calculated by summing the segmented areas multiplied by slice 
thickness. Lacunar infarcts were rated and defi ned as areas with a diameter >2 mm and 
≤15 mm with low signal intensity on T1 and FLAIR, ruling out enlarged perivascular spaces 
and infraputaminal pseudolacunes.32-34 All imaging analyses were performed by raters 
blinded to clinical information. In a random sample of 10%, inter-rater variability for total 
WML volume yielded an intra-class correlation coeffi cient of 0.99; intra- and inter-rater 
reliability for number of lacunar infarcts a weighted kappa of 0.80 and 0.88. 
We computed grey and white matter tissue and cerebrospinal fl uid probability maps 
using Statistical Parametric Mapping 5 (Wellcome Department of Cognitive Neurology, 
University College London, UK) unifi ed segmentation routines on the T1 images.92 Binary 
tissue maps were created by thresholding the probability maps at 0.5. Total grey and 
white matter volumes were calculated by summing all voxel volumes that belonged to that 
class. Total brain volume was taken as the sum of total grey and total white matter volume.
Furthermore, we performed voxel-based morphometry style applied to the WML maps. 
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For this, we modifi ed the optimized Functional MRI of the Brain (FMRIB) Software Library 
voxel-based morphometry protocol (www.fmrib.ox.ac.uk/fsl).173 Firstly, we registered the 
skull-stripped T1 images of the study subjects (n=429) non-linearly to the Montreal 
Neurological Institute 152 T1 template using FMRIB nonlinear registration tool (http://wqw.
fmrib.ox.ac.uk/fsl/fnirt) and averaged them to obtain the group-specifi c template. 
Subsequently, these T1 images were non-linearly normalized to the group-specifi c 
template. Then we registered the WML maps to the T1 images using the transformation 
matrix from the registration parameters of skull-stripped FLAIR images to the T1-images 
that were obtained using FMRIB linear image registration tool (http://www.fmrib.ox.ac.uk/
fsl/fl irt). Next, we normalized the WML maps non-linearly to the group-specifi c template 
using the transformation parameters of T1 images to the group-specifi c template. To 
correct for the stretching and contraction of the WMLs due to the non-linear registration, 
the normalized WML images were divided by the Jacobian of the warp fi eld, allowing us 
to make inferences about the WML volume within a voxel. Finally, these images were 
smoothed with an isotropic Gaussian kernel with a sigma of 2 mm to account for the 
inter-subject variability.
Diffusion tensor imaging analysis
Diffusion data were fi rst pre-processed using an in-house developed algorithm for 
patching artefacts from cardiac and head motion.174 In short, this iteratively-reweighted-
least-squares algorithm produces robust diffusion tensor estimates and provides 
weightings, which are used to detect and correct head and cardiac motion artifacts in the 
diffusion-weighted data. Next, affi ne misalignments from eddy currents and subject 
motion were corrected simultaneously by minimization of the residual diffusion tensor 
errors.175 Using DTIFit within FMRIB diffusion toolbox, we created the FA, MD, and the 
axial and radial diffusivity images, which were then fed into the TBSS pipeline.171 In short, 
a FA skeleton was created by thinning the mean FA image based on the FA values. 
Subsequently, this skeleton was thresholded at 0.3 to include the major white matter 
tracts and to account for the inter-subject variability. All normalized FA data were then 
projected onto this skeleton. By applying the projection vectors from each subject’s 
FA-to-skeleton transformation, we projected the images of MD, axial and radial diffusivity 
onto the mean FA skeleton. During the normalisation procedures the images were not 
modulated with the Jacobian of the spatial transformations (i.e. not corrected for the brain 
volume). These data were then fed into voxel-wise cross-subject statistics. 
In addition, we obtained the mean FA, MD, and axial and radial diffusivity for the three 
parts of the corpus callosum by performing ROI analyses. We created the masks for 
genu, body and splenium of the corpus callosum by applying the white matter atlas (JHU 
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white matter labels, provided by FSL) on the mean FA skeleton. The genu contains fi bers 
connecting areas of the prefrontal cortex, the body of the premotor, motor and 
somatosensory cortex and the splenium of the parietal, temporal and occipital cortex.176 
The masks were visually inspected and miscellaneous voxels that belonged to other 
regions, like the cingulum bundle, were excluded. 
Measurement of gait
Quantitative gait analysis was performed with a 5.6-m electronic portable walkway 
(GAITRite, MAP/CIR Inc., Havertown, PA) with sensor pads connected to a computer. This 
system has strong concurrent validity and test-retest reliability.71,177 
The participants walked twice at self-selected normal gait speed on low-heeled shoes. 
They started two meters before the carpet and walked until two meters behind it in order 
to measure steady-state walking. We measured velocity (m/s), consisting of both the 
stride length (m) (the distance between the heel points of two consecutive footprints of 
the same foot) and cadence (number of steps per minute), and the stride width (cm) (the 
distance between one midpoint of a footprint and the line of progression of the opposite 
foot). For this study, we choose velocity, stride length and width because of our previous 
demonstrated good associations with both neuroimaging aspects of SVD116 and the 
known association of velocity with risk of falls.140  As velocity is determined by stride length 
and cadence, this latter gait parameter was also included. 
Other measurements
For assessment of vascular risk factors, structured questionnaires were used together 
with measurements of blood pressure taken on several separate occasions. The risk 
factors were presence of hypertension (mean blood pressure ≥140/90 mmHg and/or use 
of antihypertensive medications),141 diabetes (treatment with antidiabetic medications), 
hypercholesterolemia (treatment with lipid-lowering medications) and smoking status. 
Body mass index was also recorded. We used the Mini Mental State Examination score 
(range 0–30) to assess global cognitive status.64 Functional independence was assessed 
using the Barthel Index (range 0–20).84 The total score on the motor section of the Unifi ed 
Parkinson’s Disease Rating Scale (27 items, score 0-4)74 was rated by two trained raters.
Statistical analysis 
The baseline characteristics were presented as mean ± standard deviation (SD) and for 
the skewed distributed parameters the median and interquartile range were calculated. 
The quantitative GAITRite parameters were averaged over two walks. When one trial was 
missing (n=3), the remaining measures were used. 
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We performed inter-subject voxel-wise regression analyses between WML volume (within a 
voxel) and the gait parameters (gait velocity, length, cadence and stride width), while 
adjusting for age, sex and height. Secondly, for the TBSS analyses, we assessed voxel-wise 
regression coeffi cients between the skeletal DTI parameters (FA and MD) and gait, while 
adjusting for the same confounding factors. To test whether the associations between DTI 
and gait parameters were attributable to the SVD or general atrophy of the brain, we repeated 
these analyses with additional adjustment for WML volume and number of lacunar infarcts or 
total brain volume. We performed the voxel-wise statistical analyses for both WMLs and 
TBSS data using permutation-based statistical interference tool for non-parametric approach 
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Table 1 Characteristics of the study population
Characteristics n=429
Demographic and clinical characteristics
Age, yrs 65.2 (8.9)
Female, no. 194 (45.2)
Height, m 1.7 (0.1)
Body Mass Index, kg/m2 26.6 (4.0)
Subjects with hypertension, no. 310 (72.3)
Subjects with diabetes mellitus, no. 60 (14.0)
Subjects with hypercholesterolemia, no. 190 (44.3)
Smokers, current, no. 64 (14.9)
Smokers, former, no. 233 (54.3)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
UPDRS motor score† 0.0 (0.0; 1.0)
Neuroimaging characteristics
Age-Related White Matter Changes scale† 1.0 (1.0; 2.0)
Total brain volume, ml 1098.2 (119.3)
White matter volume, ml 467.2 (64.8)
White matter lesion volume, ml† 6.5 (3.2; 17.8)
Subjects with lacunar infarct(s), no. 133 (31.0)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 112.0 (10.8)
Stride width, cm 10.8 (3.1)
Data represent number of subjects (%), mean (standard deviation) or †median (interquartile range)
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as a part of FMRIB Software Library.171,178 The number of the permutation tests was set at 
5000 and signifi cant associations were determined using the threshold-free cluster- 
enhancement with a threshold of P<0.05, corrected for the multiple comparisons.179 Thirdly, 
for the ROI analyses, we computed (SPSS statistical software, version 16.0) regression 
coeffi cients  of the mean FA, MD, and axial and radial diffusivity of the three ROIs in the 
corpus callosum (genu, body and splenium) with gait, while adjusting for age, sex, height 
and total brain volume. Subsequently, we adjusted for the same DTI parameter in the other 
two regions of the corpus callosum to test an independent effect of the DTI parameter in 
the three areas. Regression coeffi cients were presented as standardized beta-values. 
Results
Characteristics
Table 1 shows the demographic, clinical, imaging and gait characteristics. Mean age of 
the study population (n=429) was 65.2 years (SD 8.9) and 194 (45.2%) were women. 
Median volume percentage NAWM of the whole-brain white matter was high: 98.6% 
(interquartile range 96.3%-99.3%). 
White matter lesions and gait
WMLs were predominantly located in the frontal periventricular regions (Figure 1). 
Signifi cant associations between WMLs and lower gait velocity, shorter stride length and 
broader stride width were observed in multiple white matter regions, except for the 
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Figure 1   The probability distribution of the white matter lesions
WMLs are in blue and color-coded in percent (color bar), thresholded from 5 to 90%. The red lines indicate 
areas with a positive association between the FA and gait velocity. Adjusted for age, sex, height, 
thresholded at P<0.05 and corrected for multiple comparisons. These images are projected onto the 
spatially normalized (Montreal Neurological Institute stereotactic space) and averaged (n=429) FA map.
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Figure 2   The probability distribution of the white matter lesions
Voxel-wise analysis of the WMLs negatively associated with gait velocity, stride length and cadence, and 
positively with stride width. Adjusted for age, sex, height, thresholded at P<0.05 and corrected for multiple 
comparisons. The statistical maps are superimposed onto the spatially normalized (Montreal Neurological 
Institute stereotactic space) and averaged (n=429) T1 structural map.
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temporal lobe, brainstem and cerebellum (Figure 2). No signifi cant associations were 
identifi ed between WMLs and cadence. The strongest signifi cance (P<0.001) with gait 
velocity was found in the centrum semiovale  on the right side and at a slightly lower 
signifi cance level (P<0.005) also on the left side. The regions with a signifi cance P<0.001 
for stride length were more widespread than for gait velocity. These regions were located 
in the periventricular frontal lobes and centrum semiovale on both sides. WMLs in the 
centrum semiovale showed also the highest association with stride width.
Microstructural integrity of the white matter and gait
As shown in Figure 3A the FA at almost all voxels on the skeleton were positively related to 
gait velocity, stride length and negatively to stride width, including the supra- and 
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Figure 3   Association between fractional anisotropy and gait
Voxel-wise analysis of the FA positively associated with gait velocity, stride length and cadence, and 
negatively with stride width. Adjusted for age, sex and height (panel A), or age, sex, height, white matter 
lesions and number of lacunar infarcts (panel B), thresholded at P<0.05 and corrected for multiple 
comparisons. The statistical maps are superimposed onto the spatially normalized (Montreal Neurological 
Institute stereotactic space) and averaged (n=429) FA map.
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infratentorial regions (but not the hippocampal regions and fornices). On the other hand, a 
signifi cant positive relationship between FA and cadence was found in only a few voxels on 
the skeleton. We found a similar distribution for the inverse relationship between the MD and 
these gait parameters, except for the cingulum and infratentorial white matter areas. Of 
note, these associations were not only within the WMLs, but also where the probability of 
the WMLs was low (<5%) or even absent (Figure 1). The voxels with the strongest signifi cance 
(P<0.001) between the FA and gait velocity were located in the corpus callosum along its 
complete course and in relation to the MD also in the posterior limb of the internal capsule. 
Similar associations were found for the relationship between the FA and MD and stride 
length and stride width. In addition, a high signifi cant association (P<0.001) was identifi ed 
in the middle portion of the cingulum bundle in the relationship between the FA and stride 
length. No associations with a P<0.001 were found with regard to cadence.
Additional adjustment for total brain volume did not change this pattern for the velocity, 
stride length and stride width. However, these relationships disappeared after additional 
control for WMLs and lacunar infarcts, except for some associations between the FA and 
stride length in the genu and splenium of the corpus callosum and between the MD and 
stride length in the body of the corpus callosum (Figure 3B). With regard to cadence, no 
signifi cant associations were found after additional adjustment for both total brain volume 
or WMLs and lacunar infarcts. 
As DTI parameters in the corpus callosum showed the strongest signifi cant associations 
with gait, we analyzed the corpus callosum in more anatomical detail by segmenting it in 
three regions. We found a lower FA and a higher MD in the genu signifi cantly related to a 
lower gait velocity, independent of the DTI parameters in the other two segments (FA 
standardized β=0.18, P=0.021; MD standardized β=-0.21, P=0.010) (Table 2). This was 
mainly due to a change in stride length and to a lesser extent in cadence. The relationship 
between DTI parameters and stride width was less clear after adjusting for the same DTI 
parameter in the other two segments (MD genu standardized β=0.16, P=0.065; MD body 
standardized β=0.17, P=0.088). These associations with the FA and MD were mainly driven 
by changes in the radial diffusivity, but not in axial diffusivity.
Discussion
We found that in subjects with cerebral SVD a lower FA and higher MD in multiple regions of 
the white matter skeleton were associated with a lower gait performance. These regions were 
located both in the WMLs and the NAWM. The regions that showed the highest signifi cant 
relationships to gait were the internal capsule and the corpus callosum, especially the genu. 
White matter integrity and gait disturbances: a TBSS study
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Some methodological issues need to be considered. Firstly, cerebral SVD is a term used 
in different contexts (i.e., pathological, neuroimaging, and clinical aspects). As mentioned 
earlier, neuroimaging has a central role in defi ning SVD. WMLs and lacunar infarcts are 
widely accepted signs of cerebral SVD. However, lacunar infarcts may also result from 
non-SVD-related mechanisms, such as embolism from the heart or proximal arteries.159 
We therefore cannot rule out some misclassifi cation of lacunar infarcts as SVD-related in 
our study. As the majority of lacunar strokes are SVD-related159 and the lacunar infarcts in 
our study were all accompanied by some degree of WMLs, favouring an underlying 
SVD-related mechanism,160 we feel that this misclassifi cation would be rather small and 
did not greatly inﬂ uenced our results. Secondly, our results are based on cross-sectional 
data, which prevents us from making causal inference. Our study has a longitudinal 
design and follow-up is already planned to evaluate the effect of progression of SVD on 
(changes in) gait. Thirdly, in moderate to severe stages of SVD, WMLs are diffusely 
distributed throughout the white matter that might lead to a diffuse loss of microstructural 
integrity. Hence, WMLs or loss of structural integrity in one region may be related to those 
in other regions. This prevents us to draw conclusions about the importance of WMLs or 
loss of microstructural integrity at a specifi c location in relation to gait disturbances, 
independent of other affected white matter regions. To overcome this problem, we 
analyzed the corpus callosum more specifi cally in three segments and with additional 
adjustment for the microstructural integrity in the other two segments. Finally, vascular 
risk factors such as hypertension or diabetes were intentionally not taken into account, as 
they were considered a part of the causal chain between SVD and gait. Disturbances of 
the peripheral neuromuscular or skeletal systems were also not included as confounders, 
because these factors were considered as independent contributors to gait disturbances. 
To our knowledge, this is the fi rst study using both voxel-wise MRI and DTI methods to 
investigate the pathophysiological mechanisms underlying gait disorders in SVD. Another 
strength is the manual segmentation of the WMLs and quantitative assessment of gait. 
Finally, our study is large, with a high response, and with all subjects examined by only 
two investigators in a single center.
We found that WMLs as well as loss of white matter microstructural integrity were 
associated with a lower gait velocity, mainly due to a reduction in stride length, and a 
broader stride width. In contrast, only a few voxels with loss of integrity (indicated by a low 
FA and high MD) were related to a lower cadence and WMLs were not. We found in our 
previous study a similar lack of association between cadence and total WML volume. 
Only lacunar infarcts, in the frontal lobe and brainstem, were related to a lower cadence.116 
This, together with the observed discrepancy between a reduced stride length and intact 
cadence control in patients with Parkinson’s disease and normal pressure hydrocephalus,106 
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suggests that this gait characteristic is less inﬂ uenced by the white matter than stride 
length, at least at the supraspinal level. It would be interesting in future studies to unravel 
the underlying mechanisms of cadence control in more detail.  
Using TBSS, we found that disruption of almost all regions on the skeleton, corresponding 
to multiple association, projection and commissural fi bers, was associated with a lower 
gait performance. The involvement of multiple regions is consistent with a positron-emis-
sion-tomography study in healthy individuals that reported activation in multiple cortical 
and subcortical regions after walking, such as the primary motor and somatosensory 
cortex, the parahippocampal, fusiform and occipital gyri, cerebellum and pontomesence-
phalic tegmentum and deactivations in the multisensory vestibular cortices.13 In addition, 
even more brain regions are involved in motor control in elderly than young adults.180 
Interestingly, the majority of voxels on the skeleton with loss of microstructural integrity 
related to gait disturbances was localized in regions were the WML probability was low or 
even absent. The integrity of the commissural fi bers in the corpus callosum showed even 
the strongest signifi cant association with gait. This highlights the importance of micro-
structural integrity of fi bers in the NAWM in gait disorders, in addition to WMLs visible on 
conventional MRI. 
Both MRI techniques revealed that a shorter stride length was predominantly related to 
abnormalities in the frontal white matter (the frontal WMLs and the microstructural integrity 
of the genu). Previous quantitative volumetric MRI studies are conﬂ icting. Srikanth et al. 
demonstrated that especially frontal WMLs were related to poorer gait,148 whereas one 
other small study reported this for parieto-occipital WMLs.169 The observed relationship 
between the microstructural integrity of the genu and gait is in line with two smaller DTI 
studies.43,44 A novel fi nding in our study is that this relationship was independent of the 
integrity of the other corpus callosum segments. The genu is known to contain fi bers 
connecting the bilateral prefrontal cortex.176 As the prefrontal cortex receives, among 
others, information from virtually all sensory systems and has preferential connections 
with the motor processing structures, it is proposed to play a central role in the cognitive 
control of motor performance.145 This part of the frontal lobe was seen to be additionally 
involved in motor performance in elderly, in contrast to young adults.180 Moreover, elderly 
are thought to rely more on bilateral activation of the frontal cortices during motor 
performance,180 reﬂ ecting the importance of commissural fi bres at older age. Hence, our 
data suggest that loss of microstructural integrity of the genu of the corpus callosum 
could lead to decreased cognitive control and subsequently to gait disturbances at older 
age.
As loss of microstructural integrity of fi bers in the NAWM played an important role in the 
gait disturbances in our subjects with SVD, it would be interesting to know more about the 
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mechanisms underlying this loss of integrity. The introduction of WMLs and lacunar 
infarcts in the association between the microstructural integrity of the NAWM and gait 
signifi cantly weakened this relationship, suggesting that the damage to this NAWM might 
be, in part, SVD-related. Some associations in the corpus callosum still existed after 
adjustment for WMLs and lacunar infarcts, suggesting also a mechanism other than SVD. 
This is in line with another study, showing that different pathological mechanisms, such 
as vascular, and degenerative diseases often coexist in one subject.49 Injury to the NAWM 
by SVD in our study may have occurred by at least two mechanisms or a combination 
thereof. SVD could have a direct effect on the NAWM. This hypothesis is indirectly 
supported by a MRI study reporting on an increased blood-brain permeability, which is 
thought to play a role in SVD, in the NAWM181 and a pathological study showing reduced 
myelin staining in the NAWM of the lateral corpus callosum,182 in subjects with SVD. 
Another possibility is the remote effect of WMLs on the NAWM by antero (Wallerian) or 
retrograde neuronal degeneration of fi bers in the surrounding NAWM traversing these 
lesions, as indicated by pathological studies among patients with multiple sclerosis.183,184 
Wallerian degeneration after ischemic stroke is furthermore a well-known phenomenon.185 
WMLs in the frontal white matter, shown to be a predilection site of WMLs and relevant in 
gait disturbances in our study, may have, at least in part, affected the microstructural 
integrity of the genu of the corpus callosum through this mechanism. 
The pattern of changes in FA, MD, and axial and radial diffusivity may provide some 
information on these underlying histopathological mechanisms of loss of callosal integrity 
in our study, although the exact (combination of) histopathological processes leading to 
changes in the diffusion tensors are diffi cult to predict in humans. A low FA, high MD, with 
a predominantly high radial diffusivity and to a lesser extent axial diffusivity were 
associated with an impaired gait performance. This pattern is believed to be mainly 
determined by an increase in extra-axonal ﬂ uid and lower membrane density,46 e.g. as a 
result of loss of myelin166 or axons or axonal atrophy.46 Both the direct effect of SVD and 
chronic Wallerian degeneration secondary to WMLs can mirror this DTI pattern. Direct 
effects of small vessel disease on the NAWM can result in an increased blood-brain 
permeability and hence in an accumulation of ﬂ uid in the extracellular space, leading to a 
predominant increase in radial diffusivity. On the other hand, our results are also in 
agreement with previous DTI studies in chronic Wallerian degeneration,186 although a 
reduction in axial diffusivity has also been described in this process.187 At present, we 
therefore can only speculate on the mechanisms responsible for the observed association 
between the microstructural integrity of the NAWM and gait. 
In conclusion, our study provides new insight into the pathophysiology of gait disturbances 
in older adults with SVD. They are likely attributable to loss of microstructural integrity of 
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multiple white matter fi bers connecting different cortical and subcortical regions, 
mediating intra- and particularly interhemispheric integration of motor and sensory 
signals. Especially damage to the callosal fi bers of the genu projecting to the prefrontal 
areas is thought to be important, which might indicate loss of cognitive control on motor 
processing. DTI, e.g. by using TBSS, complements voxel-based morphometry analysis of 
the WMLs as DTI reveals functionally relevant injury of white matter integrity underlying 
gait disturbances in these subjects not detected by conventional MRI and is as such a 
promising method in examining the consequences of cerebral SVD. As cerebral SVD is 
treatable,188 and probably direct effects of SVD on the NAWM also, future studies are 
needed to elucidate the underlying mechanism of abnormalities in the NAWM in subjects 
with SVD.
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Conventional MRI versus diffusion 
tensor imaging and motor performance 
in cerebral small vessel disease

4.1
Gait disturbances in small vessel disease: 
the value of diffusion tensor imaging
Submitted as
de Laat KF, van Norden AG, Borm GF, Norris DG, Zwiers MP, van Dijk EJ, de Leeuw F-E. 
Gait disturbances in small vessel disease: the value of diffusion tensor imaging.
Abstract
Background and objectives
Diffusion tensor imaging (DTI), a MRI technique to assess the integrity of normal-appear-
ing white matter (NAWM) and white matter lesions (WMLs), is advocated as an innovative 
method which adds to our understanding of the mechanisms of gait (and cognitive) 
impairment in people with cerebral small vessel disease (SVD). However, the relative 
importance of conventional MRI and DTI parameters in gait disturbances in subjects with 
SVD, and with that the relevance of DTI in clinical practice, has never been investigated. 
Methods
483 individuals with SVD, aged between 50 and 85 years, without dementia or 
parkinsonism, underwent MRI scanning. WML, white and grey matter volume, number 
of microbleeds, lacunar and territorial infarcts, and mean diffusivity (MD) of WMLs, 
NAWM and total white matter were related to quantitative gait parameters in multivariate 
regression models, after adjustment for age and sex.
Results
All MRI parameters together accounted for 3-7% of the variance in gait (stride 
length>velocity>stride width>cadence) on top of  the 12-35% explained by age and sex. 
When they were considered separately, the MD of the total white matter had the strongest 
association with gait, mainly due to the MD of the NAWM. However, when the MD of 
WMLs and NAWM were added to the model with conventional MRI parameters, there was 
no (substantially) increase in variance in gait.
Conclusions
Although the MD of the total white matter is an useful parameter in longitudinal studies to 
investigate whether it could be a surrogate disease marker in treatment trials, DTI has no 
added value in individual patients with SVD.
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Introduction
There is increasing interest in the contribution of cerebral small vessel disease (SVD) to 
gait disturbances (next to cognitive decline) in elderly people. Different manifestations of 
SVD, such as white matter lesions (WMLs), lacunar infarcts and microbleeds, have been 
related to gait disturbances.23,25,116,189 However, usually only a few percent of the total white 
matter is visually affected on conventional MRI by these lesions,42 while the integrity of the 
remaining largest part, the normal-appearing white matter (NAWM), and the possible 
effect this may have on gait, cannot be assessed by conventional MRI. A relatively new 
MRI technique, diffusion tensor imaging (DTI),93 is able to measure the microstructural 
integrity of this NAWM.45 In addition, it is highly sensitive to the microstructural integrity 
within the WMLs. It is often advocated as a promising technique and has been proven to 
add to our understanding in the mechanisms of gait (and cognitive) disturbances in 
patients with SVD.190,191
However, the relative importance of each of these MRI parameters in gait disturbances in 
patients with SVD, and with that the value of DTI in clinical practice, is not clear. It has 
never been investigated which (combination of) MRI parameter(s) explain(s) most of the 
variance in gait. It is furthermore unknown to what extent the microstructural integrity of 
the WMLs and NAWM contributes to gait disturbances in patients with SVD, ón top of the 
abnormalities already seen on conventional MRI.
We therefore investigated, in patients with SVD, which (combination of) MRI parameter(s) 
accounted for the largest portion of variance in gait. Secondly, we determined the 
additional variance in gait explained by the microstructural integrity of the WMLs and 
NAWM to that explained by abnormalities visible on conventional MRI.
Methods
Study population
This study is embedded in the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort study that 
investigates risk factors and clinical consequences of brain changes as assessed by MRI 
among older adults with cerebral SVD, with the development of dementia or parkinsonism 
as the primary study outcome. 
The RUN DMC cohort consists of 503 people, aged between 50-85 years, with WMLs 
and/or lacunar infarct(s) on neuroimaging and acute (transient ischemic attack or lacunar 
syndrome) or subacute (cognitive, motor or depressive) symptoms of SVD, recruited from 
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the Department of Neurology.117 As suggested for clinical studies, patients were primarily 
selected on brain imaging features, since clinical symptoms of SVD are more heterogeneous 
and typically mild at the onset of cerebral SVD.12 Exclusion criteria were: (a) dementia;60 (b) 
parkinson(ism);61,101 (c) intracranial hemorrhage; (d) life expectancy of <6 months; (e) 
intracranial space-occupying lesion; (f) (psychiatric) disease interfering with cognitive 
testing; (g) use of acetylcholine-esterase inhibitors, neuroleptic agents, L-dopa or 
dopa-a(nta)gonists; (h) non-SVD-related WMLs (e.g. multiple sclerosis) (i) prominent visual 
or hearing impairment; (j) language barrier; (k) MRI contraindications or known 
claustrophobia. Additional exclusion criteria for this study were: (l) inability to walk 6 meters 
unaided (n=4), (m) conditions not related to SVD that affected gait (e.g. joint fusion, severe 
arthritis, psychogenic gait disturbance) (n=12). Tissue segmentation or DTI postprocessing 
was not possible in 4 scans, yielding a fi nal sample size of 483 subjects.  
All participants signed an informed consent form. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
MRI techniques
MRI scans of all subjects were acquired on a single 1.5 Tesla scanner (Magnetom Sonata, 
Siemens Medical Solutions, Erlangen, Germany). The protocol included a 3D T1 magnet-
ization-prepared rapid gradient-echo sequence [repetition time (TR)/echo time (TE)/
inversion time (TI) 2250/3.68/850ms; fl ip angle 15°; voxel size 1.0x1.0x1.0 mm], a fl uid-
attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 9000/84/2200 ms; voxelsize 
1.0x1.2x5.0 mm, plus an interslice gap of 1.0 mm), a gradient-echo T2*-weighted 
sequence (TR/TE 800/26 ms: voxel size 1.3x1.0x5.0 mm, plus an interslice gap of 1.0 mm) 
and a DTI sequence (TR/TE 10100/93 ms, voxelsize 2.5x2.5x2.5 mm, 4 unweighted scans, 
30 diffusion-weighted scans, b-value 900 s/mm2). 
Measurement of conventional MRI parameters
WMLs were manually segmented, and the number of lacunar infarcts, territorial infarcts 
(diameter >15 mm in known arterial territories) and microbleeds rated according to a 
standardized protocol.117 Grey matter and white matter and cerebrospinal fl uid probability 
maps were obtained by automated segmentation on the T1 images using Statistical 
Parametric Mapping (SPM5) (http://www.fi l.ion.ucl.ac.uk/spm/).92 Subsequently, the grey 
and white matter volume were calculated by summing all voxels of the corresponding 
tissue class. Mutual information co-registration (SPM5) was used to align WML maps to 
the T1 image and to yield a NAWM map (the complement of WMLs in the white matter). 
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Measurement of DTI parameters
The diffusion-weighted images of each subject were realigned on the mean of the realigned 
unweighted images using mutual information co-registration (SPM5). The diffusion tensor93 
and its eigenvalues were computed using a SPM5 add-on (http://sourceforge.net/projects/
spmtools). Spurious negative eigenvalues were set to zero, after which the mean diffusivity 
(MD) was calculated.94 The mean unweighted image was used to compute the co-registration 
parameters to the T1 image, which were then applied to all diffusion-weighted images and 
results. We checked all images visually for motion artifacts and co-registration errors. Then, 
we calculated the volume averaged MD in the WMLs, the NAWM and the total white matter.
Measurement of gait
As reported previously,116 we measured gait velocity (m/s), stride length (m), cadence 
(steps/minute) and stride width (cm) at self-selected speed, using the 5.6m GAITRite 
system (CIR Systems Inc., Havertown, PA).
Other measurements
For assessment of vascular risk factors, structured questionnaires were used and an 
experienced research nurse measured the blood pressure three times in the supine 
position after fi ve minutes of rest. The risk factors were presence of hypertension (mean 
blood pressure ≥140/90 mmHg and/or use of antihypertensive medications),141 diabetes 
(treatment with antidiabetic medications), hypercholesterolemia (treatment with lipid- 
lowering medications) and smoking status. We used the Mini Mental State Examination 
score (range 0–30) to assess global cognitive status.64 Functional independence was 
assessed using the Barthel Index (range 0–20).84
Statistical analysis
The baseline characteristics are presented as mean ± standard deviation (SD) and for 
the positively skewed WML volume, the median and interquartile range was calculated. 
The quantitative GAITRite parameters were averaged over two trials. When one trial was 
missing (n=3), the remaining measures were used. 
In all analyses, we used the MD rather than the fractional anisotropy in relation to gait as 
we wanted to investigate the (set of) variables that explained gait best, and MD was found 
to be the strongest predictor of gait in our previous study.192 
Firstly, we used Pearson’s correlations to assess the associations between age and MRI 
parameters (grey and white matter and WML volume, number of microbleeds, lacunar 
infarcts and territorial infarcts, and the mean MD of the WMLs, NAWM and total white 
matter) and their mutual correlations. The WML volume was log transformed. 
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Secondly, we performed a multiple regression analysis (with age and sex included in 
every model) for each gait parameter separately to establish which MRI parameter 
(conventional MRI or DTI parameter) explained most of the variance in the different gait 
characteristics. Here, we also investigated the MD of the total white matter as it captures 
all abnormalities of the white matter in one parameter.
Thirdly, we established which set of MRI parameters explained most of the variance in 
gait, by adding these parameters in an automated stepwise fashion to optimize the model 
fi t (with introduction of age and sex prior to MRI parameters). To unravel which part of the 
variance in gait was explained by the microstructural integrity of the WMLs and which part 
by that of the NAWM, we introduced both the MD of the WMLs and NAWM and not the MD 
of the total white matter.
Fourthly, we assessed in a multiple regression model the increase of variance explained 
in gait with DTI over conventional MRI by adding the MD of the WMLs in the model that 
already contained all SVD-related changes seen with conventional MRI (grey and white 
matter and WML volume, number of microbleeds, lacunar infarcts and territorial infarcts). 
The same was done for the MD of the NAWM. 
Collinearity diagnostic procedures (tolerance statistic) in each model did not reveal 
collinearity between the MRI parameters to such an extent that it could possibly affect the 
regression model.
We furthermore studied whether results changed when we excluded persons with 
territorial infarcts. Because these did not differ markedly, we present the results for the 
whole group.
Results
Characteristics
Table 1 shows the characteristics of the study population (n=483). Mean age was 65.6 
years (SD 8.8) and 43.3% were women. In all patients, the largest part of the white matter 
consisted of NAWM with a median percentage of 98.5% (interquartile range 96.0-99.2). 
Table 2 represents the correlations between the distinct MRI parameters. Most MRI 
parameters were signifi cantly correlated to each other, apart from some correlations with 
territorial infarcts and microbleeds. The mean MD of the NAWM and total white matter, 
which were almost equal to each other, were most strongly and positively correlated with 
WML volume (and the MD of the WMLs) and age. 
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Value of each MRI parameter separately in the assessment of gait
Although almost all MRI parameters separately were signifi cantly associated with the four 
gait characteristics after adjustment for age and sex (Table 3), the mean MD of the total 
white matter explained the most variance, mainly due to the MD of the NAWM. Additional 
to age and sex, it counted for another 2-5% of the variance in the different gait character-
istics, resulting in 38% for stride length, 26% for velocity, 19% for stride width and 14% for 
Conventional MRI versus DTI
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Table 1 Characteristics of the study population
Characteristics n=483
Demographic and clinical characteristics
Age, yrs 65.6 (8.8)
Female, no. 209 (43.3)
Body Mass Index, kg/m2 27.1 (4.0)
Subjects with hypertension, no. 357 (73.9)
Subjects with diabetes mellitus, no. 72 (14.9)
Subjects with hypercholesterolemia, no. 228 (47.2)
Smokers, current, no. 72 (14.9)
Smokers, former, no. 265 (54.9)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Neuroimaging characteristics
Grey matter volume, ml 629.1 (67.5)
White matter volume, ml 464.4 (66.5)
WML volume, ml† 7.1 (3.4; 18.0)
NAWM volume, ml 450.3 (70.4)
Subjects with microbleed(s), no. 52 (10.8)
Subjects with lacunar infarct(s), no. 165 (34.2)
Subjects with territorial infarct(s), no. 55 (11.4)
Mean MD in WMLs, ml 1.00 (0.07)
Mean MD in NAWM, x10-3 mm2/s 0.89 (0.04)
Mean MD in total white matter, x10-3 mm2/s 0.89 (0.05)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 111.5 (10.8)
Stride width, cm 11.0 (3.1)
Data are number of subjects (%), means (standard deviation) or †medians (interquartile range).
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cadence. However, when we compared these results to the variance explained by WML 
volume or number of lacunar infarcts, we found that the MD of the total WM accounted for 
signifi cantly, but only slightly more variance in gait than these conventional MRI 
parameters. 
Value of a combination of MRI parameters in the assessment of gait
We furthermore determined which set of MRI (both conventional as well as DTI) parameters 
best described the variance in gait (Table 4). The total explained variance of all MRI 
parameters together (with age and sex accounting for the fi rst 12-35%) ranged from 3-7%. 
The MD of the NAWM accounted for the largest percentage of variation in gait velocity, 
stride width and cadence, followed by one or more of the following conventional 
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Table 4 Value of a combination of MRI parameters in the assessment of gait
Step in 
model
MRI parameters
(independent variables 
remaining in model)
Total explained 
variance (%)
Standardized 
beta-value
P-value
Gait velocity (m/s)
1 Age and sex 22.0
2 NAWM, mean MD 25.6 -0.25 <0.001
3 Grey matter volume 27.0 0.15 0.003
4 Lacunar infarcts, no. 28.1 -0.12 0.008
Stride length (m)
1 Age and sex 35.2
2 Lacunar infarcts, no. 38.3 -0.18 <0.001
3 White matter volume 39.8 0.15 0.001
4 WML volume 40.8 -0.13 0.004
5 Grey matter volume 41.4 0.11 0.03
6 Microbleeds, no. 41.9 -0.08 0.03
Cadence (steps/min)
1 Age and sex 12.2
2 NAWM, mean MD 14.8 -0.21 <0.001
Stride width (cm)
1 Age and sex 14.5
2 NAWM, mean MD 18.4 0.26 <0.001
3 WML volume 19.3 0.12 0.03
4 White matter volume 20.0 -0.11 0.05
Age and sex were introduced in the model prior to MRI parameters. MRI parameters were then added in 
a stepwise fashion. Total explained variance and standardized beta-value describe the values till that step 
as variables are progressively added to the model. 
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parameters: grey matter, white matter or WML volume and number of lacunar infarcts. For 
stride length, these conventional MRI parameters together and the number of microbleeds 
explained all 7% of the variance. 
 
Value of DTI of NAWM over conventional MRI parameters in the assessment 
of gait
Table 5 shows the results of the added value of the mean MD of the WMLs or NAWM in 
terms of explained variance in the different gait characteristics. In this model, age and sex 
explained 12-35% of the variation in gait and the conventional MRI parameters accounted 
Conventional MRI versus DTI
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Table 5  Value of DTI of WMLs or NAWM over conventional MRI parameters in the 
assessment of gait
Step in 
model
MRI parameter Total explained 
variance (%)
Standardized 
beta-value
P-value
Gait velocity (m/s)
1 Age and sex 22.0
2 Conventional MRI parameters 29.1
3 WML, mean MD 29.1 -0.03 0.62
3 NAWM, mean MD 29.4 -0.09 0.19
Stride length (m)
1 Age and sex 35.2
2 Conventional MRI parameters 42.2
3 WML, mean MD 42.2 -0.02 0.64
3 NAWM, mean MD 42.2 -0.03 0.59
Cadence (steps/min)
1 Age and sex 12.2
2 Conventional MRI parameters 15.4
3 WML, mean MD 15.5 -0.06 0.37
3 NAWM, mean MD 16.2 -0.15 0.03
Stride width (cm)
1 Age and sex 14.5
2 Conventional MRI parameters 20.1
3 WML, mean MD 21.0 0.14 0.03
3 NAWM, mean MD 20.7 0.12 0.07
Age and sex were introduced in the model prior to conventional MRI parameters. Conventional MRI 
parameters were then added and subsequently mean MD of the WMLs ór NAWM. Total explained 
variance and standardized beta-value describe the values till that step as variables are progressively 
added to the model.
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for another 3-7%. Although the MD of the WMLs and the MD of the NAWM caused a 
signifi cant increase in the explained variance in stride width and cadence respectively, 
this was only 1%.
Discussion
Our study showed that, in subjects with SVD, all MRI parameters (conventional and DTI) 
together explained 3-7% of the variance in the different gait characteristics (stride 
length>velocity>stride width>cadence) (upon the 12-35% explained by age and sex). 
When all MRI parameters were considered separately, the mean MD of the total white 
matter had the strongest association with gait, which was mainly due to the microstruc-
tural integrity of the NAWM. WML volume, the number of lacunar infarcts and brain volume 
also exerted an independent, but less strong inﬂ uence on gait. However, when the value 
of DTI on top of conventional MRI was studied, the mean MD of the WMLs and NAWM did 
not (substantially) contribute to the assessment of gait to that already explained by 
conventional MRI parameters. 
Strengths of our study include the large sample size of subjects, the high response rate 
and the recruitment of subjects in a single research center. In addition, we performed 
multimodal MRI, on a single scanner, with quantitative assessment of most parameters 
(WMLs, grey and white matter volume and gait). Our study also has potential limitations, 
which need to be considered. Firstly, our data are cross-sectional, limiting conclusions 
regarding causality. However, the RUN DMC study has a longitudinal design and follow-up 
is currently being executed.117 Secondly, although the collinearity between the MRI 
parameters were not to such an extent that it could bias the regression models, Pearson’s 
correlations showed that there was at least some multicollinearity between predictors. 
This makes it diffi cult to assess the individual importance of a predictor. Thirdly, our 
participants have a relatively high mobility and most of them have a very mild to moderate 
WML load. As the integrity of the NAWM in most patients will therefore be relatively high, 
this probably has limited the statistical power to detect an additional value of MD of the 
NAWM to that of the conventional MRI parameters. However, as all our participants were 
independently functioning individuals, we feel that our study population reﬂ ects commu-
nity-dwelling people with SVD, indicating a reasonable to high external validity of our 
study.  
All MRI parameters together were able to explain only up to 3-7% of the variance in gait. 
There may be several explanations for this observation apart from the relatively healthy 
study population. As the etiology of gait impairment in elderly people is multifactorial, 
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including for example disturbances in the peripheral nervous system and the skeletal 
system, the relative contribution of each factor in the variance of gait is only small. We 
examined furthermore the comfortable gait speed instead of the maximum speed, which 
has been shown to have a larger interindividual variation and greater decline with 
increased decade of age than the former.193 Finally, age and sex accounted for the fi rst 
12-35% of the explained variance. As the severity of SVD increases with age, we are not 
able to unravel which part of this percentage is in fact due to SVD.
Our fi ndings furthermore showed that the mean MD of the total white matter, among all 
MRI parameters, was the strongest predictor of variance in overall gait, although the WML 
volume or number of lacunar infarcts accounted for an almost equal amount of variance. 
This is in line with two other cross-sectional studies among subjects with WMLs, that 
addressed the association with cognitive function, another symptom of SVD.21,22 However, 
these results contrast with a study among patients with cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), showing 
brain atrophy to be strongest related to cognitive impairment and disability.194 Other large 
studies among subjects with sporadic SVD are therefore needed to replicate our fi ndings.
This fi nding could be of clinical interest as it suggest that the MD of the total white matter 
may be a surrogate endpoint in clinical trials on SVD. There is increasing interest in one 
surrogate marker for motor and cognitive disturbances to evaluate therapeutic effects 
earlier and more readily than by clinical observation alone. Although the mean MD of the 
total white matter explained only 1-2% more in gait than WML volume, it could well be of 
more value due to its superior sensitivity to changes over time as found in longitudinal 
studies among patients with SVD and CADASIL.21,195 Further studies evaluating the effect 
of changes in WML volume and DTI measures in the white matter on gait are therefore 
needed.
The strong association between the mean MD of the total white matter and gait was 
mainly due to damage to the NAWM. However, when we investigated the added value of 
the mean MD of the NAWM additional to conventional MRI, it accounted for very little extra 
variance in gait. An explanation for this fi nding may be the high correlation between WML 
volume and the mean MD of the NAWM we found, which is in line with other studies.162 
This suggests that WML volume as seen on conventional MRI can be considered an 
indirect marker of the NAWM integrity. From a pathophysiological point of view, this may 
indicate that damage to the NAWM does not occur entirely independent of WMLs, but 
may be rather a consequence of the same pathogenic mechanism that is related to WMLs 
(e.g. SVD) or occurs secondarily to these WMLs (e.g. by Wallerian degeneration). Although 
this damage to the NAWM could be important in the development of gait disturbances, 
DTI (with the protocol and analysis used in this study) does not seem to be necessary in 
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daily clinical practice to estimate the overall damage within the white matter in a patient 
with SVD in order to assess its contribution to a found gait disturbance. Our study 
suggests that the WML volume and number of lacunar infarcts in combination with the 
extent of brain atrophy, assessed on a conventional MRI sequence (e.g. FLAIR), is 
probably suffi cient to assess to what extent SVD contributes to the gait disturbances in 
clinical practice. 
In conclusion, DTI parameters do not seem to be of added value to conventional MRI 
parameters in explaining the variance of gait in individual subjects with SVD in everyday 
clinical practice. Nevertheless, DTI of the entire white matter accounts for (slightly) more 
variance in gait than total WML volume or the number of lacunar infarcts. Future studies 
are needed to investigate whether DTI parameters of the total white matter (or conventional 
MRI markers, such as WML volume) could serve as surrogate outcome measure in future 
therapeutic trials in patients with SVD. Future studies should be longitudinal to demonstrate 
the sensitivity of changes over time in DTI parameters in comparison to conventional MRI 
parameters and their association with gait (as well as cognition).
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Motor performance in individuals with cerebral small 
vessel disease: an MRI study 
Cerebral small vessel disease (SVD) is a very common disease among older adults and 
is visible on MRI as white matter lesions (WMLs), lacunar infarcts and/or microbleeds. 
Subjects with SVD may have acute symptoms such as transient ischemic attacks and 
lacunar syndromes, and/or subacute symptoms. These subacute symptoms not only 
include cognitive, but probably also motor disturbances, which are often a neglected, but 
nevertheless important problem as they are associated with increased morbidity and 
mortality. There is not much known on the role of WMLs, their severity and location and 
the surrounding white matter on motor performance.
In this thesis we describe the associations between MRI abnormalities in SVD and motor 
performance.
Association between cerebral small vessel disease and motor performance: 
a conventional MRI approach
In chapter 2 we report on the associations between WMLs, lacunar infarcts, microbleeds, 
cortical thickness and gait disturbances and the impact of their location. We furthermore 
studied the relationship between WMLs, lacunar infarcts and their location and mild 
parkinsonians signs (MPS). WMLs were characterized by volume and location [frontal, 
parietal, occipital, temporal lobes, sublobar (basal ganglia, thalamus, internal and 
external capsula, insula) and limbic areas (cingulate gyrus)]. The number of microbleeds 
and lacunar infarcts in the whole brain and in the abovementioned locations were rated 
and cortical thickness was calculated in each Brodmann area using a surface-based 
cortical thickness analysis. Gait was assessed with the GAITRite system and the Tinetti 
and Timed-Up-and-Go test. The presence of MPS was based on the motor section of the 
Unifi ed Parkinson’s Disease Rating Scale. 
All subjects had some degree of WMLs. Lacunar infarct(s) were present in ±31% and 
microbleeds in ±11%. Of all the participants, ±12% had a gait velocity <1 m/s and ±21% 
had MPS. We found that WML volume, number of lacunar infarcts, number of microbleeds 
and cortical thickness were related to gait. Subjects with a higher load of one of these MRI 
markers of SVD had a lower gait velocity, especially due to a shorter stride length, than 
those with a lower load. Cadence (step frequency), was only associated with lacunar 
infarcts and cortical thickness. Subjects with severe WMLs or ≥1 lacunar infarct(s) had a 
higher risk of the presence of MPS than those without. We furthermore found a threshold-
effect of WMLs; especially those with a WML volume >20 ml had a signifi cantly higher risk 
of gait disturbances and MPS than those with a lower WML load. 
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The most important locations with regard to gait performance for WMLs were the frontal 
lobe, limbic and sublobar areas; for lacunar infarcts the frontal lobe, thalamus, and 
brainstem; and for microbleeds the frontal, temporal lobe and basal ganglia, including the 
thalamus. WMLs in the frontal and parietal lobe and lacunar infarcts in the thalamus 
seemed to be most associated with the presence of MPS. 
Association between cerebral small vessel disease and motor performance: 
a diffusion tensor imaging approach
In chapter 3 we describe the associations between the microstructural integrity, assessed 
with diffusion tensor imaging (DTI), within the WMLs and the normal-appearing white 
matter (NAWM) and gait, using two different ways of analyzing DTI data: calculation of the 
mean fractional anisotropy (FA) and mean diffusivity (MD) in WMLs and NAWM and 
various other regions-of-interest and Tract-Based Spatial Statistics (TBSS), a method 
restricted to the white matter voxels that constitute the skeleton of the brain’s connectional 
architecture. The fi rst method was also used in relation to the presence of MPS.
We found that the mean MD and FA of the WMLs was associated with respectively gait 
disturbances and the presence of MPS. We furthermore showed that the mean FA and 
MD of the NAWM in subjects was related to their motor performance. Although the 
strength of these associations diminished after additional adjustment for the coexisting 
WML volume and number of lacunar infarcts, associations with some gait parameters 
(e.g. cadence, stride width) remained signifi cant. Moreover, TBSS revealed that tracts 
with the strongest associations with gait performance were situated in the NAWM. 
In both methods, loss of white matter integrity of numerous regions was related to gait 
disturbances. Using TBSS, we were able to investigate the strongest spatially localizing 
associations in the corpus callosum, predominantly in the genu, containing fi bers to the 
prefrontal lobe. Our fi nding in chapter 3.3 also pointed to the frontal lobe to play an 
important role in the presence of MPS.
Conventional MRI versus diffusion tensor imaging
Because our studies in chapter 3 suggested that damage to the NAWM is an important 
factor in the development of gait disturbances in SVD, we investigated in chapter 4 the 
additional variance in gait explained by DTI measures of the NAWM to that of conventional 
MRI abnormalities in SVD. We found that this accounted for very little additional explained 
variance in gait in addition to the coexisting conventional MRI markers of SVD (e.g. WMLs 
and lacunar infarcts). 
We furthermore examined whether the mean MD of the whole white matter was a stronger 
predictor of variance in gait performance than one of the conventional MRI markers of 
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SVD. The mean MD of the white matter was the main contributor to the explanation of 
variance of all gait parameters, although the explained variance due to this parameter 
was only ±1% more than that of WML volume. Of note, the total explained variance of all 
cerebral MRI markers, apart from age and sex (which explained 22% of the variance in 
gait velocity), was ±7%.
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The overall aim of the studies described in this thesis was to provide a better understanding 
of the cerebral substrate underlying gait disturbances and (other) parkinsonian signs in 
individuals with cerebral small vessel disease (SVD). The studies were conducted as part 
of the RUN DMC study, a prospective cohort study on the determinants and cognitive, 
motor and mood consequences of functional and structural brain changes among 503 
individuals with cerebral SVD, aged between 50 and 85 years. None of the participants 
suffered from dementia or parkinsonism during baseline assessment in 2006. All subjects 
underwent comprehensive MRI scanning of the brain. We also obtained detailed clinical 
and quantitative information on motor performance, including gait disturbances, 
bradykinesia, rigidity and tremor.
Here we provide a general discussion of the most important methodological considerations 
and main fi ndings of the studies in this thesis. Finally, some clinical implications and 
 recommendations for future research are given.
Methodological considerations
Study design
The observational studies presented in this thesis are based on cross-sectional data. 
Although cross-sectional data are limited in their interpretation regarding causality, they 
are useful in generating hypotheses. Because of the longitudinal design of the RUN DMC 
study (with repeated MRI scans at baseline and at fi ve-year follow-up in 2011), we will be 
able to investigate changes over time with respect to imaging parameters, gait and the 
development of parkinsonism.
Internal validity
The internal validity of a study is dependent on the degree of systematic error, including 
the measurement of the determinant, outcome and the associations between these 
variables. Most systematic errors can be classifi ed into three general categories: selection 
bias, information bias and confounding.
Selection bias occurs if the relationship between a determinant (severity of SVD) and an 
outcome (motor performance) differs between those included in the study and those 
potentially eligible for the study, but do not participate. In the RUN DMC study, the 
response rate was high (71.3%). Non-participants, compared to participants, were older 
and the percentage with severe white matter lesions (WMLs) (according to a semi- 
quantitative rating scale; the Age-Related White Matter Changes scale172) was higher. 
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We obviously could not collect data on their motor performance, but it is likely that this is 
affected by the older age. We therefore most likely missed the extremes of both the SVD 
and motor performance distribution and therefore feel that it did not greatly inﬂ uence the 
magnitude of the found associations. 
Information bias may be introduced as a result of measurement error in the assessment 
of the determinant (severity of SVD) or outcome (motor performance), which can lead to 
misclassifi cation in those variables. An error in the assessment of the determinant is 
called differential if it is dependent on outcome status, and non-differential otherwise. 
Whether errors are differential or non-differential may have implications for the direction 
of the bias that may result. Differential measurement errors give rise to an under- or 
overestimation of the strength of the association, while non-differential errors usually 
tends to bias the results towards the null.
In an attempt to minimize differential measurement errors of the determinant (severity of 
SVD), all imaging analyses were performed by raters blinded to clinical information. Some 
measurement error (an underestimation) may have occurred in the assessment of the 
severity of SVD, particularly in the number of microbleeds, due to the choice of MRI 
techniques used in this study. Recent studies have shown that the use of longer echo 
times, a higher resolution (in particular the use of thinner scanning sections), an increased 
magnetic fi eld strength to 3 Tesla and post-processing techniques such as susceptibility-
weigthed imaging improve the detection of microbleeds.36 However, it is not clear whether 
this increased detection is linearly present across the whole range of microbleeds (most 
likely leading to non-differential measurement error), or if this predominantly plays a role 
in those with multiple microbleeds (which probably would have resulted in differential 
measurement error). 
Measurements of the outcome (motor performance) were assessed before MRI scanning 
and therefore independent of knowledge about the determinant, minimizing any observer 
bias. Therefore the assessment of the outcome could only suffer from random error. This 
error can have implications for precision but not for validity.
Finally, we have to consider potential confounding variables. When we describe an 
association between a determinant (MRI marker of SVD) and the outcome variable (motor 
performance), a third variable correlating with both the determinant and the outcome may 
(partially) account for an observed association. The most important confounders in the 
relationship between MRI markers of SVD and motor performance are age, and potentially 
gender and other neuroimaging characteristics. Because of our large study sample size 
we were able to adjust for these variables. An interesting  issue is the adjustment for other 
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MRI markers of SVD, in particular WMLs, for example in the association between the 
integrity of the normal-appearing white matter (NAWM) and motor performance. Additional 
adjustment for WML volume weakened the association between the integrity of the NAWM 
and motor performance. When we performed a stratifi ed analysis to evaluate the potential 
confounding effect of the WML volume, we found only in the group with severe WMLs a 
signifi cant association between the integrity of the NAWM and gait. However, the question 
remains whether WML volume is a true confounder in this case or an antecedent and 
therefore a factor in the causal relationship of these two variables or both, as discussed 
below. We therefore presented these analyses in two models: with and without adjustment 
for WML volume.
Precision
Precision of a study is determined by the degree of absence of random error.
We tried to enhance the precision in our study in several ways. Firstly, our study has a 
large sample size (n=503). Secondly, we attempted to minimize any random error in the 
assessment of the determinants (severity of MRI-defi ned SVD). They were collected from 
a single scanner and research center, without adjustments in hard- or software during the 
study period. Moreover, most of the determinants (WML volume, cortical thickness, DTI 
measures of the white matter) were assessed quantitatively. In addition, two investigators 
independently assessed 10% of all scans for WML volume, number of lacunar infarcts 
and microbleeds with a high inter-rater variability. Thirdly, to guarantee the precision of the 
outcome variables (motor performance), we assessed gait not only semi-quantitatively, 
but also quantitatively using the GAITRite, which has a strong test-retest reliability, also in 
elderly people.71,177 Moreover, we repeated the test two or three times.  The presence of 
mild parkinsonian signs (MPS) was assessed with the motor section of the Unifi ed 
Parkinson’s Disease Rating scale. Because this test has a subjective nature, all subjects 
were rated by two experienced residents in neurology with a high inter-rater agreement.
External validity
External validity involves the extent to which the results of a study can be generalized 
beyond the sample. The RUN DMC study benefi ts from a large group of subjects with 
SVD with a broad age range. Consecutive patients referred to the Department of 
Neurology and who underwent neuroimaging, were selected for potential participation. 
This enabled us to include individuals with some degree of SVD, defi ned by neuroimaging. 
We selected subjects primarily based on generally accepted neuroimaging criteria for 
SVD,12 and subsequently asked them for symptoms of SVD. Although all subjects were 
seen in a university hospital, we feel that they represent a group of patients with SVD 
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referred to a general hospital as most of them were seen as a fi rst opinion. We therefore 
think that our results may be generalized to other subjects with SVD referred to a general 
Department of Neurology. Moreover, we think that our results can also be generalized to 
community-dwelling people with SVD. In the general population a minimal degree of 
WMLs is found in >90% of individuals over 60 years of age1 and is associated with some 
degree of cognitive dysfunction,50 mostly in otherwise independently living people. 
Because we excluded patients with dementia or parkinsonism, our participants had a 
high Mini Mental State Examination and a fast walking speed, representing independently 
functioning people. In addition, the prevalence of risk factors of SVD was very similar to 
those of other cohorts of community-dwelling older adults with WMLs of similar age.24 We 
therefore feel that our results can not only be generalized to patients with SVD in a hospital, 
but also to community-dwelling people with SVD, indicating a reasonable to high external 
validity of our study.
General discussion of the main findings
Association between cerebral SVD and motor performance: a conventional 
MRI approach 
The association between WML volume and gait performance or MPS is in accordance 
with previous studies.23-26,109 We also showed that the frequent co-occurring lacunar 
infarcts are also related to motor performance, independent of the WML volume, which 
was relatively understudied before. Furthermore, we were the fi rst to report that 
microbleeds may also be associated with gait performance, independent of coexisting 
WMLs and lacunar infarcts.
Interestingly, we found that cortical thickness was also related to gait. This association 
weakened, but did not disappear after adjustment for subcortical WMLs and lacunar 
infarcts. This suggests that cortical atrophy may be another aspect of SVD found on MRI. 
Cortical thinning in subjects with SVD can arise from (a combination of) several mechanisms, 
many of which remain to be elucidated. It could be that cortical thinning is partially due to 
the subcortical WMLs and lacunar infarcts through antero- or retrograde neuronal 
degeneration of fi bers traversing these lesions, which is also seen in pathological studies 
among patients with multiple sclerosis.183,184 Another possibility is direct ischemic damage 
to the cortex, such as microinfarcts, as was also found in pathological studies among 
patients with SVD.7,8 Finally, the association between cortical thickness and gait was not 
entirely explained by subcortical cerebrovascular pathology. This may suggest that also 
other processes (e.g. degenerative), which often co-occur with SVD,49 may play a role. 
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Association between cerebral small vessel disease and motor performance: 
a DTI approach
We found that the WML volume and the MD of the NAWM were highly correlated to each 
other, which is in line with other studies in which larger WML volumes were related to a 
higher MD and lower FA in the NAWM.162 This suggests that WML volume, as seen on 
conventional MRI, represents an indirect marker of the NAWM integrity. This could 
therefore clarify the weak association between the microstructural integrity of the NAWM 
and motor performance when controlling for coexisting WMLs and lacunar infarcts. From 
a pathophysiological perspective, this suggest that damage to the NAWM in SVD does 
not occur entirely independent of WMLs, but is rather a consequence of the same 
pathogenic SVD-related mechanisms as in WMLs (i.e. an effect of the same vascular risk 
factors) or occurs secondarily to these WMLs (e.g. by secondary neuronal degeneration). 
Although the independent association between the microstructural integrity of the NAWM 
and motor performance is weak, loss of microstructural integrity of this part of the white 
matter does play an important role in the presence of motor disturbances in SVD. In 
chapter 4.2 we highlighted the importance of damage to the microstructural integrity of 
the corpus callosum, usually without WMLs on conventional MRI, in motor disturbances. 
In conclusion, all our fi ndings suggest that SVD is a widespread disease throughout the 
whole brain, also in the NAWM. Although DTI does not add a lot to conventional MRI from 
a clinical perspective,  DTI is a promising tool in investigating the pathophysiological 
processes underlying motor disturbances in SVD. 
Location of lesions
The exact cerebral networks impaired in gait and other motor disturbances due to SVD have 
not been identifi ed yet. One hypothesis states that gait disturbances and (other) parkinsonian 
signs are due to interruption of the basal ganglia-thalamo-frontal cortical circuits leading to 
a reduction in the thalamocortical drive and subsequently to motor disturbances.62,148 
However, concrete evidence is lacking. Our fi ndings support this hypothesis, but also 
showed that the networks involved may be more widespread, as lesions in the parietal and 
temporal lobe and the limbic area were also associated with motor disturbances. These 
areas receive or integrate multisensory information (e.g. vestibular, somatosensory and 
visual information). Interestingly, all these regions showed (de)activations during walking in 
functional MRI and positron-emission-tomography studies.13 
Of all locations of lesions found to be involved in motor disturbances,  the frontal lobe was 
the most consistent one in all our studies, especially (disruption of fi bers to) the prefrontal 
lobe. That part of the frontal lobe is proposed to play a role in the cognitive control of 
motor performance, as it receives information from virtually all sensory systems and has 
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preferential connections with the motor processing structures.145 We therefore conclude 
that motor disturbances (especially gait impairment) could be the result of disruption of 
multiple fi bers in the white matter at locations directly or indirectly involved in the cognitive 
control of motor performance. From this perspective, we can understand that patients 
with SVD not only have cognitive disturbances due to disruption of white matter tracts, as 
found in other studies50,161 and also ours,196 but also have motor disturbances. 
Of note, at this stage we cannot prove a causal relationship between disruption of these 
areas and motor disturbances, because our results are based on cross-sectional data. 
Moreover, SVD, especially in moderate to severe stages, is diffusively distributed 
throughout the white matter. Hence, lesions in one region may be related to those in other 
regions. This prevents us from drawing strong conclusions about the importance of 
lesions at a specifi c location in relation to motor performance, independent of other 
affected white matter regions.
Gait parameters
In this thesis work, we also performed a quantitative gait assessment, the GAITRite. This 
allowed us to study several specifi c gait parameters in more detail. Not all gait parameters 
were equally affected by SVD. In contrast to other studies, we measured the two main 
determinants of gait velocity; stride length and cadence. We found that subjects with SVD 
walked slower, especially due to smaller steps. Stride length declined signifi cantly more 
with increasing severity of SVD than velocity decreased, indicating an initial compensatory 
change in cadence in patients with SVD. These results suggest that measuring stride 
length instead of velocity could lead to an earlier detection of gait abnormalities in SVD. 
The associations found in our studies between SVD (WML, lacunar infarcts,  microstructural 
integrity) and stride length variability and stride time variability were weaker than with the 
abovementioned  parameters. As our study population is a relatively mild affected, it 
could be that gait deterioration in subjects with SVD fi rst affects stride length (and 
therefore gait velocity) and variability of gait not until SVD progresses.
Explained variance by cerebral small vessel disease
We found that cerebral SVD accounted for only a small part of the variance in gait. There 
may be several explanations for this observation. Firstly, proper gait is the result of multiple 
intact functioning systems as discussed in the introduction: central nervous system at the 
cerebral and spinal level, but also the peripheral nervous system with the organs of sense, 
and the muscle and skeletal system. Therefore, the etiology of gait disturbances in older 
adults is multifactorial with cerebral SVD accounting for only a part of the motor 
disturbances. Secondly, as our participants were all relatively healthy with a relatively high 
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mobility, it is not surprisingly that cerebral SVD contributed for ±7% of motor performance. 
Thirdly, all subjects were asked to walk at a self-selected comfortable gait speed instead 
of walking at maximum speed, because of the high test-retest reliability in preferred gait 
speed71 and comparison with other large studies.24,26 The gait speed that a patient selects 
is furthermore a well-known indicator of overall gait performance,197 and is commonly 
used to monitor performance and evaluate the effects of treatment. However, it has been 
shown that the interindividual variation in maximum gait speed is larger than that in 
comfortable gait speed, with a greater decline in maximum gait speed compared with 
comfortable gait speed with increased decade of age.193 It therefore seems conceivable 
that analysis while walking at challenging fast walking speed may be more sensitive to 
identify a decline in gait velocity due to cerebral SVD. As a consequence, the variance in 
fast gait speed explained by cerebral SVD may be higher than the 7% obtained at 
preferred speed. Fourthly, we adjusted for potential confounders such as age and sex, 
which accounted for the fi rst 35% of the explained variance in stride length and 22% in 
gait speed. As the severity of SVD increases with age, we are not able to unravel  which 
part of this 35% is in fact due to SVD. 
Clinical relevance
Our results may be of use in clinical practice during the diagnostic process in a patient 
with SVD. They may help in estimating the clinical impact of SVD found on MRI in an older 
adult referred for gait/motor problems to for example a neurologist or geriatrician. On an 
individual level it is often diffi cult for a clinician to separate whether the vascular changes 
found on MRI are the sole cause for the patient’s motor symptoms, whether they add to 
another disease process, of if they are even unrelated to the clinical symptomatology. 
Although conventional MRI sequences are insuffi ciently sensitive and specifi c to detect 
all the tissue changes related to SVD,  our results show that the two conventional T1- and 
T2-weighted sequences will be suffi cient in the clinical setting. An additional DTI sequence 
is not necessary. If the patient has roughly >2 lacunar infarcts or a volume of WMLs >20 
ml (Figure 1) (comparable with a score of ≥2 in the frontal or parieto-occipital areas on the 
Age-Related White Matter Changes scale172), it seems plausible that the gait impairment 
or presence of (mild) parkinsonian signs observed can be attributed to the SVD (after 
exclusion of other causes). The location of these lesions is of less importance, because 
lesions at almost all locations, except for the occipital lobe, were found to be associated 
with motor performance.
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Recommendations for future research
Future studies are needed to test the hypotheses generated in this thesis.
Firstly, as the observed associations between microbleeds, cortical thickness or the mi-
crostructural integrity of the white matter and gait/MPS have not or only sporadically been 
reported previously, our results need to be replicated in other cross-sectional studies.
Secondly, future studies are warranted to investigate the neural pathways disrupted in 
motor disturbances, particularly in parkinsonian signs, in more detail, using voxel-based 
methods, such as Tract-Based Spatial Statistics, instead of rather large regions-of interest 
such as the whole frontal lobe. Other ways to study these networks are motor imagery of 
walking in combination with functional MRI or resting state functional MRI. It would also 
be interesting to include the infratentorial regions in these analyses, such as the 
mesencephalic motor regions.
Thirdly, as our studies were all cross-sectional, which prevents us from making causal 
inference, longitudinal studies with serial neuroimaging assessments of all the MRI 
markers of SVD are of major importance. If a change in the severity of a MRI marker of 
SVD can be related to a change in motor performance, it would greatly enhance evidence 
for a causal relationship. This would also be interesting regarding the role of the location 
of the lesions: whether they play a causal role or are only related to other lesions at other 
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important locations. The RUN DMC study has a longitudinal design and follow-up with 
both neuroimaging and motor assessment is already planned in 2011.
Fourthly, a major question to be answered is whether and which proportion of subjects 
with SVD will eventually progress to more extensive SVD with (vascular) parkinsonism. It 
is unclear whether MPS and parkinsonism represent categories within a single continuum 
versus truly distinct events with separate pathophysiologies. As our results could imply a 
vascular contribution to MPS, we suggest that MPS could be, to some extent, a prodromal 
stage of full-blown (vascular) parkinsonism. The follow-up of the RUN DMC study may 
clarify this issue. 
If the transition from MPS to parkinsonism coincides with increasing severity of for 
example WMLs, this would further encourage studies on modifi able risk factors for the 
development and progression of SVD. Blood pressure for example is recognized as a 
major risk factor for WMLs, but evidence for the benefi t of antihypertensive therapy on 
WML progression is still scarce.198 Ultimately, future studies should unravel whether 
adequate treatment of vascular risk factors in subjects with SVD may reduce the course 
of MRI lesions of SVD, and subsequently reduce the number  of patients with impaired 
gait or parkinsonism.
Finally, our study and other studies suggest that MRI markers of SVD (WML volume or the 
mean MD of the white matter) could serve as a surrogate marker for (cognitive and) motor 
disturbances in future therapeutic trials. However, a requirement for a surrogate marker in 
SVD is the correlation with motor performance (and cognition) over time. Future studies 
are needed evaluating the effect of changes in WML volume and DTI markers in the white 
matter on motor performance, and which parameter shows the most rapid decrease or 
increase over time.
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Chapter 5.2
Box 1 Final conclusions and recommendations
Final conclusions
• Cerebral SVD affects motor performance, with stride length being most affected.
• WMLs and lacunar infarcts are related to gait disturbances and (other) parkinsonian signs. 
Microbleeds also play a role, but to a lesser extent.
• Gait is not only explained by subcortical SVD, but also by cortical atrophy. 
• The microstructural integrity of the WMLs themselves is related to motor performance.
• The microstructural integrity of the normal-appearing white matter on conventional MRI is also 
affected, especially in patients with moderate or severe WMLs, and is related to motor 
disturbances. 
• Motor disturbances in patients with cerebral SVD seem to be the result of damage to widespread 
networks involved in motor control: the basal ganglia-thalamo-frontal cortical circuits, as well as 
networks located in the limbic area, parietal and temporal lobe and corpus callosum.
• DTI is a promising tool from a pathophysiological point of view (i.e. in investigating the underlying 
mechanisms of motor impairment in patients with SVD), but not yet from a clinical perspective. 
Recommendations for clinical practice
MRI sequences needed to assess SVD:
• a T1-weighted and FLAIR sequence for the assessment of WML volume and number of 
lacunar infarcts
• a gradient-echo T2*-weighted or DTI sequence for clinical purpose is not helpful
When to consider cerebral SVD as a cause of motor impairment:
• a WML volume >20 ml (i.e. an Age-Related White Matter Changes scale of ≥2 in the frontal 
regions and/or in the parieto-occipital regions)
• and/or a number of lacunar infarcts >2-3
• location of the lesions is not important
Recommendations for future research 
• Investigate the disconnection and compensation of networks, including those in the 
infratentorial regions, in motor disturbances in SVD in more detail using techniques such 
as Tract-Based Spatial Statistics or (resting state) functional MRI.
• Perform a  longitudinal study to assess causality between SVD-related MRI lesions and 
motor performance.
• Investigate whether a DTI parameter could be a surrogate marker for motor (and cognitive) 
decline in longitudinal studies.
• When a relationship between (progression of) SVD and the transition from mild 
parkinsonian signs to parkinsonism has been established, intervention studies with 
modification of risk factors of SVD are warranted.
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Motorisch functioneren bij personen met cerebrale 
microangiopathie: een MRI studie
Cerebrale microangiopathie en motorische beperkingen
Cerebrale microangiopathie, dat wil zeggen schade aan de kleine vaten in de hersenen, 
wordt in het Engels ook wel 'cerebral small vessel disease' genoemd. De gevolgen van 
deze beschadigde kleine bloedvaten zijn zichtbaar op MRI-scans als  wittestofafwijkingen, 
lacunaire (kleine) infarcten en microbloedingen. Deze beschadigingen komen veel voor 
bij ouderen: meer dan 90% heeft ze in meer of mindere mate. Door de toenemende 
vergrijzing kan dit tot steeds meer gezondheidsproblemen leiden. Door die bloedvatbe-
schadigingen kunnen namelijk stoornissen in de doorbloeding van de hersenen ontstaan, 
wat kan leiden tot acute uitvalsverschijnselen (zoals bijvoorbeeld een verlamming aan 
één zijde van het lichaam, of problemen met het spreken). Als de uitval binnen 24 uur is 
hersteld, spreekt men van een zogenaamde 'transient ischemic attack' (TIA). Als de 
klachten langer blijven bestaan, is er sprake van een herseninfarct. Daarnaast kunnen 
patiënten met cerebrale microangiopathie ook subacute klachten krijgen, wat zich dan uit 
in problemen met de cognitie en/of motoriek. Men denkt dat deze aandoening de 
wittestofbanen beschadigt en daardoor de verbindingen tussen belangrijke hersen-
gebieden verbreekt. Door die onderbrekingen zouden vervolgens bijvoorbeeld problemen 
met de motoriek, zoals loopstoornissen en andere parkinson istische verschijnselen 
(bradykinesie, rigiditeit, tremor en balansstoornissen) kunnen optreden. Tot nu toe is dit 
echter onvoldoende onderzocht. 
Niet iedere persoon met wittestofafwijkingen heeft echter (in dezelfde mate) problemen 
met de motoriek. Hiervoor kunnen meerdere oorzaken zijn. Allereerst zou de ernst van de 
wittestofafwijkingen, het aantal lacunaire infarcten, het aantal  microbloedingen en de plek in 
de hersenen waar deze afwijkingen gelegen zijn, een rol kunnen spelen. Daarnaast zou 
de atrofi e (het dunner worden) van de cortex (hersenschors), wat veelal ook optreedt bij 
deze personen, een belangrijke factor kunnen zijn. Bovendien zijn niet alle wittestof-
afwijkingen hetzelfde. Alhoewel ze er op een scan allemaal hetzelfde uitzien, kan de 
 microstructurele integriteit ervan (de intactheid van de wittestofbanen) heel verschillend 
zijn. Het zou kunnen dat juist die personen, waarbij de onderliggende microstructurele 
integriteit ter plaatse van de wittestofafwijkingen daadwerkelijk afgenomen is, stoornissen 
in hun motoriek hebben. Ook de microstructurele integriteit van de witte stof die er 
normaal uitziet op conventionele MRI kan beschadigd zijn en zou daarmee kunnen 
bijdragen aan de aanwezigheid van loopstoornissen of andere parkinsonistische 
verschijnselen. Deze microstructurele integriteit van de witte stof kan met een nieuwe MRI 
techniek, “diffusion tensor imaging (DTI)” onderzocht worden. Tenslotte zou ook hierbij de 
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locatie van de beschadigingen in de microstructurele integriteit van belang kunnen zijn in 
het al dan niet ontstaan van beperkingen in de motoriek.
Daarom hebben we in dit proefschrift bij personen met cerebrale microangiopathie de 
relatie tussen bovengenoemde MRI-kenmerken en het motorisch functioneren 
onderzocht. Daarnaast hebben we gekeken naar de aanvullende waarde van DTI ten 
opzichte van conventionele MRI in deze relatie. De studies zijn gebaseerd op de “Radboud 
University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort” (RUN 
DMC) studie; een prospectieve cohort studie bij 503 mensen die verwezen zijn naar de 
afdeling neurologie, tussen de 50 en 85 jaar oud, met tekenen van cerebrale microangio-
pathie. Bij het eerste dwarsdoorsnede-onderzoek in 2006, waar dit proefschrift op 
gebaseerd is, had niemand dementie of parkinsonisme. Bij alle deelnemers werd een 
MRI gemaakt en werd het lopen in kaart gebracht door middel van onder andere de 
GAITRite, en de aanwezigheid van milde parkinsonistische verschijnselen door middel 
van de Unifi ed Parkinson’s Disease Rating Scale. De studiemethode staat verder uitgelegd 
in hoofdstuk 1.
Een conventionele MRI benadering
In hoofdstuk 2 onderzochten we de relaties tussen enerzijds het volume van  witte stof- 
 afwijkingen, het aantal lacunaire infarcten, het aantal microbloedingen en de cortexdikte 
en anderzijds het lopen. Ook het belang van de locatie van deze afwijkingen werd 
bestudeerd. Daarnaast bestudeerden we de relaties tussen het volume van wittestof-
afwijkingen, het aantal lacunaire infarcten, hun locatie en de aanwezigheid van milde 
parkinsonistische verschijnselen. 
We vonden dat het volume van wittestofafwijkingen, het aantal lacunaire infarcten, het 
aantal microbloedingen en de cortexdikte gerelateerd waren aan het lopen, ook 
onafhankelijk van elkaar. De aanwezigheid van ernstige wittestofafwijkingen of lacunaire 
infarcten was ook gerelateerd aan de aanwezigheid van milde parkinsonistische 
verschijnselen. Personen met uitgebreidere afwijkingen liepen langzamer dan degenen 
met weinig afwijkingen, met name door een kortere staplengte. Deze stoornissen traden 
vooral op bij personen die veel wittestofafwijkingen (>20 ml) en/of meerdere lacunaire 
infarcten hadden. De wittestofafwijkingen die geassocieerd waren met een slechtere 
motoriek waren gelokaliseerd in de frontaal- en parietaalkwab, het limbische systeem en 
het sublobaire gebied (basale ganglia, capsula interna en externa); de lacunaire infarcten 
in de frontaalkwab, thalamus en hersenstam; de microbloedingen in de frontaal- en 
temporaalkwab en de basale ganglia, waaronder de thalamus; en een dunnere cortex in 
meerdere gebieden, waaronder de prefrontale cortex, de parietaalkwab, het limbische 
systeem en de visuele associatiegebieden.
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Hieruit kunnen we concluderen dat bij personen met cerebrale microangiopathie de mate 
van het motorisch functioneren bepaald wordt door de ernst van de wittestofafwijkingen 
en het aantal lacunaire infarcten en microbloedingen. Bovendien lijken de  loopstoornissen 
niet alleen een gevolg te zijn van beschadigingen in de witte stof, maar ook die van de 
grijze stof (cortex). Tenslotte hebben we aangetoond dat niet alleen afwijkingen in de 
frontaalkwab en thalamus, zoals aangetoond in eerdere studies, maar ook in de gebieden 
daarbuiten geassocieerd zijn met problemen van de motoriek, wat suggereert dat het 
netwerk dat betrokken is bij de motoriek zeer uitgebreid is.
Relatie tussen “small vessel disease” en motorisch functioneren: 
Een “diffusion tensor imaging” benadering
In hoofdstuk 3 beschrijven we de relaties tussen enerzijds de microstructurele integriteit, 
gemeten met DTI, van de wittestofafwijkingen zelf en de normaal ogende witte stof en 
anderzijds het lopen, danwel de aanwezigheid van milde parkinsonistische verschijnselen. 
Allereerst hebben we in een tweetal studies onderzocht of de microstructurele integriteit 
van de wittestofafwijkingen zelf correleerde met verschillende loopparameters en de 
aanwezigheid van milde parkinsonistische verschijnselen. Hetzelfde hebben we 
onderzocht voor de normaal ogende witte stof, die veruit het grootste deel van de witte 
stof vormde bij alle deelnemers. 
We vonden dat de integriteit van zowel de wittestofafwijkingen zelf als de normaal ogende 
witte stof inderdaad gerelateerd was aan het motorisch functioneren. Deze relaties 
werden echter minder sterk of verdwenen zelfs na corrigeren voor de aanwezige wittestof-
afwijkingen en lacunaire infarcten. In een andere studie hebben we de DTI-gegevens met 
een nieuwere methode, de zogenaamde “Tract-Based Spatial Statistics”, geanalyseerd 
om specifi eker naar het belang van de lokatie van deze beschadigingen te kijken. Hierbij 
viel op dat met name beschadigingen van de normaal ogende witte stof, en met name het 
genu van het corpus callosum, sterk gerelateerd waren aan de loopstoornissen. Het genu 
bevat de banen die de prefrontale kwabben met elkaar verbinden en van belang zijn voor 
de cognitieve controle op de motoriek.
Uit deze DTI-studies kunnen we dus concluderen dat de onderliggende microstructurele 
integriteit van de wittestofafwijkingen en van de normaal ogende witte stof samenhangt 
met de mate van motorisch functioneren. Dat de relaties in de normaal ogende witte stof 
verzwakten of soms zelfs verdwenen na extra corrigeren voor het volume van wittestof-
afwijkingen en het aantal lacunaire infarcten, kan worden verklaard door de sterke 
samen hang tussen het volume van wittestofafwijkingen en de microstructurele integriteit 
van de normaal ogende witte stof: hoe meer wittestofafwijkingen, hoe ernstiger de 
normaal ogende stof beschadigd was. Dit suggereert dat schade in de normaal ogende 
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witte stof niet geheel onafhankelijk optreedt van de hoeveelheid wittestofafwijkingen, 
maar min of meer tegelijkertijd als een gevolg van dezelfde risicofactoren (bijvoorbeeld 
hypertensie) of secundair aan deze wittestofafwijkingen (bijvoorbeeld door secundaire 
neuronale degeneratie).
Conventionele MRI in vergelijking met DTI
In onze eerdere studies zagen we dat DTI een duidelijk toegevoegde waarde heeft vanuit 
pathofysiologisch oogpunt. In hoofdstuk 4 onderzochten we of het maken van een 
DTI-scan naast de conventionele MRI-scans ook nuttig is om als clinicus beter in te 
kunnen schatten in hoeverre de loopstoornis van de patiënt gerelateerd is aan eventuele 
vaatbeschadigingen in de hersenen. Uit onze eerdere studies bleek namelijk dat de 
beschadiging van de nog normaal ogende witte stof, die in beeld gebracht kan worden 
door middel van DTI, gerelateerd is aan loopstoornissen. Het bleek dat de hoeveelheid 
variantie in lopen die verklaard werd door de microstructurele integriteit van de normaal 
ogende witte stof nauwelijks bijdroeg aan dat wat verklaard werd door de  MRI-afwijkingen 
op conventionele MRI-scans (wittestofafwijkingen, lacunaire infarcten, microbloedingen 
en atrofi e). 
Daarnaast wilden we weten of het maken van een DTI-scan wetenschappelijk van 
aanvullende waarde kan zijn bij bijvoorbeeld trials bij personen met cerebrale microan-
giopathie. Daarvoor hebben we gekeken of de gemiddelde diffusiviteit, een parameter 
van de microstructurele integriteit, van de gehele witte stof een betere voorspeller zou zijn 
voor het lopen dan de afwijkingen die op conventionele MRI-scans te zien zijn bij SVD. 
Hoewel deze gemiddelde diffusiviteit van de witte stof meer verklaarde dan elk van de 
andere MRI-afwijkingen apart, was dit maar iets meer dan bijvoorbeeld het volume van 
wittestofafwijkingen. Bovendien werd slechts zon 6% van de variantie in de loopsnelheid, 
bovenop een model met leeftijd en geslacht (wat 22% verklaard), verklaard door het 
volume van wittestofafwijkingen, aantal lacunaire infarcten en microbloedingen en atrofi e 
van zowel witte als grijze stof bij elkaar.
Hieruit kunnen we concluderen dat, hoewel DTI vanuit pathofysiologisch oogpunt van 
belang is bij de verheldering van cerebrale microangiopathie en de daaraan gerelateerde 
motorische beperkingen, het klinisch niet van toegevoegde waarde is. Conventionele 
MRI-scans lijken in de klinische praktijk voldoende om goed in te schatten of de 
loopstoornis die een patiënt heeft, gerelateerd kan worden aan deze aandoening of niet. 
Zoals we in een van onze studies onderzocht hebben, is dit vanaf ongeveer 20 ml witte-
stofafwijkingen, wat overeenkomt met een Age-Related White Matter Changes  schaal 
van 2 of meer op een conventionele MRI-scan. Een DTI-scan is hierbij niet nodig om de 
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schade in de normaal ogende witte stof vast te stellen. Of een DTI-parameter wel een 
goede marker kan zijn voor het ontwikkelen van parkinsonisme of dat het gebruikt kan 
worden als surrogaatmarker van bijvoorbeeld loopstoornissen in trials bij personen met 
cerebrale microangiopathie, zal in verdere longitudinale studies onderzocht moeten 
worden.
Nederlandse samenvatting
5
A
Appendices
List of abbreviations
References
Acknowledgements | Dankwoord
Curriculum vitae
List of publications
Dissertations of the Radboud Stroke Center Nijmegen
Dissertations of the Parkinson Center Nijmegen
Donders Graduate School for Cognitive Neuroscience Series
A
Appendices
List of abbreviations
References
Acknowledgements | Dankwoord
Curriculum vitae
List of publications
Dissertations of the Radboud Stroke Center Nijmegen
Dissertations of the Parkinson Center Nijmegen
Donders Graduate School for Cognitive Neuroscience Series

195
List of abbreviations
BA = Brodmann area
CADASIL =  cerebral autosomal dominant arteriopathy ortical infarcts 
and leukoencephalopthy 
CI = confidence interval
CV = coefficients of variation
DTI = diffusion tensor imaging
FA = fractional anisotropy
FLAIR = fluid-attenuated inversion recovery
FMRIB = functional MRI of the brain
FWE = family-wise error 
MD = mean diffusivity
MPS = mild parkinsonian signs
MRI = magnetic resonance imaging
NAWM = normal-appearing white matter
OR = odds ratio
ROIs = regions-of-interest
RUN DMC =  Radboud University Nijmegen Diffusion tensor 
and Magnetic resonance imaging Cohort
SD = standard deviation
SPM = Statistical Parametric Mapping
SVD = small vessel disease
TIA = transient ischemic attack
TBSS = Tract-Based-Spatial-Statistics
TE = echo time
TI = inversion time
TR = repetition time
TUG = Timed-Up-and-Go test
UPDRS = Unified Parkinson’s Disease Rating Scale
WMLs = white matter lesions
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